Publication Results

Generate Report

Add publications by marking their checkboxes, or

Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers.

Russo S,  Walker JL,  Carlson JW,  Carter J,  Ward LC,  Covens A,  Tanner EJ 3rd,  Armer JM,  Ridner S,  Hayes S,  Taghian AG,  Brunelle C,  Lopez-Acevedo M,  Davidson BA,  Schaverien MV,  Ghamande SA,  Bernas M,  Cheville AL,  Yost KJ,  Schmitz K,  Coyle B,  Zucker J,  Enserro D,  Pugh S,  Paskett ED,  Ford L,  McCaskill-Stevens W
Gynecol Oncol 2020 Nov 4
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials ;  Office of the Director ;  NCI Community Oncology Research Program
PubMed ID: 33158510
PMC ID: not available

A Transcriptome-Wide Association Study Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer.

Zhong J,  Jermusyk A,  Wu L,  Hoskins JW,  Collins I,  Mocci E,  Zhang M,  Song L,  Chung CC,  Zhang T,  Xiao W,  Albanes D,  Andreotti G,  Arslan AA,  Babic A,  Bamlet WR,  Beane-Freeman L,  Berndt S,  Borgida A,  Bracci PM,  Brais L,  Brennan P,  Bueno-de-Mesquita B,  Buring J,  Canzian F,  Childs EJ,  Cotterchio M,  Du M,  Duell EJ,  Fuchs C,  Gallinger S,  Gaziano JM,  Giles GG,  Giovannucci E,  Goggins M,  Goodman GE,  Goodman PJ,  Haiman C,  Hartge P,  Hasan M,  Helzlsouer KJ,  Holly EA,  Klein EA,  Kogevinas M,  Kurtz RJ,  LeMarchand L,  Malats N,  Männistö S,  Milne R,  Neale RE,  Ng K,  Obazee O,  Oberg AL,  Orlow I,  Patel AV,  Peters U,  Porta M,  Rothman N,  Scelo G,  Sesso HD,  Severi G,  Sieri S,  Silverman D,  Sund M,  Tjønneland A,  Thornquist MD,  Tobias GS,  Trichopoulou A,  Van Den Eeden SK,  Visvanathan K,  Wactawski-Wende J,  Wentzensen N,  White E,  Yu H,  Yuan C,  Zeleniuch-Jacquotte A,  Hoover R,  Brown K,  Kooperberg C,  Risch HA,  Jacobs EJ,  Li D,  Yu K,  Shu XO,  Chanock SJ,  Wolpin BM,  Stolzenberg-Solomon RZ,  Chatterjee N,  Klein AP,  Smith JP,  Kraft P,  Shi J,  Petersen GM,  Zheng W,  Amundadottir LT
J Natl Cancer Inst 2020 Oct 1;112(10):1003-1012
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialNCI Community Oncology Research Program
PubMed ID: 31917448
PMC ID: PMC7566474

The Patient-Provider Relationship: Predictors of black/African American Cancer Patients' Perceived Quality of Care and Health Outcomes.

Asare M,  Fakhoury C,  Thompson N,  Culakova E,  Kleckner AS,  Adunlin G,  Reifenstein K,  Benavidez GA,  Kamen CS
Health Commun 2020 Sep;35(10):1289-1294
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31167572
PMC ID: PMC6893107 [available on September 01, 2021]

Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424.

Fisher BJ,  Pugh SL,  Macdonald DR,  Chakravatri A,  Lesser GJ,  Fox S,  Rogers CL,  Werner-Wasik M,  Doyle T,  Bahary JP,  Fiveash JB,  Bovi JA,  Howard SP,  Michael Yu HH,  D'Souza D,  Laack NN,  Barani IJ,  Kwok Y,  Wahl DR,  Strasser JF,  Won M,  Mehta MP
Int J Radiat Oncol Biol Phys 2020 Jul 15;107(4):720-725
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 32251755
PMC ID: PMC7456814 [available on July 15, 2021]

Patterns of Failure Observed in the 2-Step Institution Credentialing Process for NRG Oncology/Radiation Therapy Oncology Group 1005 (NCT01349322) and Lessons Learned.

Li XA,  Moughan J,  White JR,  Freedman GM,  Arthur DW,  Galvin J,  Xiao Y,  McNulty S,  Lyons JA,  Kavadi VS,  Fields MT,  Mitchell MP,  Anderson BM,  Lock MI,  Kokeny KE,  Bazan JG,  Currey AD,  Hijal T,  Cheston SB,  Vicini FA
Pract Radiat Oncol 2020 Jul-Aug;10(4):265-273
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31790823
PMC ID: PMC7255922 [available on July 01, 2021]

Utility of topical agents for radiation dermatitis and pain: a randomized clinical trial.

Ryan Wolf J,  Gewandter JS,  Bautista J,  Heckler CE,  Strasser J,  Dyk P,  Anderson T,  Gross H,  Speer T,  Dolohanty L,  Bylund K,  Pentland AP,  Morrow GR
Support Care Cancer 2020 Jul;28(7):3303-3311
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31758326
PMC ID: PMC7242117

NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma.

Lee EQ,  Zhang P,  Wen PY,  Gerstner ER,  Reardon DA,  Aldape KD,  deGroot JF,  Pan E,  Raizer JJ,  Kim LJ,  Chmura SJ,  Robins HI,  Connelly JM,  Battiste JD,  Villano JL,  Wagle N,  Merrell RT,  Wendland MM,  Mehta MP
Cancer 2020 Jun 15;126(12):2821-2828
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 32154928
PMC ID: PMC7245544 [available on June 15, 2021]

Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx.

Wagner LI,  Gray RJ,  Sparano JA,  Whelan TJ,  Garcia SF,  Yanez B,  Tevaarwerk AJ,  Carlos RC,  Albain KS,  Olson JA Jr,  Goetz MP,  Pritchard KI,  Hayes DF,  Geyer CE,  Dees EC,  McCaskill-Stevens WJ,  Minasian LM,  Sledge GW Jr,  Cella D
J Clin Oncol 2020 Jun 10;38(17):1875-1886
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsNCI Community Oncology Research Program ;  Office of the Director
PubMed ID: 32271671
PMC ID: PMC7280048 [available on June 10, 2021]

Querying Patients With Cancer About Sexual Health and Sexual and Gender Minority Status: A Qualitative Study of Health-Care Providers.

Cathcart-Rake E,  O'Connor JM,  Ridgeway JL,  Breitkopf CR,  Guire LJM,  Olson EA,  Kaur JS,  Leventakos K,  Jatoi A
Am J Hosp Palliat Care 2020 Jun;37(6):418-423
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31601116
PMC ID: PMC7145741

Chemotherapy-induced peripheral neuropathy (CIPN) and its treatment: an NIH Collaboratory study of claims data.

Gewandter JS,  Kleckner AS,  Marshall JH,  Brown JS,  Curtis LH,  Bautista J,  Dworkin RH,  Kleckner IR,  Kolb N,  Mohile SG,  Mustian KM
Support Care Cancer 2020 Jun;28(6):2553-2562
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31494735
PMC ID: PMC7060096 [available on June 01, 2021]

Healthcare utilization and cost of care in elderly breast cancer patients enrolled in SWOG clinical trials.

Hershman DL,  Till C,  Wright JD,  Accordino M,  Vaidya R,  Barlow WE,  Ramsey S,  Unger JM
Breast Cancer Res Treat 2020 Jun;181(2):455-463
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 32306168
PMC ID: not available

Vitamin D Pathway and Other Related Polymorphisms and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial.

Torkko K,  Till C,  Tangen CM,  Goodman PJ,  Song X,  Schenk JM,  Lucia MS,  Peters U,  van Bokhoven A,  Thompson IM,  Neuhouser ML
Cancer Prev Res (Phila) 2020 Jun;13(6):521-530
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 32102946
PMC ID: PMC7272271 [available on December 01, 2020]

Improvement in Patient-Reported Outcomes With Intensity-Modulated Radiotherapy (RT) Compared With Standard RT: A Report From the NRG Oncology RTOG 1203 Study.

Yeung AR,  Pugh SL,  Klopp AH,  Gil KM,  Wenzel L,  Westin SN,  Gaffney DK,  Small W Jr,  Thompson S,  Doncals DE,  Cantuaria GHC,  Yaremko BP,  Chang A,  Kundapur V,  Mohan DS,  Haas ML,  Kim YB,  Ferguson CL,  Deshmukh S,  Bruner DW,  Kachnic LA
J Clin Oncol 2020 May 20;38(15):1685-1692
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 32073955
PMC ID: PMC7238486 [available on May 20, 2021]

How (and why) to ask the older cancer patient about sexual health and sexual minority status.

Cathcart-Rake E,  O'Connor JM,  Jacobson A,  McGuire L,  Jatoi A
J Geriatr Oncol 2020 May;11(4):576-578
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31447290
PMC ID: PMC7035152 [available on May 01, 2021]

Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil, and Leucovorin Versus Oxaliplatin, 5-Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG-ACRIN Research Group (E5204).

Chakravarthy AB,  Zhao F,  Meropol NJ,  Flynn PJ,  Wagner LI,  Sloan J,  Diasio RB,  Mitchell EP,  Catalano P,  Giantonio BJ,  Catalano RB,  Haller DG,  Awan RA,  Mulcahy MF,  O'Brien TE,  Santala R,  Cripps C,  Weis JR,  Atkins JN,  Leichman CG,  Petrelli NJ,  Sinicrope FA,  Brierley JD,  Tepper JE,  O'Dwyer PJ,  Sigurdson ER,  Hamilton SR,  Cella D,  Benson AB 3rd
Oncologist 2020 May;25(5):e798-e807
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31852811
PMC ID: PMC7216434

Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study.

Chase D,  Huang HQ,  Monk BJ,  Ramondetta LM,  Penson RT,  Gil K,  Landrum LM,  Leitao M,  Oaknin A,  Huh WK,  Pulaski HL,  Robison K,  Guntupalli SR,  Richardson D,  Salani R,  Sill MW,  Wenzel LB,  Tewari KS
Int J Gynecol Cancer 2020 May;30(5):596-601
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 32114513
PMC ID: not available

A randomized phase II trial evaluating two non-pharmacologic interventions in cancer survivors for the treatment of sleep-wake disturbances: NCCTG N07C4 (Alliance).

Barton DL,  Atherton PJ,  Satele DV,  Qin R,  Dakhil S,  Pipe T,  Hobday T,  Fee-Schroeder K,  Loprinzi CL
Support Care Cancer 2020 Apr 19
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 32307658
PMC ID: PMC7572569 [available on October 19, 2021]

Neurological safety of oxaliplatin in patients with uncommon variants in Charcot-Marie-tooth disease genes.

Le-Rademacher JG,  Lopez CL,  Kanwar R,  Major-Elechi B,  Abyzov A,  Banck MS,  Therneau TM,  Sloan JA,  Loprinzi CL,  Beutler AS
J Neurol Sci 2020 Apr 15;411:116687
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 32018185
PMC ID: PMC7096263

Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.

Brown PD,  Gondi V,  Pugh S,  Tome WA,  Wefel JS,  Armstrong TS,  Bovi JA,  Robinson C,  Konski A,  Khuntia D,  Grosshans D,  Benzinger TLS,  Bruner D,  Gilbert MR,  Roberge D,  Kundapur V,  Devisetty K,  Shah S,  Usuki K,  Anderson BM,  Stea B,  Yoon H,  Li J,  Laack NN,  Kruser TJ,  Chmura SJ,  Shi W,  Deshmukh S,  Mehta MP,  Kachnic LA,  for NRG Oncology
J Clin Oncol 2020 Apr 1;38(10):1019-1029
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 32058845
PMC ID: PMC7106984 [available on April 01, 2021]

Racial/Ethnic Differences in Comprehension of Biospecimen Collection: a Nationwide University of Rochester Cancer Center NCI Community Oncology Research Program Study.

Asare M,  Heckler CE,  Culakova E,  Kamen CS,  Kleckner AS,  Minasian LM,  Wendler DS,  Feige M,  Weil CJ,  Long J,  Cole SK,  Onitilo AA,  Peppone LJ,  Morrow GR,  Janelsins MC
J Cancer Educ 2020 Apr;35(2):292-300
Major Program(s) or Research Group(s): NCI Community Oncology Research Program ;  Office of the Director
PubMed ID: 30612315
PMC ID: PMC6612536

Psychometric development of a new body image scale for breast cancer survivors.

Biederman E,  Cohee A,  Monahan P,  Stump T,  Champion V
Health Care Women Int 2020 Apr;41(4):397-411
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31237491
PMC ID: PMC6930352 [available on April 01, 2021]

Associations of inflammation with frailty in patients with breast cancer aged 50 and over receiving chemotherapy.

Gilmore N,  Kadambi S,  Lei L,  Loh KP,  Mohamed M,  Magnuson A,  Cole S,  Esparaz BT,  Giguere JK,  Mohile S,  Janelsins M
J Geriatr Oncol 2020 Apr;11(3):423-430
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30992181
PMC ID: PMC6790284

More opioids, more constipation? Evaluation of longitudinal total oral opioid consumption and self-reported constipation in patients with cancer.

Roeland EJ,  Sera CJ,  Ma JD
Support Care Cancer 2020 Apr;28(4):1793-1797
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31332514
PMC ID: not available

Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218.

Alvarez Secord A,  Bell Burdett K,  Owzar K,  Tritchler D,  Sibley AB,  Liu Y,  Starr MD,  Brady JC,  Lankes HA,  Hurwitz HI,  Mannel RS,  Tewari KS,  O'Malley DM,  Gray H,  Bakkum-Gamez JN,  Fujiwara K,  Boente M,  Deng W,  Burger RA,  Birrer MJ,  Nixon AB
Clin Cancer Res 2020 Mar 15;26(6):1288-1296
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31919136
PMC ID: PMC7073274

Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221).

Ambrosone CB,  Zirpoli GR,  Hutson AD,  McCann WE,  McCann SE,  Barlow WE,  Kelly KM,  Cannioto R,  Sucheston-Campbell LE,  Hershman DL,  Unger JM,  Moore HCF,  Stewart JA,  Isaacs C,  Hobday TJ,  Salim M,  Hortobagyi GN,  Gralow JR,  Budd GT,  Albain KS
J Clin Oncol 2020 Mar 10;38(8):804-814
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31855498
PMC ID: PMC7062457 [available on March 10, 2021]

A cohort study of quality of life in partners of young breast cancer survivors compared to partners of healthy controls.

Cohee A,  Storey S,  Winger JG,  Cella D,  Stump T,  Monahan PO,  Champion VL
J Patient Rep Outcomes 2020 Mar 6;4(1):19
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 32144626
PMC ID: PMC7060298

Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer.

Bradley JD,  Hu C,  Komaki RR,  Masters GA,  Blumenschein GR,  Schild SE,  Bogart JA,  Forster KM,  Magliocco AM,  Kavadi VS,  Narayan S,  Iyengar P,  Robinson CG,  Wynn RB,  Koprowski CD,  Olson MR,  Meng J,  Paulus R,  Curran WJ Jr,  Choy H
J Clin Oncol 2020 Mar 1;38(7):706-714
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31841363
PMC ID: PMC7048161 [available on March 01, 2021]

Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question-Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head: A Phase II Randomized Clinical Trial.

Abrams RA,  Winter KA,  Safran H,  Goodman KA,  Regine WF,  Berger AC,  Gillin MT,  Philip PA,  Lowy AM,  Wu A,  DiPetrillo TA,  Corn BW,  Seaward SA,  Haddock MG,  Song S,  Jiang Y,  Fisher BJ,  Katz AW,  Mehta S,  Willett CG,  Crane CH
Am J Clin Oncol 2020 Mar;43(3):173-179
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31985516
PMC ID: PMC7280743 [available on March 01, 2021]

Longitudinal assessment of the impact of higher body mass index on cancer-related fatigue in patients with breast cancer receiving chemotherapy.

Inglis JE,  Janelsins MC,  Culakova E,  Mustian KM,  Lin PJ,  Kleckner IR,  Peppone LJ
Support Care Cancer 2020 Mar;28(3):1411-1418
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31267279
PMC ID: PMC7243469

Marital Status and Overall Survival in Patients with Resectable Pancreatic Cancer: Results of an Ancillary Analysis of NRG Oncology/RTOG 9704.

Reyngold M,  Winter KA,  Regine WF,  Abrams RA,  Safran H,  Hoffman JP,  Mowat RB,  Hayes JP,  Kessel IL,  DiPetrillo T,  Narayan S,  Chen Y,  Ben-Josef E,  Delouya G,  Suh JH,  Meyer J,  Haddock MG,  Feldman M,  Gaur R,  Yost K,  Peterson RA,  Sherr DL,  Moughan J,  Crane CH
Oncologist 2020 Mar;25(3):e477-e483
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 32162826
PMC ID: PMC7066692

Enrollment of adolescents and young adults onto SWOG cancer research network clinical trials: A comparative analysis by treatment site and era.

Roth ME,  Unger JM,  O'Mara AM,  Lewis MA,  Budd T,  Johnson RH,  Pollock BH,  Blanke C,  Freyer DR
Cancer Med 2020 Mar;9(6):2146-2152
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 32009305
PMC ID: PMC7064039

Geriatric oncology health services research: Cancer and Aging Research Group infrastructure core.

Wong ML,  Lichtman SM,  Morrow GR,  Simmons J,  Hargraves T,  Gross CP,  Lund JL,  Lowenstein LM,  Walter LC,  McDermott CL,  Mohile SG,  Cohen HJ
J Geriatr Oncol 2020 Mar;11(2):350-354
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31326392
PMC ID: PMC6980419 [available on January 17, 2021]

Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening.

Comstock CE,  Gatsonis C,  Newstead GM,  Snyder BS,  Gareen IF,  Bergin JT,  Rahbar H,  Sung JS,  Jacobs C,  Harvey JA,  Nicholson MH,  Ward RC,  Holt J,  Prather A,  Miller KD,  Schnall MD,  Kuhl CK
JAMA 2020 Feb 25;323(8):746-756
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 32096852
PMC ID: PMC7276668

NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2.

Fehrenbacher L,  Cecchini RS,  Geyer CE Jr,  Rastogi P,  Costantino JP,  Atkins JN,  Crown JP,  Polikoff J,  Boileau JF,  Provencher L,  Stokoe C,  Moore TD,  Robidoux A,  Flynn PJ,  Borges VF,  Albain KS,  Swain SM,  Paik S,  Mamounas EP,  Wolmark N
J Clin Oncol 2020 Feb 10;38(5):444-453
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31821109
PMC ID: PMC7007289 [available on February 10, 2021]

Meta-analysis of 16 studies of the association of alcohol with colorectal cancer.

McNabb S,  Harrison TA,  Albanes D,  Berndt SI,  Brenner H,  Caan BJ,  Campbell PT,  Cao Y,  Chang-Claude J,  Chan A,  Chen Z,  English DR,  Giles GG,  Giovannucci EL,  Goodman PJ,  Hayes RB,  Hoffmeister M,  Jacobs EJ,  Joshi AD,  Larsson SC,  Le Marchand L,  Li L,  Lin Y,  Männistö S,  Milne RL,  Nan H,  Newton CC,  Ogino S,  Parfrey PS,  Petersen PS,  Potter JD,  Schoen RE,  Slattery ML,  Su YR,  Tangen CM,  Tucker TC,  Weinstein SJ,  White E,  Wolk A,  Woods MO,  Phipps AI,  Peters U
Int J Cancer 2020 Feb 1;146(3):861-873
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialNCI Community Oncology Research Program
PubMed ID: 31037736
PMC ID: PMC6819207 [available on February 01, 2021]

Communication With Older Patients With Cancer Using Geriatric Assessment: A Cluster-Randomized Clinical Trial From the National Cancer Institute Community Oncology Research Program.

Mohile SG,  Epstein RM,  Hurria A,  Heckler CE,  Canin B,  Culakova E,  Duberstein P,  Gilmore N,  Xu H,  Plumb S,  Wells M,  Lowenstein LM,  Flannery MA,  Janelsins M,  Magnuson A,  Loh KP,  Kleckner AS,  Mustian KM,  Hopkins JO,  Liu JJ,  Geer J,  Gorawara-Bhat R,  Morrow GR,  Dale W
JAMA Oncol 2020 Feb 1;6(2):196-204
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31697365
PMC ID: PMC6865234

Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3).

Trifiletti DM,  Ballman KV,  Brown PD,  Anderson SK,  Carrero XW,  Cerhan JH,  Whitton AC,  Greenspoon J,  Parney IF,  Laack NN,  Ashman JB,  Bahary JP,  Hadjipanayis CG,  Urbanic JJ,  Barker FG 2nd,  Farace E,  Khuntia D,  Giannini C,  Buckner JC,  Galanis E,  Roberge D
Int J Radiat Oncol Biol Phys 2020 Feb 1;106(2):255-260
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31654784
PMC ID: PMC6957747 [available on February 01, 2021]

GOG 244-The lymphedema and gynecologic cancer (LEG) study: Incidence and risk factors in newly diagnosed patients.

Carlson JW,  Kauderer J,  Hutson A,  Carter J,  Armer J,  Lockwood S,  Nolte S,  Stewart BR,  Wenzel L,  Walker J,  Fleury A,  Bonebrake A,  Soper J,  Mathews C,  Zivanovic O,  Richards WE,  Tan A,  Alberts DS,  Barakat RR
Gynecol Oncol 2020 Feb;156(2):467-474
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31837831
PMC ID: PMC7018616 [available on February 01, 2021]

Complications and Survivorship Trends After Primary Debulking Surgery for Ovarian Cancer.

Xu Z,  Becerra AZ,  Justiniano CF,  Aquina CT,  Fleming FJ,  Boscoe FP,  Schymura MJ,  Sinno AK,  Chaoul J,  Morrow GR,  Minasian L,  Temkin SM
J Surg Res 2020 Feb;246:34-41
Major Program(s) or Research Group(s): NCI Community Oncology Research Program ;  Office of the Director
PubMed ID: 31561176
PMC ID: PMC6917987 [available on February 01, 2021]

A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry.

Du Z,  Weinhold N,  Song GC,  Rand KA,  Van Den Berg DJ,  Hwang AE,  Sheng X,  Hom V,  Ailawadhi S,  Nooka AK,  Singhal S,  Pawlish K,  Peters ES,  Bock C,  Mohrbacher A,  Stram A,  Berndt SI,  Blot WJ,  Casey G,  Stevens VL,  Kittles R,  Goodman PJ,  Diver WR,  Hennis A,  Nemesure B,  Klein EA,  Rybicki BA,  Stanford JL,  Witte JS,  Signorello L,  John EM,  Bernstein L,  Stroup AM,  Stephens OW,  Zangari M,  Van Rhee F,  Olshan A,  Zheng W,  Hu JJ,  Ziegler R,  Nyante SJ,  Ingles SA,  Press MF,  Carpten JD,  Chanock SJ,  Mehta J,  Colditz GA,  Wolf J,  Martin TG,  Tomasson M,  Fiala MA,  Terebelo H,  Janakiraman N,  Kolonel L,  Anderson KC,  Le Marchand L,  Auclair D,  Chiu BC,  Ziv E,  Stram D,  Vij R,  Bernal-Mizrachi L,  Morgan GJ,  Zonder JA,  Huff CA,  Lonial S,  Orlowski RZ,  Conti DV,  Haiman CA,  Cozen W
Blood Adv 2020 Jan 14;4(1):181-190
Major Program(s) or Research Group(s): Cancer Prevention Fellowship ProgramNCI Community Oncology Research Program
PubMed ID: 31935283
PMC ID: PMC6960456

Effect of a Behavioral Intervention to Increase Vegetable Consumption on Cancer Progression Among Men With Early-Stage Prostate Cancer: The MEAL Randomized Clinical Trial.

Parsons JK,  Zahrieh D,  Mohler JL,  Paskett E,  Hansel DE,  Kibel AS,  Liu H,  Seisler DK,  Natarajan L,  White M,  Hahn O,  Taylor J,  Hartman SJ,  Stroup SP,  Van Veldhuizen P,  Hall L,  Small EJ,  Morris MJ,  Pierce JP,  Marshall J
JAMA 2020 Jan 14;323(2):140-148
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31935026
PMC ID: PMC6990696

A pooled analysis of the cardiac events in the trastuzumab adjuvant trials.

de Azambuja E,  Ponde N,  Procter M,  Rastogi P,  Cecchini RS,  Lambertini M,  Ballman K,  Aspitia AM,  Zardavas D,  Roca L,  Gelber RD,  Piccart-Gebhart M,  Suter T
Breast Cancer Res Treat 2020 Jan;179(1):161-171
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31605311
PMC ID: PMC6989393 [available on January 01, 2021]

Intellectual Equipoise and Challenges: Accruing Patients With Advanced Cancer to a Trial Randomizing to Surgical or Nonsurgical Management (SWOG S1316).

Deutsch GB,  Deneve JL,  Al-Kasspooles MF,  Nfonsam VN,  Gunderson CC,  Secord AA,  Rodgers P,  Hendren S,  Silberfein EJ,  Grant M,  Sloan J,  Sun V,  Arnold KB,  Anderson GL,  Krouse RS
Am J Hosp Palliat Care 2020 Jan;37(1):12-18
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31122027
PMC ID: PMC6868288 [available on January 01, 2021]

Attitudes of Clinicians about Screening Head and Neck Cancer Survivors for Lung Cancer Using Low-Dose Computed Tomography.

Dukes K,  Seaman AT,  Hoffman RM,  Christensen AJ,  Kendell N,  Sussman AL,  Vélez-Bermúdez M,  Volk RJ,  Pagedar NA
Ann Otol Rhinol Laryngol 2020 Jan;129(1):23-31
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31409114
PMC ID: PMC6945809

Geriatric assessment among older adults receiving intensive therapy for acute myeloid leukemia: Report of CALGB 361006 (Alliance).

Klepin HD,  Ritchie E,  Major-Elechi B,  Le-Rademacher J,  Seisler D,  Storrick L,  Sanford BL,  Marcucci G,  Zhao W,  Geyer SA,  Ballman KV,  Powell BL,  Baer MR,  Stock W,  Cohen HJ,  Stone RM,  Larson RA,  Uy GL
J Geriatr Oncol 2020 Jan;11(1):107-113
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31668825
PMC ID: PMC6943189 [available on January 01, 2021]

Prospective follow-up of quality of life for participants undergoing risk-reducing salpingo-oophorectomy or ovarian cancer screening in GOG-0199: An NRG Oncology/GOG study.

Mai PL,  Huang HQ,  Wenzel LB,  Han PK,  Moser RP,  Rodriguez GC,  Boggess J,  Rutherford TJ,  Cohn DE,  Kauff ND,  Phillips KA,  Wilkinson K,  Wenham RM,  Hamilton C,  Powell MA,  Walker JL,  Greene MH,  Hensley ML
Gynecol Oncol 2020 Jan;156(1):131-139
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31759774
PMC ID: PMC6980744 [available on January 01, 2021]

Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial.

Vicini FA,  Cecchini RS,  White JR,  Arthur DW,  Julian TB,  Rabinovitch RA,  Kuske RR,  Ganz PA,  Parda DS,  Scheier MF,  Winter KA,  Paik S,  Kuerer HM,  Vallow LA,  Pierce LJ,  Mamounas EP,  McCormick B,  Costantino JP,  Bear HD,  Germain I,  Gustafson G,  Grossheim L,  Petersen IA,  Hudes RS,  Curran WJ Jr,  Bryant JL,  Wolmark N
Lancet 2019 Dec 14;394(10215):2155-2164
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31813636
PMC ID: PMC7199428 [available on December 14, 2020]

Incidence of Late Relapses in Patients With HER2-Positive Breast Cancer Receiving Adjuvant Trastuzumab: Combined Analysis of NCCTG N9831 (Alliance) and NRG Oncology/NSABP B-31.

Chumsri S,  Li Z,  Serie DJ,  Mashadi-Hossein A,  Colon-Otero G,  Song N,  Pogue-Geile KL,  Gavin PG,  Paik S,  Moreno-Aspitia A,  Perez EA,  Thompson EA
J Clin Oncol 2019 Dec 10;37(35):3425-3435
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31622131
PMC ID: PMC6900835 [available on December 10, 2020]

Engaging older patients with cancer and their caregivers as partners in cancer research.

Gilmore NJ,  Canin B,  Whitehead M,  Sedenquist M,  Griggs L,  Finch L,  Grossman V,  Targia V,  Wells M,  Kamen C,  Flannery M,  Magnuson A,  Plumb S,  Obrecht S,  Lowenstein LM,  Lopez G,  Anderson J,  Berenberg J,  Vogel V,  Bearden J,  Dale W,  Mohile SG
Cancer 2019 Dec 1;125(23):4124-4133
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31420878
PMC ID: PMC6856383 [available on December 01, 2020]

Comparative Age-Based Prospective Multi-Institutional Observations of 12,367 Patients Enrolled to the American College of Surgeons Oncology Group (ACOSOG) Z901101 Trials (Alliance).

Al-Refaie WB,  Decker PA,  Ballman KV,  Pisters PWT,  Posner MC,  Hunt KK,  Meyers B,  Weinberg AD,  Nelson H,  Newman L,  Tan A,  Le-Rademacher JG,  Hurria A,  Jatoi A
Ann Surg Oncol 2019 Dec;26(13):4213-4221
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31605327
PMC ID: PMC6868343 [available on December 01, 2020]

GOG 244 - The LymphEdema and Gynecologic cancer (LEG) study: The association between the gynecologic cancer lymphedema questionnaire (GCLQ) and lymphedema of the lower extremity (LLE).

Carter J,  Huang HQ,  Armer J,  Carlson JW,  Lockwood S,  Nolte S,  Stewart BR,  Kauderer J,  Hutson A,  Walker JL,  Fleury AC,  Bonebrake A,  Soper JT,  Mathews C,  Zivanovic O,  Richards WE,  Tan A,  Alberts DS,  Barakat RR,  Wenzel L
Gynecol Oncol 2019 Dec;155(3):452-460
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31679787
PMC ID: PMC6900449 [available on December 01, 2020]

Gleason pattern 5 is associated with an increased risk for metastasis following androgen deprivation therapy and radiation: An analysis of RTOG 9202 and 9902.

Hamstra DA,  Pugh SL,  Lepor H,  Rosenthal SA,  Pienta KJ,  Gomella L,  Peters C,  D'Souza DP,  Zeitzer KL,  Jones CU,  Hall WA,  Horwitz E,  Pisansky TM,  Souhami L,  Hartford AC,  Dominello M,  Feng F,  Sandler HM
Radiother Oncol 2019 Dec;141:137-143
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31540746
PMC ID: PMC6912855 [available on December 01, 2020]

Effects of exercise on inflammation in patients receiving chemotherapy: a nationwide NCORP randomized clinical trial.

Kleckner IR,  Kamen C,  Cole C,  Fung C,  Heckler CE,  Guido JJ,  Culakova E,  Onitilo AA,  Conlin A,  Kuebler JP,  Mohile S,  Janelsins M,  Mustian KM
Support Care Cancer 2019 Dec;27(12):4615-4625
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30937600
PMC ID: PMC6774911 [available on December 01, 2020]

A phase II randomized, double-blind trial of a polyvalent Vaccine-KLH conjugate (NSC 748933 IND# 14384) + OPT-821 versus OPT-821 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer who are in second or third complete remission: An NRG Oncology/GOG study.

O'Cearbhaill RE,  Deng W,  Chen LM,  Lucci JA 3rd,  Behbakht K,  Spirtos NM,  Muller CY,  Benigno BB,  Powell MA,  Berry E,  Tewari KS,  Hanjani P,  Lankes HA,  Aghajanian C,  Sabbatini PJ
Gynecol Oncol 2019 Dec;155(3):393-399
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31653510
PMC ID: PMC6900458 [available on December 01, 2020]

Positive effects of acupressure bands combined with relaxation music/instructions on patients most at risk for chemotherapy-induced nausea.

Peoples AR,  Culakova E,  Heckler CE,  Shayne M,  O'Connor TL,  Kirshner JJ,  Bushunow PW,  Morrow GR,  Roscoe JA
Support Care Cancer 2019 Dec;27(12):4597-4605
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30929028
PMC ID: PMC6768770 [available on December 01, 2020]

Variations in prostate biopsy recommendation and acceptance confound evaluation of risk factors for prostate cancer: Examining race and BMI.

Tangen CM,  Schenk J,  Till C,  Goodman PJ,  Barrington W,  Lucia MS,  Thompson IM
Cancer Epidemiol 2019 Dec;63:101619
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31639607
PMC ID: PMC6938232 [available on December 01, 2020]

Cachexia and Sarcopenia in Older Adults with Cancer: A Comprehensive Review.

Dunne RF,  Loh KP,  Williams GR,  Jatoi A,  Mustian KM,  Mohile SG
Cancers (Basel) 2019 Nov 25;11(12)
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31769421
PMC ID: PMC6966439

Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer.

Coleman RL,  Spirtos NM,  Enserro D,  Herzog TJ,  Sabbatini P,  Armstrong DK,  Kim JW,  Park SY,  Kim BG,  Nam JH,  Fujiwara K,  Walker JL,  Casey AC,  Alvarez Secord A,  Rubin S,  Chan JK,  DiSilvestro P,  Davidson SA,  Cohn DE,  Tewari KS,  Basen-Engquist K,  Huang HQ,  Brady MF,  Mannel RS
N Engl J Med 2019 Nov 14;381(20):1929-1939
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31722153
PMC ID: PMC6941470

Effect of Caspofungin vs Fluconazole Prophylaxis on Invasive Fungal Disease Among Children and Young Adults With Acute Myeloid Leukemia: A Randomized Clinical Trial.

Fisher BT,  Zaoutis T,  Dvorak CC,  Nieder M,  Zerr D,  Wingard JR,  Callahan C,  Villaluna D,  Chen L,  Dang H,  Esbenshade AJ,  Alexander S,  Wiley JM,  Sung L
JAMA 2019 Nov 5;322(17):1673-1681
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31688884
PMC ID: PMC6865545

A phase 1 and randomized, placebo-controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872.

Galanis E,  Anderson SK,  Twohy EL,  Carrero XW,  Dixon JG,  Tran DD,  Jeyapalan SA,  Anderson DM,  Kaufmann TJ,  Feathers RW,  Giannini C,  Buckner JC,  Anastasiadis PZ,  Schiff D
Cancer 2019 Nov 1;125(21):3790-3800
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31290996
PMC ID: PMC6788934

Two-dimensional speckle-tracking strain detects subclinical cardiotoxicity in older patients treated for acute myeloid leukemia.

Cascino GJ,  Voss WB,  Canaani J,  Furiasse N,  Rademaker A,  Ky B,  Luger S,  Altman JK,  Foran JM,  Litzow MR,  Tallman MS,  Rigolin V,  Akhter N
Echocardiography 2019 Nov;36(11):2033-2040
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31705570
PMC ID: PMC6874906

Changing functional status within 6 months posttreatment is prognostic of overall survival in patients with head and neck cancer: NRG Oncology Study.

Eldridge RC,  Pugh SL,  Trotti A,  Hu K,  Spencer S,  Yom SS,  Rosenthal D,  Read N,  Desai A,  Gore E,  Shenouda G,  Mishra MV,  Bruner D,  Xiao C
Head Neck 2019 Nov;41(11):3924-3932
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31435980
PMC ID: PMC6865821

Breast Screening Utilization and Cost Sharing Among Employed Insured Women Following the Affordable Care Act: Impact of Race and Income.

Fazeli Dehkordy S,  Fendrick AM,  Bell S,  Kamdar N,  Kobernik E,  Dalton VK,  Carlos RC
J Womens Health (Larchmt) 2019 Nov;28(11):1529-1537
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30985249
PMC ID: PMC6862944

Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60-75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study.

Ustun C,  Le-Rademacher J,  Wang HL,  Othus M,  Sun Z,  Major B,  Zhang MJ,  Storrick E,  Lafky JM,  Chow S,  Mrózek K,  Attar EC,  Nand S,  Bloomfield CD,  Cripe LD,  Tallman MS,  Appelbaum F,  Larson RA,  Marcucci G,  Roboz GJ,  Uy GL,  Stone RM,  Jatoi A,  Shea TC,  de Lima M,  Foran JM,  Sandmaier BM,  Litzow MR,  Erba HP,  Hurria A,  Weisdorf DJ,  Artz AS
Leukemia 2019 Nov;33(11):2599-2609
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31073153
PMC ID: PMC6842042

Cognitive functioning following brain irradiation as part of cancer treatment: Characterizing better cognitive performance.

Wong SS,  Case LD,  Avis NE,  Cummings TL,  Cramer CK,  Rapp SR
Psychooncology 2019 Nov;28(11):2166-2173
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31418491
PMC ID: PMC6858925

Oncology clinical trials and insurance coverage: An update in a tenuous insurance landscape.

Obeng-Gyasi S,  Kircher SM,  Lipking KP,  Keele BJ,  Benson AB,  Wagner LI,  Carlos RC
Cancer 2019 Oct 15;125(20):3488-3493
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31251394
PMC ID: PMC6763351

Perceived risk for cancer progression and psychological status in chronic lymphocytic leukemia patients: CALGB 70603 (Alliance).

Deshields TL,  Dueck AC,  Rogers K,  Brown JR,  Shanafelt T,  Mintzer D,  Byrd JC
Leuk Lymphoma 2019 Oct;60(10):2580-2583
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30916608
PMC ID: PMC6764912

Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial.

National Lung Screening Trial Research Team
J Thorac Oncol 2019 Oct;14(10):1732-1742
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31260833
PMC ID: PMC6764895

Pilot Feasibility Study of an Oncology Financial Navigation Program in Brain Cancer Patients.

Sadigh G,  Gallagher K,  Obenchain J,  Benson A 3rd,  Mitchell E,  Sengupta S,  Carlos RC
J Am Coll Radiol 2019 Oct;16(10):1420-1424
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31585660
PMC ID: PMC6779332

Effectiveness of exercise-based rehabilitation on functional capacity and quality of life in head and neck cancer patients receiving chemo-radiotherapy.

Samuel SR,  Maiya AG,  Fernandes DJ,  Guddattu V,  Saxena PUP,  Kurian JR,  Lin PJ,  Mustian KM
Support Care Cancer 2019 Oct;27(10):3913-3920
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30919154
PMC ID: PMC6728220

A Phase II Multicenter Study of the Addition of Azacitidine to Reduced-Intensity Conditioning Allogeneic Transplant for High-Risk Myelodysplasia (and Older Patients with Acute Myeloid Leukemia): Results of CALGB 100801 (Alliance).

Vij R,  Le-Rademacher J,  Laumann K,  Hars V,  Owzar K,  Shore T,  Vasu S,  Cashen A,  Isola L,  Shea T,  DeMagalhaes-Silverman M,  Hurd D,  Meehan K,  Beardell F,  Devine S
Biol Blood Marrow Transplant 2019 Oct;25(10):1984-1992
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31212080
PMC ID: PMC6790289

Measurements of adiposity as prognostic biomarkers for survival with anti-angiogenic treatment in epithelial ovarian cancer: An NRG Oncology/Gynecologic Oncology Group ancillary data analysis of GOG 218.

Wade KNS,  Brady MF,  Thai T,  Wang Y,  Zheng B,  Salani R,  Tewari KS,  Gray HJ,  Bakkum-Gamez JN,  Burger RA,  Moore KN,  Bookman MA
Gynecol Oncol 2019 Oct;155(1):69-74
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31409486
PMC ID: PMC7048388

Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial.

Sparano JA,  Gray RJ,  Makower DF,  Albain KS,  Saphner TJ,  Badve SS,  Wagner LI,  Kaklamani VG,  Keane MM,  Gomez HL,  Reddy PS,  Goggins TF,  Mayer IA,  Toppmeyer DL,  Brufsky AM,  Goetz MP,  Berenberg JL,  Mahalcioiu C,  Desbiens C,  Hayes DF,  Dees EC,  Geyer CE Jr,  Olson JA Jr,  Wood WC,  Lively T,  Paik S,  Ellis MJ,  Abrams J,  Sledge GW Jr
JAMA Oncol 2019 Sep 30
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31566680
PMC ID: PMC6777230

Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial.

Muss HB,  Polley MC,  Berry DA,  Liu H,  Cirrincione CT,  Theodoulou M,  Mauer AM,  Kornblith AB,  Partridge AH,  Dressler LG,  Cohen HJ,  Kartcheske PA,  Perez EA,  Wolff AC,  Gralow JR,  Burstein HJ,  Mahmood AA,  Sutton LM,  Magrinat G,  Parker BA,  Hart RD,  Grenier D,  Hurria A,  Jatoi A,  Norton L,  Hudis CA,  Winer EP,  Carey L
J Clin Oncol 2019 Sep 10;37(26):2338-2348
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31339827
PMC ID: PMC6900836

Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer.

Tewari KS,  Burger RA,  Enserro D,  Norquist BM,  Swisher EM,  Brady MF,  Bookman MA,  Fleming GF,  Huang H,  Homesley HD,  Fowler JM,  Greer BE,  Boente M,  Liang SX,  Ye C,  Bais C,  Randall LM,  Chan JK,  Ferriss JS,  Coleman RL,  Aghajanian C,  Herzog TJ,  DiSaia PJ,  Copeland LJ,  Mannel RS,  Birrer MJ,  Monk BJ
J Clin Oncol 2019 Sep 10;37(26):2317-2328
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31216226
PMC ID: PMC6879307

Factors Associated With Lymphedema in Women With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy and Axillary Dissection.

Armer JM,  Ballman KV,  McCall L,  Ostby PL,  Zagar E,  Kuerer HM,  Hunt KK,  Boughey JC
JAMA Surg 2019 Sep 1;154(9):800-809
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31314062
PMC ID: PMC6647005

The Evolving Design of NIH-Funded Cardio-Oncology Studies to Address Cancer Treatment-Related Cardiovascular Toxicity.

Minasian L,  Dimond E,  Davis M,  Adhikari B,  Fagerstrom R,  Fabian C,  Floyd J,  Unger JM,  Douglas PS,  Mustian KM,  Chow EJ,  Lipshultz S,  Hundley WG,  Armenian S,  Ky B
JACC CardioOncol 2019 Sep;1(1):105-113
Major Program(s) or Research Group(s): Breast and Gynecologic CancerBiometryNCI Community Oncology Research Program ;  Office of the Director
PubMed ID: 32529192
PMC ID: PMC7288847

Micronodules Detected on Computed Tomography During the National Lung Screening Trial: Prevalence and Relation to Positive Studies and Lung Cancer.

Munden RF,  Chiles C,  Boiselle PM,  Sicks JD,  Aberle DR,  Gatsonis CA
J Thorac Oncol 2019 Sep;14(9):1538-1546
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31295576
PMC ID: PMC6708760

N-Acetylcysteine Rinse for Thick Secretion and Mucositis of Head and Neck Chemoradiotherapy (Alliance MC13C2): A Double-Blind Randomized Clinical Trial.

Sio TT,  Blanchard MJ,  Novotny PJ,  Patel SH,  Rwigema JM,  Pederson LD,  McGee LA,  Gamez ME,  Seeger GR,  Martenson JA,  Grover Y,  Neben Wittich MA,  Garces YI,  Foote RL,  Miller RC,  Halyard MY
Mayo Clin Proc 2019 Sep;94(9):1814-1824
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31405750
PMC ID: PMC6742495

A comparison of nurses' and physicians' perception of cancer treatment burden based on reported adverse events.

Lee SM,  Miao J,  Wu R,  Unger JM,  Cheung K,  Hershman DL
Health Qual Life Outcomes 2019 Aug 22;17(1):146
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31438967
PMC ID: PMC6704545

Trends in Medical Aid in Dying in Oregon and Washington.

Al Rabadi L,  LeBlanc M,  Bucy T,  Ellis LM,  Hershman DL,  Meyskens FL Jr,  Taylor L,  Blanke CD
JAMA Netw Open 2019 Aug 2;2(8):e198648
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31397857
PMC ID: PMC6692681

Stromal Tumor-infiltrating Lymphocytes in NRG Oncology/NSABP B-31 Adjuvant Trial for Early-Stage HER2-Positive Breast Cancer.

Kim RS,  Song N,  Gavin PG,  Salgado R,  Bandos H,  Kos Z,  Floris G,  Eynden GGGMVD,  Badve S,  Demaria S,  Rastogi P,  Fehrenbacher L,  Mamounas EP,  Swain SM,  Wickerham DL,  Costantino JP,  Paik S,  Wolmark N,  Geyer CE,  Lucas PC,  Pogue-Geile KL
J Natl Cancer Inst 2019 Aug 1;111(8):867-871
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30888406
PMC ID: PMC6695304

Online health community experiences of sexual minority women with cancer.

Lee YJ,  Kamen C,  Margolies L,  Boehmer U
J Am Med Inform Assoc 2019 Aug 1;26(8-9):759-766
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31361002
PMC ID: PMC6696497

Coping Among Breast Cancer Survivors: A Confirmatory Factor Analysis of the Brief COPE.

Rand KL,  Cohee AA,  Monahan PO,  Wagner LI,  Shanahan ML,  Champion VL
J Nurs Meas 2019 Aug 1;27(2):259-276
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31511409
PMC ID: PMC6787924

Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia.

Shanafelt TD,  Wang XV,  Kay NE,  Hanson CA,  O'Brien S,  Barrientos J,  Jelinek DF,  Braggio E,  Leis JF,  Zhang CC,  Coutre SE,  Barr PM,  Cashen AF,  Mato AR,  Singh AK,  Mullane MP,  Little RF,  Erba H,  Stone RM,  Litzow M,  Tallman M
N Engl J Med 2019 Aug 1;381(5):432-443
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31365801
PMC ID: PMC6908306

Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patients.

Fuh KC,  Java JJ,  Chan JK,  Kapp DS,  Monk BJ,  Burger RA,  Young RC,  Alberts DS,  McGuire WP,  Markman M,  Bell J,  Ozols RF,  Armstrong DK,  Aghajanian C,  Bookman MA,  Mannel RS
Gynecol Oncol 2019 Aug;154(2):420-425
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31229298
PMC ID: PMC6941471

Quality of life in pediatric acute myeloid leukemia: Report from the Children's Oncology Group.

Nagarajan R,  Gerbing R,  Alonzo T,  Johnston DL,  Aplenc R,  Kolb EA,  Meshinchi S,  Barakat LP,  Sung L
Cancer Med 2019 Aug;8(9):4454-4464
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31190442
PMC ID: PMC6675729

Personalized Decision Making in Early Stage Breast Cancer: Applying Clinical Prediction Models for Anthracycline Cardiotoxicity and Breast Cancer Mortality Demonstrates Substantial Heterogeneity of Benefit-Harm Trade-off.

Upshaw JN,  Ruthazer R,  Miller KD,  Parsons SK,  Erban JK,  O'Neill AM,  Demissei B,  Sledge G,  Wagner L,  Ky B,  Kent DM
Clin Breast Cancer 2019 Aug;19(4):259-267.e1
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31175052
PMC ID: PMC6667295

Osteoporosis in colorectal cancer survivors: analysis of the linkage between SWOG trial enrollees and Medicare claims.

Barzi A,  Hershman DL,  Till C,  Barlow WE,  Ramsey S,  Lenz HJ,  Hochster HS,  Unger JM
Arch Osteoporos 2019 Jul 28;14(1):83
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31352608
PMC ID: PMC6852789

Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early Stage Endometrial Cancer.

Randall ME,  Filiaci V,  McMeekin DS,  von Gruenigen V,  Huang H,  Yashar CM,  Mannel RS,  Kim JW,  Salani R,  DiSilvestro PA,  Burke JJ,  Rutherford T,  Spirtos NM,  Terada K,  Anderson PR,  Brewster WR,  Small W,  Aghajanian CA,  Miller DS
J Clin Oncol 2019 Jul 20;37(21):1810-1818
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30995174
PMC ID: PMC6804858

Effects of Age and Immune Landscape on Outcome in HER2-Positive Breast Cancer in the NCCTG N9831 (Alliance) and NSABP B-31 (NRG) Trials.

Chumsri S,  Serie DJ,  Li Z,  Pogue-Geile KL,  Soyano-Muller AE,  Mashadi-Hossein A,  Warren S,  Lou Y,  Colon-Otero G,  Knutson KL,  Perez EA,  Moreno-Aspitia A,  Thompson EA
Clin Cancer Res 2019 Jul 15;25(14):4422-4430
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30808774
PMC ID: PMC6634998

Willingness to bear adversity and beliefs about the curability of advanced cancer in older adults.

Loh KP,  Mohile SG,  Epstein RM,  McHugh C,  Flannery M,  Culakova E,  Lei L,  Wells M,  Gilmore N,  Babu D,  Whitehead MI,  Dale W,  Hurria A,  Wittink M,  Magnuson A,  Conlin A,  Thomas M,  Berenberg J,  Duberstein PR
Cancer 2019 Jul 15;125(14):2506-2513
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30920646
PMC ID: PMC6602839

Association of Magnetic Resonance Imaging and a 12-Gene Expression Assay With Breast Ductal Carcinoma In Situ Treatment.

Lehman CD,  Gatsonis C,  Romanoff J,  Khan SA,  Carlos R,  Solin LJ,  Badve S,  McCaskill-Stevens W,  Corsetti RL,  Rahbar H,  Spell DW,  Blankstein KB,  Han LK,  Sabol JL,  Bumberry JR,  Gareen I,  Snyder BS,  Wagner LI,  Miller KD,  Sparano JA,  Comstock C
JAMA Oncol 2019 Jul 1;5(7):1036-1042
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsNCI Community Oncology Research Program
PubMed ID: 30653209
PMC ID: PMC6583020

Impact of Diabetes on the Symptoms of Breast Cancer Survivors.

Storey S,  Cohee A,  Gathirua-Mwangi WG,  Vachon E,  Monahan P,  Otte J,  Stump TE,  Cella D,  Champion V
Oncol Nurs Forum 2019 Jul 1;46(4):473-484
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31225841
PMC ID: PMC6936108

Reimbursing Patients for Participation in Cancer Clinical Trials.

Unger JM,  Fleury ME
JAMA Oncol 2019 Jul 1;5(7):932-934
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31169875
PMC ID: not available

Examiner accuracy in cognitive testing in multisite brain-tumor clinical trials: an analysis from the Alliance for Clinical Trials in Oncology.

Cerhan JH,  Anderson SK,  Butts AM,  Porter AB,  Jaeckle K,  Galanis E,  Brown PD
Neurooncol Pract 2019 Jul;6(4):283-288
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31386061
PMC ID: PMC6660817

Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D Supplementation in Premenopausal Women at High Risk for Breast Cancer (SWOG S0812).

Crew KD,  Anderson GL,  Hershman DL,  Terry MB,  Tehranifar P,  Lew DL,  Yee M,  Brown EA,  Kairouz SS,  Kuwajerwala N,  Bevers T,  Doster JE,  Zarwan C,  Kruper L,  Minasian LM,  Ford L,  Arun B,  Neuhouser M,  Goodman GE,  Brown PH
Cancer Prev Res (Phila) 2019 Jul;12(7):481-490
Major Program(s) or Research Group(s): Office of the Director ;  NCI Community Oncology Research Program
PubMed ID: 31138522
PMC ID: PMC6609474

NRG Oncology/RTOG 0438: A Phase 1 Trial of Highly Conformal Radiation Therapy for Liver Metastases.

Dawson LA,  Winter KA,  Katz AW,  Schell MC,  Brierley J,  Chen Y,  Kopek N,  Crane CH,  Willett CG
Pract Radiat Oncol 2019 Jul-Aug;9(4):e386-e393
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30825666
PMC ID: PMC6592755

Expanded validation of the EPIC bowel and urinary domains for use in women with gynecologic cancer undergoing postoperative radiotherapy.

Gil KM,  Pugh SL,  Klopp AH,  Yeung AR,  Wenzel L,  Westin SN,  Gaffney DK,  Small W Jr,  Thompson S,  Doncals DE,  Cantuaria GHC,  Yaremko BP,  Chang A,  Kundapur V,  Mohan DS,  Haas ML,  Kim YB,  Ferguson CL,  Deshmukh S,  Kachnic LA,  Bruner DW
Gynecol Oncol 2019 Jul;154(1):183-188
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31104905
PMC ID: PMC6918674

Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG).

Jaeckle KA,  Anderson SK,  Twohy EL,  Dixon JG,  Giannini C,  Jenkins R,  Egorin MJ,  Sarkaria JN,  Brown PD,  Flynn PJ,  Schwerkoske J,  Buckner JC,  Galanis E
J Neurooncol 2019 Jul;143(3):573-581
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31119479
PMC ID: PMC6717651

"Treat us with dignity": a qualitative study of the experiences and recommendations of lesbian, gay, bisexual, transgender, and queer (LGBTQ) patients with cancer.

Kamen CS,  Alpert A,  Margolies L,  Griggs JJ,  Darbes L,  Smith-Stoner M,  Lytle M,  Poteat T,  Scout N,  Norton SA
Support Care Cancer 2019 Jul;27(7):2525-2532
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30411237
PMC ID: PMC6506401

The association of health-related quality of life and cognitive function in patients receiving memantine for the prevention of cognitive dysfunction during whole-brain radiotherapy.

Laack NN,  Pugh SL,  Brown PD,  Fox S,  Wefel JS,  Meyers C,  Choucair A,  Khuntia D,  Suh JH,  Roberge D,  Wendland MM,  Bruner D
Neurooncol Pract 2019 Jul;6(4):274-282
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31386073
PMC ID: PMC6660822

Understanding, measuring, and addressing the financial impact of cancer on adolescents and young adults.

Salsman JM,  Bingen K,  Barr RD,  Freyer DR
Pediatr Blood Cancer 2019 Jul;66(7):e27660
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30756484
PMC ID: PMC6777708

Rasch model-based testing of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire-Chemotherapy-Induced Peripheral Neuropathy (QLQ-CIPN20) using Alliance for Clinical Trials in Oncology (Alliance) A151408 study data.

Smith EML,  Zanville N,  Kanzawa-Lee G,  Donohoe C,  Bridges C,  Loprinzi C,  Le-Rademacher J,  Yang JJ
Support Care Cancer 2019 Jul;27(7):2599-2608
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30460399
PMC ID: PMC6527492

The addition of paclitaxel to doxorubicin and cisplatin and volume-directed radiation does not improve overall survival (OS) or long-term recurrence-free survival (RFS) in advanced endometrial cancer (EC): A randomized phase III NRG/Gynecologic Oncology Group (GOG) study.

Spirtos NM,  Enserro D,  Homesley HD,  Gibbons SK,  Cella D,  Morris RT,  DeGeest K,  Lee RB,  Miller DS
Gynecol Oncol 2019 Jul;154(1):13-21
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31053405
PMC ID: PMC6852648

Advanced pancreatic cancer clinical trials: The continued underrepresentation of older patients.

White MN,  Dotan E,  Catalano PJ,  Cardin DB,  Berlin JD
J Geriatr Oncol 2019 Jul;10(4):540-546
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30573201
PMC ID: PMC6579713

Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer.

Sparano JA,  Gray RJ,  Ravdin PM,  Makower DF,  Pritchard KI,  Albain KS,  Hayes DF,  Geyer CE Jr,  Dees EC,  Goetz MP,  Olson JA Jr,  Lively T,  Badve SS,  Saphner TJ,  Wagner LI,  Whelan TJ,  Ellis MJ,  Paik S,  Wood WC,  Keane MM,  Gomez Moreno HL,  Reddy PS,  Goggins TF,  Mayer IA,  Brufsky AM,  Toppmeyer DL,  Kaklamani VG,  Berenberg JL,  Abrams J,  Sledge GW Jr
N Engl J Med 2019 Jun 20;380(25):2395-2405
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31157962
PMC ID: PMC6709671

Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trials.

Fakhry C,  Zhang Q,  Gillison ML,  Nguyen-Tân PF,  Rosenthal DI,  Weber RS,  Lambert L,  Trotti AM 3rd,  Barrett WL,  Thorstad WL,  Yom SS,  Wong SJ,  Ridge JA,  Rao SSD,  Spencer S,  Fortin A,  Raben D,  Harris J,  Le QT
Cancer 2019 Jun 15;125(12):2027-2038
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30913305
PMC ID: PMC6594017

Association between body mass index and response to duloxetine for aromatase inhibitor-associated musculoskeletal symptoms in SWOG S1202.

Henry NL,  Unger JM,  Till C,  Schott AF,  Crew KD,  Lew DL,  Fisch MJ,  Moinpour CM,  Wade JL 3rd,  Hershman DL
Cancer 2019 Jun 15;125(12):2123-2129
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30861098
PMC ID: PMC6675412

Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer.

Matei D,  Filiaci V,  Randall ME,  Mutch D,  Steinhoff MM,  DiSilvestro PA,  Moxley KM,  Kim YM,  Powell MA,  O'Malley DM,  Spirtos NM,  Small W Jr,  Tewari KS,  Richards WE,  Nakayama J,  Matulonis UA,  Huang HQ,  Miller DS
N Engl J Med 2019 Jun 13;380(24):2317-2326
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31189035
PMC ID: PMC6948006

Effective stakeholder engagement: design and implementation of a clinical trial (SWOG S1415CD) to improve cancer care.

Barger S,  Sullivan SD,  Bell-Brown A,  Bott B,  Ciccarella AM,  Golenski J,  Gorman M,  Johnson J,  Kreizenbeck K,  Kurttila F,  Mason G,  Myers J,  Seigel C,  Wade JL 3rd,  Walia G,  Watabayashi K,  Lyman GH,  Ramsey SD
BMC Med Res Methodol 2019 Jun 11;19(1):119
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31185918
PMC ID: PMC6560751

The National Cancer Institute Clinical Trials Planning Meeting for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy.

Dorsey SG,  Kleckner IR,  Barton D,  Mustian K,  O'Mara A,  St Germain D,  Cavaletti G,  Danhauer SC,  Hershman DL,  Hohmann AG,  Hoke A,  Hopkins JO,  Kelly KP,  Loprinzi CL,  McLeod HL,  Mohile S,  Paice J,  Rowland JH,  Salvemini D,  Segal RA,  Smith EL,  Stevens WM,  Janelsins MC
J Natl Cancer Inst 2019 Jun 1;111(6):531-537
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsNCI Community Oncology Research Program
PubMed ID: 30715378
PMC ID: not available

Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study.

Walker JL,  Brady MF,  Wenzel L,  Fleming GF,  Huang HQ,  DiSilvestro PA,  Fujiwara K,  Alberts DS,  Zheng W,  Tewari KS,  Cohn DE,  Powell MA,  Van Le L,  Davidson SA,  Gray HJ,  Rose PG,  Aghajanian C,  Myers T,  Alvarez Secord A,  Rubin SC,  Mannel RS
J Clin Oncol 2019 Jun 1;37(16):1380-1390
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31002578
PMC ID: PMC6544459

Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer.

Walsh N,  Zhang H,  Hyland PL,  Yang Q,  Mocci E,  Zhang M,  Childs EJ,  Collins I,  Wang Z,  Arslan AA,  Beane-Freeman L,  Bracci PM,  Brennan P,  Canzian F,  Duell EJ,  Gallinger S,  Giles GG,  Goggins M,  Goodman GE,  Goodman PJ,  Hung RJ,  Kooperberg C,  Kurtz RC,  Malats N,  LeMarchand L,  Neale RE,  Olson SH,  Scelo G,  Shu XO,  Van Den Eeden SK,  Visvanathan K,  White E,  Zheng W,  PanScan and PanC4 consortia,  Albanes D,  Andreotti G,  Babic A,  Bamlet WR,  Berndt SI,  Borgida A,  Boutron-Ruault MC,  Brais L,  Brennan P,  Bueno-de-Mesquita B,  Buring J,  Chaffee KG,  Chanock S,  Cleary S,  Cotterchio M,  Foretova L,  Fuchs C,  M Gaziano JM,  Giovannucci E,  Goggins M,  Hackert T,  Haiman C,  Hartge P,  Hasan M,  Helzlsouer KJ,  Herman J,  Holcatova I,  Holly EA,  Hoover R,  Hung RJ,  Janout V,  Klein EA,  Kurtz RC,  Laheru D,  Lee IM,  Lu L,  Malats N,  Mannisto S,  Milne RL,  Oberg AL,  Orlow I,  Patel AV,  Peters U,  Porta M,  Real FX,  Rothman N,  Sesso HD,  Severi G,  Silverman D,  Strobel O,  Sund M,  Thornquist MD,  Tobias GS,  Wactawski-Wende J,  Wareham N,  Weiderpass E,  Wentzensen N,  Wheeler W,  Yu H,  Zeleniuch-Jacquotte A,  Kraft P,  Li D,  Jacobs EJ,  Petersen GM,  Wolpin BM,  Risch HA,  Amundadottir LT,  Yu K,  Klein AP,  Stolzenberg-Solomon RZ
J Natl Cancer Inst 2019 Jun 1;111(6):557-567
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30541042
PMC ID: PMC6579744

A Novel, Widespread qacA Allele Results in Reduced Chlorhexidine Susceptibility in Staphylococcus epidermidis.

Addetia A,  Greninger AL,  Adler A,  Yuan S,  Makhsous N,  Qin X,  Zerr DM
Antimicrob Agents Chemother 2019 Jun;63(6)
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30988144
PMC ID: PMC6535555

Breast Screening Utilization and Cost Sharing Among Employed Insured Women After the Affordable Care Act.

Carlos RC,  Fendrick AM,  Kolenic G,  Kamdar N,  Kobernik E,  Bell S,  Dalton VK
J Am Coll Radiol 2019 Jun;16(6):788-796
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30833168
PMC ID: not available

Teaching Health-Care Providers to Query Patients With Cancer About Sexual and Gender Minority (SGM) Status and Sexual Health.

Cathcart-Rake EJ,  Breitkopf CR,  Kaur J,  O'Connor J,  Ridgeway JL,  Jatoi A
Am J Hosp Palliat Care 2019 Jun;36(6):533-537
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30599758
PMC ID: PMC6558653

Prediagnostic circulating markers of inflammation and risk of oesophageal adenocarcinoma: a study within the National Cancer Institute Cohort Consortium.

Cook MB,  Barnett MJ,  Bock CH,  Cross AJ,  Goodman PJ,  Goodman GE,  Haiman CA,  Khaw KT,  McCullough ML,  Newton CC,  Boutron-Ruault MC,  Lund E,  RutegÃ¥rd M,  Thornquist MD,  Spriggs M,  Giffen C,  Freedman ND,  Kemp T,  Kroenke CH,  Le Marchand L,  Park JY,  Simon M,  Wilkens LR,  Pinto L,  Hildesheim A,  Campbell PT
Gut 2019 Jun;68(6):960-968
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialNCI Community Oncology Research Program
PubMed ID: 30121626
PMC ID: PMC6379150

Older-Patient-Specific Cancer Trials: A Pooled Analysis of 2,277 Patients (A151715).

Dao D,  Zemla T,  Jatoi A,  Freedman RA,  Hurria A,  Muss H,  Cohen HJ,  Shulman LN,  Citron M,  Budman D,  McMurray R,  Partridge A,  Carey L,  Sedrak MS,  Lafky JM,  Le-Rademacher JG
Oncologist 2019 Jun;24(6):e284-e291
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30975921
PMC ID: PMC6656509

Beliefs About Advanced Cancer Curability in Older Patients, Their Caregivers, and Oncologists.

Loh KP,  Mohile SG,  Lund JL,  Epstein R,  Lei L,  Culakova E,  McHugh C,  Wells M,  Gilmore N,  Mohamed MR,  Kamen C,  Aarne V,  Conlin A,  Bearden J 3rd,  Onitilo A,  Wittink M,  Dale W,  Hurria A,  Duberstein P
Oncologist 2019 Jun;24(6):e292-e302
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31015317
PMC ID: PMC6656513

Test-retest repeatability and reproducibility of ADC measures by breast DWI: Results from the ACRIN 6698 trial.

Newitt DC,  Zhang Z,  Gibbs JE,  Partridge SC,  Chenevert TL,  Rosen MA,  Bolan PJ,  Marques HS,  Aliu S,  Li W,  Cimino L,  Joe BN,  Umphrey H,  Ojeda-Fournier H,  Dogan B,  Oh K,  Abe H,  Drukteinis J,  Esserman LJ,  Hylton NM,  ACRIN Trial Team and I-SPY 2 TRIAL Investigators
J Magn Reson Imaging 2019 Jun;49(6):1617-1628
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30350329
PMC ID: PMC6524146

Multicenter Randomized Controlled Trial of Omega-3 Fatty Acids Versus Omega-6 Fatty Acids for the Control of Cancer-Related Fatigue Among Breast Cancer Survivors.

Peppone LJ,  Inglis JE,  Mustian KM,  Heckler CE,  Padula GDA,  Mohile SG,  Kamen CS,  Culakova E,  Lin PJ,  Kerns SL,  Cole S,  Janelsins MC
JNCI Cancer Spectr 2019 Jun;3(2):pkz005
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31119206
PMC ID: PMC6512349

Phase II Trial of Chemopreventive Effects of Levonorgestrel on Ovarian and Fallopian Tube Epithelium in Women at High Risk for Ovarian Cancer: An NRG Oncology Group/GOG Study.

Rodriguez GC,  Kauderer J,  Hunn J,  Thaete LG,  Watkin WG,  Russell S,  Yozwiak M,  Basil J,  Hurteau J,  Lele S,  Modesitt SC,  Zivanovic O,  Zhang HH,  Bartels PH,  Alberts DS
Cancer Prev Res (Phila) 2019 Jun;12(6):401-412
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31015198
PMC ID: PMC6948151

Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415.

Thor M,  Deasy JO,  Paulus R,  Robert Lee W,  Amin MB,  Bruner DW,  Low DA,  Shah AB,  Malone SC,  Michalski JM,  Dayes IS,  Seaward SA,  Gore EM,  Albert M,  Pisansky TM,  Faria SL,  Chen Y,  Koontz BF,  Swanson GP,  Pugh SL,  Sandler HM
Radiother Oncol 2019 Jun;135:19-24
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31015166
PMC ID: PMC6582638

Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial.

Bezjak A,  Paulus R,  Gaspar LE,  Timmerman RD,  Straube WL,  Ryan WF,  Garces YI,  Pu AT,  Singh AK,  Videtic GM,  McGarry RC,  Iyengar P,  Pantarotto JR,  Urbanic JJ,  Sun AY,  Daly ME,  Grills IS,  Sperduto P,  Normolle DP,  Bradley JD,  Choy H
J Clin Oncol 2019 May 20;37(15):1316-1325
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30943123
PMC ID: PMC6524984

More on Long-Term Effects of Finasteride on Prostate Cancer Mortality. Reply.

Goodman PJ,  Tangen CM,  Thompson IM Jr
N Engl J Med 2019 May 16;380(20):e38
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31091400
PMC ID: not available

Preparing the Cardiovascular Workforce to Care for Oncology Patients: JACC Review Topic of the Week.

Hayek SS,  Ganatra S,  Lenneman C,  Scherrer-Crosbie M,  Leja M,  Lenihan DJ,  Yang E,  Ryan TD,  Liu J,  Carver J,  Mousavi N,  O'Quinn R,  Arnold A,  Banchs J,  Barac A,  Ky B
J Am Coll Cardiol 2019 May 7;73(17):2226-2235
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31047011
PMC ID: PMC7153911

Quality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy: A Phase 3 Randomized Clinical Trial.

Bruner DW,  Pugh SL,  Lee WR,  Hall WA,  Dignam JJ,  Low D,  Swanson GP,  Shah AB,  Malone S,  Michalski JM,  Dayes IS,  Seaward SA,  Nguyen PL,  Pisansky TM,  Chen Y,  Sandler HM,  Movsas B
JAMA Oncol 2019 May 1;5(5):664-670
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30763425
PMC ID: PMC6459051

Age and the Risk of Paclitaxel-Induced Neuropathy in Women with Early-Stage Breast Cancer (Alliance A151411): Results from 1,881 Patients from Cancer and Leukemia Group B (CALGB) 40101.

Barginear M,  Dueck AC,  Allred JB,  Bunnell C,  Cohen HJ,  Freedman RA,  Hurria A,  Kimmick G,  Le-Rademacher JG,  Lichtman S,  Muss HB,  Shulman LN,  Copur MS,  Biggs D,  Ramaswamy B,  Lafky JM,  Jatoi A
Oncologist 2019 May;24(5):617-623
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30409792
PMC ID: PMC6516126

Characterizing cancer cachexia in the geriatric oncology population.

Dunne RF,  Roussel B,  Culakova E,  Pandya C,  Fleming FJ,  Hensley B,  Magnuson AM,  Loh KP,  Gilles M,  Ramsdale E,  Maggiore RJ,  Jatoi A,  Mustian KM,  Dale W,  Mohile SG
J Geriatr Oncol 2019 May;10(3):415-419
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30196027
PMC ID: PMC6401352

Wireless transcutaneous electrical nerve stimulation device for chemotherapy-induced peripheral neuropathy: an open-label feasibility study.

Gewandter JS,  Chaudari J,  Ibegbu C,  Kitt R,  Serventi J,  Burke J,  Culakova E,  Kolb N,  Sluka KA,  Tejani MA,  Mohile NA
Support Care Cancer 2019 May;27(5):1765-1774
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30151681
PMC ID: PMC6393221

Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer.

Hurria A,  Soto-Perez-de-Celis E,  Allred JB,  Cohen HJ,  Arsenyan A,  Ballman K,  Le-Rademacher J,  Jatoi A,  Filo J,  Mandelblatt J,  Lafky JM,  Kimmick G,  Klepin HD,  Freedman RA,  Burstein H,  Gralow J,  Wolff AC,  Magrinat G,  Barginear M,  Muss H
J Am Geriatr Soc 2019 May;67(5):920-927
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30146695
PMC ID: PMC6391210

Quality of Life of Caregivers of Older Patients with Advanced Cancer.

Kehoe LA,  Xu H,  Duberstein P,  Loh KP,  Culakova E,  Canin B,  Hurria A,  Dale W,  Wells M,  Gilmore N,  Kleckner AS,  Lund J,  Kamen C,  Flannery M,  Hoerger M,  Hopkins JO,  Liu JJ,  Geer J,  Epstein R,  Mohile SG
J Am Geriatr Soc 2019 May;67(5):969-977
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30924548
PMC ID: not available

Effects of a Home-based Exercise Program on Anxiety and Mood Disturbances in Older Adults with Cancer Receiving Chemotherapy.

Loh KP,  Kleckner IR,  Lin PJ,  Mohile SG,  Canin BE,  Flannery MA,  Fung C,  Dunne RF,  Bautista J,  Culakova E,  Kleckner AS,  Peppone LJ,  Janelsins M,  McHugh C,  Conlin A,  Cho JK,  Kasbari S,  Esparaz BT,  Kuebler JP,  Mustian KM
J Am Geriatr Soc 2019 May;67(5):1005-1011
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31034591
PMC ID: PMC6544022

Longitudinal Relationship Between Frailty and Cognition in Patients 50 Years and Older with Breast Cancer.

Magnuson A,  Lei L,  Gilmore N,  Kleckner AS,  Lin FV,  Ferguson R,  Hurria A,  Wittink MN,  Esparaz BT,  Giguere JK,  Misleh J,  Bautista J,  Mohile SG,  Janelsins MC
J Am Geriatr Soc 2019 May;67(5):928-936
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31034595
PMC ID: PMC6490967

Immune Checkpoint Inhibitors in Real-World Treatment of Older Adults with Non-Small Cell Lung Cancer.

Muchnik E,  Loh KP,  Strawderman M,  Magnuson A,  Mohile SG,  Estrah V,  Maggiore RJ
J Am Geriatr Soc 2019 May;67(5):905-912
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30698276
PMC ID: not available

Association Between Symptom Burden and Physical Function in Older Patients with Cancer.

Pandya C,  Magnuson A,  Flannery M,  Zittel J,  Duberstein P,  Loh KP,  Ramsdale E,  Gilmore N,  Dale W,  Mohile SG
J Am Geriatr Soc 2019 May;67(5):998-1004
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30848838
PMC ID: not available

Psychometric Testing of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Chemotherapy-Induced Peripheral Neuropathy 20-Item Scale Using Pooled Chemotherapy-Induced Peripheral Neuropathy Outcome Measures Standardization and Alliance for Clinical Trials in Oncology A151408 Study Data.

Smith EML,  Banerjee T,  Yang JJ,  Bridges CM,  Alberti P,  Sloan JA,  Loprinzi C
Cancer Nurs 2019 May-Jun;42(3):179-189
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29649081
PMC ID: PMC6185825

Key design and analysis principles for quality of life and patient-reported outcomes in clinical trials.

Unger JM,  Vaidya R,  Gore JL
Urol Oncol 2019 May;37(5):324-330
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29572075
PMC ID: PMC6148417

Effect of Doxepin Mouthwash or Diphenhydramine-Lidocaine-Antacid Mouthwash vs Placebo on Radiotherapy-Related Oral Mucositis Pain: The Alliance A221304 Randomized Clinical Trial.

Sio TT,  Le-Rademacher JG,  Leenstra JL,  Loprinzi CL,  Rine G,  Curtis A,  Singh AK,  Martenson JA Jr,  Novotny PJ,  Tan AD,  Qin R,  Ko SJ,  Reiter PL,  Miller RC
JAMA 2019 Apr 16;321(15):1481-1490
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30990550
PMC ID: PMC6484809

Acquisition of sexual orientation and gender identity data among NCI Community Oncology Research Program practice groups.

Cathcart-Rake EJ,  Zemla T,  Jatoi A,  Weaver KE,  Neuman H,  Kazak AE,  Carlos R,  Gansauer L,  Unger JM,  Pajewski NM,  Kamen C
Cancer 2019 Apr 15;125(8):1313-1318
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30561776
PMC ID: PMC6443419

Treatment of Radiation-Induced Cognitive Decline in Adult Brain Tumor Patients.

Cramer CK,  Cummings TL,  Andrews RN,  Strowd R,  Rapp SR,  Shaw EG,  Chan MD,  Lesser GJ
Curr Treat Options Oncol 2019 Apr 8;20(5):42
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30963289
PMC ID: PMC6594685

A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403.

Stock W,  Luger SM,  Advani AS,  Yin J,  Harvey RC,  Mullighan CG,  Willman CL,  Fulton N,  Laumann KM,  Malnassy G,  Paietta E,  Parker E,  Geyer S,  Mrózek K,  Bloomfield CD,  Sanford B,  Marcucci G,  Liedtke M,  Claxton DF,  Foster MC,  Bogart JA,  Grecula JC,  Appelbaum FR,  Erba H,  Litzow MR,  Tallman MS,  Stone RM,  Larson RA
Blood 2019 Apr 4;133(14):1548-1559
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30658992
PMC ID: PMC6450431

Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study.

Qian F,  Wang S,  Mitchell J,  McGuffog L,  Barrowdale D,  Leslie G,  Oosterwijk JC,  Chung WK,  Evans DG,  Engel C,  Kast K,  Aalfs CM,  Adank MA,  Adlard J,  Agnarsson BA,  Aittomäki K,  Alducci E,  Andrulis IL,  Arun BK,  Ausems MGEM,  Azzollini J,  Barouk-Simonet E,  Barwell J,  Belotti M,  Benitez J,  Berger A,  Borg A,  Bradbury AR,  Brunet J,  Buys SS,  Caldes T,  Caligo MA,  Campbell I,  Caputo SM,  Chiquette J,  Claes KBM,  Margriet Collée J,  Couch FJ,  Coupier I,  Daly MB,  Davidson R,  Diez O,  Domchek SM,  Donaldson A,  Dorfling CM,  Eeles R,  Feliubadaló L,  Foretova L,  Fowler J,  Friedman E,  Frost D,  Ganz PA,  Garber J,  Garcia-Barberan V,  Glendon G,  Godwin AK,  Gómez Garcia EB,  Gronwald J,  Hahnen E,  Hamann U,  Henderson A,  Hendricks CB,  Hopper JL,  Hulick PJ,  Imyanitov EN,  Isaacs C,  Izatt L,  Izquierdo Á,  Jakubowska A,  Kaczmarek K,  Kang E,  Karlan BY,  Kets CM,  Kim SW,  Kim Z,  Kwong A,  Laitman Y,  Lasset C,  Hyuk Lee M,  Won Lee J,  Lee J,  Lester J,  Lesueur F,  Loud JT,  Lubinski J,  Mebirouk N,  Meijers-Heijboer HEJ,  Meindl A,  Miller A,  Montagna M,  Mooij TM,  Morrison PJ,  Mouret-Fourme E,  Nathanson KL,  Neuhausen SL,  Nevanlinna H,  Niederacher D,  Nielsen FC,  Nussbaum RL,  Offit K,  Olah E,  Ong KR,  Ottini L,  Park SK,  Peterlongo P,  Pfeiler G,  Phelan CM,  Poppe B,  Pradhan N,  Radice P,  Ramus SJ,  Rantala J,  Robson M,  Rodriguez GC,  Schmutzler RK,  Hutten Selkirk CG,  Shah PD,  Simard J,  Singer CF,  Sokolowska J,  Stoppa-Lyonnet D,  Sutter C,  Yen Tan Y,  Teixeira RM,  Teo SH,  Terry MB,  Thomassen M,  Tischkowitz M,  Toland AE,  Tucker KM,  Tung N,  van Asperen CJ,  van Engelen K,  van Rensburg EJ,  Wang-Gohrke S,  Wappenschmidt B,  Weitzel JN,  Yannoukakos D,  GEMO Study Collaborators,  HEBON,  EMBRACE,  Greene MH,  Rookus MA,  Easton DF,  Chenevix-Trench G,  Antoniou AC,  Goldgar DE,  Olopade OI,  Rebbeck TR,  Huo D
J Natl Cancer Inst 2019 Apr 1;111(4):350-364
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30312457
PMC ID: PMC6449171

Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology Practices.

Ramsey SD,  Unger JM,  Baker LH,  Little RF,  Loomba R,  Hwang JP,  Chugh R,  Konerman MA,  Arnold K,  Menter AR,  Thomas E,  Michels RM,  Jorgensen CW,  Burton GV,  Bhadkamkar NA,  Hershman DL
JAMA Oncol 2019 Apr 1;5(4):497-505
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30653226
PMC ID: PMC6459217

Long-term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer.

Videtic GM,  Paulus R,  Singh AK,  Chang JY,  Parker W,  Olivier KR,  Timmerman RD,  Komaki RR,  Urbanic JJ,  Stephans KL,  Yom SS,  Robinson CG,  Belani CP,  Iyengar P,  Ajlouni MI,  Gopaul DD,  Gomez Suescun JB,  McGarry RC,  Choy H,  Bradley JD
Int J Radiat Oncol Biol Phys 2019 Apr 1;103(5):1077-1084
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30513377
PMC ID: PMC6454873

Lung Cancer Screening in the National Cancer Institute Community Oncology Research Program: Availability and Service Organization.

Carlos RC,  Sicks JD,  Chiles C,  Gansauer L,  Kamen CS,  Kazak AE,  Neuman HB,  Unger JM,  Weaver KE
J Am Coll Radiol 2019 Apr;16(4 Pt A):427-434
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30819455
PMC ID: PMC6688499

Risk factors for chemotherapy-induced nausea in pediatric patients receiving highly emetogenic chemotherapy.

Dupuis LL,  Tamura RN,  Kelly KM,  Krischer JP,  Langevin AM,  Chen L,  Kolb EA,  Ullrich NJ,  Sahler OJZ,  Hendershot E,  Stratton A,  Sung L,  McLean TW
Pediatr Blood Cancer 2019 Apr;66(4):e27584
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30561134
PMC ID: not available

Understanding Decision Making about Breast Cancer Prevention in Action: The Intersection of Perceived Risk, Perceived Control, and Social Context: NRG Oncology/NSABP DMP-1.

Gunn CM,  Bokhour BG,  Parker VA,  Battaglia TA,  Parker PA,  Fagerlin A,  McCaskill-Stevens W,  Bandos H,  Blakeslee SB,  Holmberg C
Med Decis Making 2019 Apr;39(3):217-227
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsNCI Community Oncology Research Program
PubMed ID: 30803311
PMC ID: PMC6538065

Impact of chemotherapy for breast cancer on leukocyte DNA methylation landscape and cognitive function: a prospective study.

Yao S,  Hu Q,  Kerns S,  Yan L,  Onitilo AA,  Misleh J,  Young K,  Lei L,  Bautista J,  Mohamed M,  Mohile SG,  Ambrosone CB,  Liu S,  Janelsins MC
Clin Epigenetics 2019 Mar 12;11(1):45
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30867049
PMC ID: PMC6416954

Daily Lisinopril vs Placebo for Prevention of Chemoradiation-Induced Pulmonary Distress in Patients With Lung Cancer (Alliance MC1221): A Pilot Double-Blind Randomized Trial.

Sio TT,  Atherton PJ,  Pederson LD,  Zhen WK,  Mutter RW,  Garces YI,  Ma DJ,  Leenstra JL,  Rwigema JM,  Dakhil S,  Bearden JD,  van der Veen SJ,  Ganti AK,  Schild SE,  Miller RC
Int J Radiat Oncol Biol Phys 2019 Mar 1;103(3):686-696
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30395904
PMC ID: PMC6431240

Association of Patient Comorbid Conditions With Cancer Clinical Trial Participation.

Unger JM,  Hershman DL,  Fleury ME,  Vaidya R
JAMA Oncol 2019 Mar 1;5(3):326-333
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30629092
PMC ID: PMC6439841

Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation.

Unger JM,  Vaidya R,  Hershman DL,  Minasian LM,  Fleury ME
J Natl Cancer Inst 2019 Mar 1;111(3):245-255
Major Program(s) or Research Group(s): Office of the Director ;  NCI Community Oncology Research Program
PubMed ID: 30856272
PMC ID: PMC6410951

A randomized phase II study of cabozantinib versus weekly paclitaxel in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.

Matulonis UA,  Sill MW,  Makker V,  Mutch DG,  Carlson JW,  Darus CJ,  Mannel RS,  Bender DP,  Crane EK,  Aghajanian C
Gynecol Oncol 2019 Mar;152(3):548-553
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30587441
PMC ID: PMC6542283

Secondary outcomes of a behavioral sleep intervention: A randomized clinical trial.

Palesh O,  Scheiber C,  Kesler S,  Gevirtz R,  Heckler C,  Guido JJ,  Janelsins M,  Cases MG,  Tong B,  Miller JM,  Chrysson NG,  Mustian K
Health Psychol 2019 Mar;38(3):196-205
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30762399
PMC ID: PMC6892630

Fluoropyrimidine Cardiotoxicity: Time for a Contemporaneous Appraisal.

Upshaw JN,  O'Neill A,  Carver JR,  Dimond EP,  Denlinger CS,  Kircher SM,  Wagner LI,  Ky B,  Brell JM
Clin Colorectal Cancer 2019 Mar;18(1):44-51
Major Program(s) or Research Group(s): Breast and Gynecologic CancerNCI Community Oncology Research Program
PubMed ID: 30348619
PMC ID: PMC6927029

Overall Survival of Black and White Men With Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel.

Halabi S,  Dutta S,  Tangen CM,  Rosenthal M,  Petrylak DP,  Thompson IM Jr,  Chi KN,  Araujo JC,  Logothetis C,  Quinn DI,  Fizazi K,  Morris MJ,  Eisenberger MA,  George DJ,  De Bono JS,  Higano CS,  Tannock IF,  Small EJ,  Kelly WK
J Clin Oncol 2019 Feb 10;37(5):403-410
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30576268
PMC ID: PMC6804881

Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230.

Moore HCF,  Unger JM,  Phillips KA,  Boyle F,  Hitre E,  Moseley A,  Porter DJ,  Francis PA,  Goldstein LJ,  Gomez HL,  Vallejos CS,  Partridge AH,  Dakhil SR,  Garcia AA,  Gralow JR,  Lombard JM,  Forbes JF,  Martino S,  Barlow WE,  Fabian CJ,  Minasian LM,  Meyskens FL,  Gelber RD,  Hortobagyi GN,  Albain KS
J Natl Cancer Inst 2019 Feb 1;111(2):210-213
Major Program(s) or Research Group(s): Office of the Director ;  NCI Community Oncology Research Program
PubMed ID: 30371800
PMC ID: PMC6657277

Dietary Insulin Load and Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803 (Alliance).

Morales-Oyarvide V,  Yuan C,  Babic A,  Zhang S,  Niedzwiecki D,  Brand-Miller JC,  Sampson-Kent L,  Ye X,  Li Y,  Saltz LB,  Mayer RJ,  Mowat RB,  Whittom R,  Hantel A,  Benson A,  Atienza D,  Messino M,  Kindler H,  Venook A,  Ogino S,  Wu K,  Willett WC,  Giovannucci EL,  Wolpin BM,  Meyerhardt JA,  Fuchs CS,  Ng K
J Natl Cancer Inst 2019 Feb 1;111(2):170-179
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30726946
PMC ID: PMC6376913

Lymphedema symptoms and limb measurement changes in breast cancer survivors treated with neoadjuvant chemotherapy and axillary dissection: results of American College of Surgeons Oncology Group (ACOSOG) Z1071 (Alliance) substudy.

Armer JM,  Ballman KV,  McCall L,  Armer NC,  Sun Y,  Udmuangpia T,  Hunt KK,  Mittendorf EA,  Byrd DR,  Julian TB,  Boughey JC
Support Care Cancer 2019 Feb;27(2):495-503
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29980907
PMC ID: PMC6342501

Safety of pioglitazone during and after radiation therapy in patients with brain tumors: a phase I clinical trial.

Cramer CK,  Alphonse-Sullivan N,  Isom S,  Metheny-Barlow LJ,  Cummings TL,  Page BR,  Brown DR,  Blackstock AW Jr,  Peiffer AM,  Strowd RE,  Rapp S,  Lesser GJ,  Shaw EG,  Chan MD
J Cancer Res Clin Oncol 2019 Feb;145(2):337-344
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30417218
PMC ID: PMC6805132

Case-only Methods Identified Genetic Loci Predicting a Subgroup of Men with Reduced Risk of High-grade Prostate Cancer by Finasteride.

Dai JY,  LeBlanc M,  Goodman PJ,  Lucia MS,  Thompson IM,  Tangen CM
Cancer Prev Res (Phila) 2019 Feb;12(2):113-120
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30538099
PMC ID: PMC6365187

Long-Term Effects of Finasteride on Prostate Cancer Mortality.

Goodman PJ,  Tangen CM,  Darke AK,  Lucia MS,  Ford LG,  Minasian LM,  Parnes HL,  LeBlanc ML,  Thompson IM Jr
N Engl J Med 2019 Jan 24;380(4):393-394
Major Program(s) or Research Group(s): NCI Community Oncology Research Program ;  Office of the Director ;  Prostate and Urologic Cancer
PubMed ID: 30673548
PMC ID: not available

Time Interval to Biochemical Failure as a Surrogate End Point in Locally Advanced Prostate Cancer: Analysis of Randomized Trial NRG/RTOG 9202.

Dignam JJ,  Hamstra DA,  Lepor H,  Grignon D,  Brereton H,  Currey A,  Rosenthal S,  Zeitzer KL,  Venkatesan VM,  Horwitz EM,  Pisansky TM,  Sandler HM
J Clin Oncol 2019 Jan 20;37(3):213-221
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30526194
PMC ID: PMC6338393

Randomized Phase II Trial of Cisplatin and Etoposide in Combination With Veliparib or Placebo for Extensive-Stage Small-Cell Lung Cancer: ECOG-ACRIN 2511 Study.

Owonikoko TK,  Dahlberg SE,  Sica GL,  Wagner LI,  Wade JL 3rd,  Srkalovic G,  Lash BW,  Leach JW,  Leal TB,  Aggarwal C,  Ramalingam SS
J Clin Oncol 2019 Jan 20;37(3):222-229
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30523756
PMC ID: PMC6338394

Cognitive Behavioral Therapy for Insomnia Reduces Depression in Cancer Survivors.

Peoples AR,  Garland SN,  Pigeon WR,  Perlis ML,  Wolf JR,  Heffner KL,  Mustian KM,  Heckler CE,  Peppone LJ,  Kamen CS,  Morrow GR,  Roscoe JA
J Clin Sleep Med 2019 Jan 15;15(1):129-137
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30621831
PMC ID: PMC6329536

Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial.

Gillison ML,  Trotti AM,  Harris J,  Eisbruch A,  Harari PM,  Adelstein DJ,  Jordan RCK,  Zhao W,  Sturgis EM,  Burtness B,  Ridge JA,  Ringash J,  Galvin J,  Yao M,  Koyfman SA,  Blakaj DM,  Razaq MA,  Colevas AD,  Beitler JJ,  Jones CU,  Dunlap NE,  Seaward SA,  Spencer S,  Galloway TJ,  Phan J,  Dignam JJ,  Le QT
Lancet 2019 Jan 5;393(10166):40-50
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30449625
PMC ID: PMC6541928

Bladder Preservation With Twice-a-Day Radiation Plus Fluorouracil/Cisplatin or Once Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer: NRG/RTOG 0712-A Randomized Phase II Trial.

Coen JJ,  Zhang P,  Saylor PJ,  Lee CT,  Wu CL,  Parker W,  Lautenschlaeger T,  Zietman AL,  Efstathiou JA,  Jani AB,  Kucuk O,  Souhami L,  Rodgers JP,  Sandler HM,  Shipley WU
J Clin Oncol 2019 Jan 1;37(1):44-51
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30433852
PMC ID: PMC6354769

Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported Outcomes.

Hall WA,  Pugh SL,  Wefel JS,  Armstrong TS,  Gilbert MR,  Brachman DG,  Werner-Wasik M,  Wendland MM,  Brown PD,  Chao ST,  Roof KS,  Robins HI,  Mehta MP,  Curran WJ Jr,  Movsas B
Neurosurgery 2019 Jan 1;84(1):66-76
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29618054
PMC ID: PMC6500905

A Collaborative Analysis of Individual Participant Data from 19 Prospective Studies Assesses Circulating Vitamin D and Prostate Cancer Risk.

Travis RC,  Perez-Cornago A,  Appleby PN,  Albanes D,  Joshu CE,  Lutsey PL,  Mondul AM,  Platz EA,  Weinstein SJ,  Layne TM,  Helzlsouer KJ,  Visvanathan K,  Palli D,  Peeters PH,  Bueno-de-Mesquita B,  Trichopoulou A,  Gunter MJ,  Tsilidis KK,  Sánchez MJ,  Olsen A,  Brenner H,  Schöttker B,  Perna L,  Holleczek B,  Knekt P,  Rissanen H,  Yeap BB,  Flicker L,  Almeida OP,  Wong YYE,  Chan JM,  Giovannucci EL,  Stampfer MJ,  Ursin G,  Gislefoss RE,  Bjørge T,  Meyer HE,  Blomhoff R,  Tsugane S,  Sawada N,  English DR,  Eyles DW,  Heath AK,  Williamson EJ,  Manjer J,  Malm J,  Almquist M,  Marchand LL,  Haiman CA,  Wilkens LR,  Schenk JM,  Tangen CM,  Black A,  Cook MB,  Huang WY,  Ziegler RG,  Martin RM,  Hamdy FC,  Donovan JL,  Neal DE,  Touvier M,  Hercberg S,  Galan P,  Deschasaux M,  Key TJ,  Allen NE
Cancer Res 2019 Jan 1;79(1):274-285
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30425058
PMC ID: PMC6330070

Intertumoral Heterogeneity of CD3+ and CD8+ T-Cell Densities in the Microenvironment of DNA Mismatch-Repair-Deficient Colon Cancers: Implications for Prognosis.

Yoon HH,  Shi Q,  Heying EN,  Muranyi A,  Bredno J,  Ough F,  Djalilvand A,  Clements J,  Bowermaster R,  Liu WW,  Barnes M,  Alberts SR,  Shanmugam K,  Sinicrope FA
Clin Cancer Res 2019 Jan 1;25(1):125-133
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30301825
PMC ID: PMC6320300

Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study.

Adams CD,  Richmond R,  Ferreira DLS,  Spiller W,  Tan V,  Zheng J,  Würtz P,  Donovan J,  Hamdy F,  Neal D,  Lane JA,  Smith GD,  Relton C,  Eeles RA,  Haiman CA,  Kote-Jarai Z,  Schumacher FR,  Olama AAA,  Benlloch S,  Muir K,  Berndt SI,  Conti DV,  Wiklund F,  Chanock SJ,  Gapstur S,  Stevens VL,  Tangen CM,  Batra J,  Clements JA,  Gronberg H,  Pashayan N,  Schleutker J,  Albanes D,  Wolk A,  West CML,  Mucci LA,  Cancel-Tassin G,  Koutros S,  Sorensen KD,  Maehle L,  Travis RC,  Hamilton RJ,  Ingles SA,  Rosenstein BS,  Lu YJ,  Giles GG,  Kibel AS,  Vega A,  Kogevinas M,  Penney KL,  Park JY,  Stanford JL,  Cybulski C,  Nordestgaard BG,  Brenner H,  Maier C,  Kim J,  John EM,  Teixeira MR,  Neuhausen SL,  De Ruyck K,  Razack A,  Newcomb LF,  Lessel D,  Kaneva RP,  Usmani N,  Claessens F,  Townsend PA,  Dominguez MG,  Roobol MJ,  Menegaux F,  Khaw KT,  Cannon-Albright LA,  Pandha H,  Thibodeau SN,  Martin RM,  PRACTICAL consortium
Cancer Epidemiol Biomarkers Prev 2019 Jan;28(1):208-216
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30352818
PMC ID: PMC6746173

Mild cognitive impairment in long-term brain tumor survivors following brain irradiation.

Cramer CK,  McKee N,  Case LD,  Chan MD,  Cummings TL,  Lesser GJ,  Shaw EG,  Rapp SR
J Neurooncol 2019 Jan;141(1):235-244
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30406339
PMC ID: PMC6570494

Exploring Explanatory Models of Risk in Breast Cancer Risk Counseling Discussions: NSABP/NRG Oncology Decision-Making Project 1.

Gunn CM,  Bokhour B,  Parker VA,  Parker PA,  Blakeslee S,  Bandos H,  Holmberg C
Cancer Nurs 2019 Jan-Feb;42(1):3-11
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28661894
PMC ID: PMC5745305

Discovery of common and rare genetic risk variants for colorectal cancer.

Huyghe JR,  Bien SA,  Harrison TA,  Kang HM,  Chen S,  Schmit SL,  Conti DV,  Qu C,  Jeon J,  Edlund CK,  Greenside P,  Wainberg M,  Schumacher FR,  Smith JD,  Levine DM,  Nelson SC,  Sinnott-Armstrong NA,  Albanes D,  Alonso MH,  Anderson K,  Arnau-Collell C,  Arndt V,  Bamia C,  Banbury BL,  Baron JA,  Berndt SI,  Bézieau S,  Bishop DT,  Boehm J,  Boeing H,  Brenner H,  Brezina S,  Buch S,  Buchanan DD,  Burnett-Hartman A,  Butterbach K,  Caan BJ,  Campbell PT,  Carlson CS,  Castellví-Bel S,  Chan AT,  Chang-Claude J,  Chanock SJ,  Chirlaque MD,  Cho SH,  Connolly CM,  Cross AJ,  Cuk K,  Curtis KR,  de la Chapelle A,  Doheny KF,  Duggan D,  Easton DF,  Elias SG,  Elliott F,  English DR,  Feskens EJM,  Figueiredo JC,  Fischer R,  FitzGerald LM,  Forman D,  Gala M,  Gallinger S,  Gauderman WJ,  Giles GG,  Gillanders E,  Gong J,  Goodman PJ,  Grady WM,  Grove JS,  Gsur A,  Gunter MJ,  Haile RW,  Hampe J,  Hampel H,  Harlid S,  Hayes RB,  Hofer P,  Hoffmeister M,  Hopper JL,  Hsu WL,  Huang WY,  Hudson TJ,  Hunter DJ,  Ibañez-Sanz G,  Idos GE,  Ingersoll R,  Jackson RD,  Jacobs EJ,  Jenkins MA,  Joshi AD,  Joshu CE,  Keku TO,  Key TJ,  Kim HR,  Kobayashi E,  Kolonel LN,  Kooperberg C,  Kühn T,  Küry S,  Kweon SS,  Larsson SC,  Laurie CA,  Le Marchand L,  Leal SM,  Lee SC,  Lejbkowicz F,  Lemire M,  Li CI,  Li L,  Lieb W,  Lin Y,  Lindblom A,  Lindor NM,  Ling H,  Louie TL,  Männistö S,  Markowitz SD,  Martín V,  Masala G,  McNeil CE,  Melas M,  Milne RL,  Moreno L,  Murphy N,  Myte R,  Naccarati A,  Newcomb PA,  Offit K,  Ogino S,  Onland-Moret NC,  Pardini B,  Parfrey PS,  Pearlman R,  Perduca V,  Pharoah PDP,  Pinchev M,  Platz EA,  Prentice RL,  Pugh E,  Raskin L,  Rennert G,  Rennert HS,  Riboli E,  Rodríguez-Barranco M,  Romm J,  Sakoda LC,  Schafmayer C,  Schoen RE,  Seminara D,  Shah M,  Shelford T,  Shin MH,  Shulman K,  Sieri S,  Slattery ML,  Southey MC,  Stadler ZK,  Stegmaier C,  Su YR,  Tangen CM,  Thibodeau SN,  Thomas DC,  Thomas SS,  Toland AE,  Trichopoulou A,  Ulrich CM,  Van Den Berg DJ,  van Duijnhoven FJB,  Van Guelpen B,  van Kranen H,  Vijai J,  Visvanathan K,  Vodicka P,  Vodickova L,  Vymetalkova V,  Weigl K,  Weinstein SJ,  White E,  Win AK,  Wolf CR,  Wolk A,  Woods MO,  Wu AH,  Zaidi SH,  Zanke BW,  Zhang Q,  Zheng W,  Scacheri PC,  Potter JD,  Bassik MC,  Kundaje A,  Casey G,  Moreno V,  Abecasis GR,  Nickerson DA,  Gruber SB,  Hsu L,  Peters U
Nat Genet 2019 Jan;51(1):76-87
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialNCI Community Oncology Research Program
PubMed ID: 30510241
PMC ID: PMC6358437

Social Support, Insomnia, and Adherence to Cognitive Behavioral Therapy for Insomnia After Cancer Treatment.

Kamen C,  Garland SN,  Heckler CE,  Peoples AR,  Kleckner IR,  Cole CL,  Perlis ML,  Morrow GR,  Mustian KM,  Roscoe JA
Behav Sleep Med 2019 Jan-Feb;17(1):70-80
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28128982
PMC ID: PMC5577382

Response to Crevenna and Ashbury, Vallance and Bolam, and Crevenna and Keilani regarding the effects of exercise on chemotherapy-induced peripheral neuropathy.

Kleckner IR,  Kamen C,  Gewandter JS,  Mohile NA,  Heckler CE,  Culakova E,  Fung C,  Janelsins MC,  Asare M,  Lin PJ,  Reddy PS,  Giguere J,  Berenberg J,  Kesler SR,  Mustian KM
Support Care Cancer 2019 Jan;27(1):7-8
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30374766
PMC ID: PMC6381835

Influence of Yoga on Cancer-Related Fatigue and on Mediational Relationships Between Changes in Sleep and Cancer-Related Fatigue: A Nationwide, Multicenter Randomized Controlled Trial of Yoga in Cancer Survivors.

Lin PJ,  Kleckner IR,  Loh KP,  Inglis JE,  Peppone LJ,  Janelsins MC,  Kamen CS,  Heckler CE,  Culakova E,  Pigeon WR,  Reddy PS,  Messino MJ,  Gaur R,  Mustian KM
Integr Cancer Ther 2019 Jan-Dec;18:1534735419855134
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31165647
PMC ID: PMC6552348

Communication about geriatric assessment domains in advanced cancer settings: "Missed opportunities".

Lowenstein LM,  Volk RJ,  Street R,  Flannery M,  Magnuson A,  Epstein R,  Mohile SG
J Geriatr Oncol 2019 Jan;10(1):68-73
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29884597
PMC ID: PMC6281774

Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial.

Mamounas EP,  Bandos H,  Lembersky BC,  Jeong JH,  Geyer CE Jr,  Rastogi P,  Fehrenbacher L,  Graham ML,  Chia SK,  Brufsky AM,  Walshe JM,  Soori GS,  Dakhil SR,  Seay TE,  Wade JL 3rd,  McCarron EC,  Paik S,  Swain SM,  Wickerham DL,  Wolmark N
Lancet Oncol 2019 Jan;20(1):88-99
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30509771
PMC ID: PMC6691732

Cancer and Aging: Reflections for Elders (CARE): A pilot randomized controlled trial of a psychotherapy intervention for older adults with cancer.

Nelson CJ,  Saracino RM,  Roth AJ,  Harvey E,  Martin A,  Moore M,  Marcone D,  Poppito SR,  Holland J
Psychooncology 2019 Jan;28(1):39-47
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30296337
PMC ID: PMC6476184

Systematic Review of Randomized Controlled Trials of Exercise Interventions Using Digital Activity Trackers in Patients With Cancer.

Schaffer K,  Panneerselvam N,  Loh KP,  Herrmann R,  Kleckner IR,  Dunne RF,  Lin PJ,  Heckler CE,  Gerbino N,  Bruckner LB,  Storozynsky E,  Ky B,  Baran A,  Mohile SG,  Mustian KM,  Fung C
J Natl Compr Canc Netw 2019 Jan;17(1):57-63
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30659130
PMC ID: PMC6519727

Identifying clinical practice guidelines for the supportive care of children with cancer: A report from the Children's Oncology Group.

Seelisch J,  Sung L,  Kelly MJ,  Raybin JL,  Beauchemin M,  Dvorak CC,  Kelly KP,  Nieder ML,  Noll RB,  Thackray J,  Ullrich NJ,  Cabral S,  Dupuis LL,  Robinson PD
Pediatr Blood Cancer 2019 Jan;66(1):e27471
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30259647
PMC ID: PMC6249051

Let's Talk About Those Herbs You Are Taking: Ethical Considerations for Communication With Patients With Cancer About Complementary and Alternative Medicine.

Tenner L,  Hlubocky FJ,  Blanke CD,  LeBlanc TW,  Marron JM,  McGinnis MM,  Spence RA,  Taylor LP
J Oncol Pract 2019 Jan;15(1):44-49
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30629899
PMC ID: PMC6804900

Randomized phase II/III confirmatory treatment selection design with a change of survival end points: Statistical design of Radiation Therapy Oncology Group 1216.

Zhang QE,  Wu Q,  Harari PM,  Rosenthal DI
Head Neck 2019 Jan;41(1):37-45
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30549358
PMC ID: PMC6587571

Nutritional Interventions for Treating Cancer-Related Fatigue: A Qualitative Review.

Inglis JE,  Lin PJ,  Kerns SL,  Kleckner IR,  Kleckner AS,  Castillo DA,  Mustian KM,  Peppone LJ
Nutr Cancer 2019;71(1):21-40
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30688088
PMC ID: PMC6456409

Opportunities for cannabis in supportive care in cancer.

Kleckner AS,  Kleckner IR,  Kamen CS,  Tejani MA,  Janelsins MC,  Morrow GR,  Peppone LJ
Ther Adv Med Oncol 2019;11:1758835919866362
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31413731
PMC ID: PMC6676264

Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL.

Woyach JA,  Ruppert AS,  Heerema NA,  Zhao W,  Booth AM,  Ding W,  Bartlett NL,  Brander DM,  Barr PM,  Rogers KA,  Parikh SA,  Coutre S,  Hurria A,  Brown JR,  Lozanski G,  Blachly JS,  Ozer HG,  Major-Elechi B,  Fruth B,  Nattam S,  Larson RA,  Erba H,  Litzow M,  Owen C,  Kuzma C,  Abramson JS,  Little RF,  Smith SE,  Stone RM,  Mandrekar SJ,  Byrd JC
N Engl J Med 2018 Dec 27;379(26):2517-2528
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30501481
PMC ID: PMC6325637

Acupuncture for Aromatase Inhibitor-Related Joint Pain Among Breast Cancer Patients.

Hershman DL,  Unger JM,  Crew K
JAMA 2018 Dec 4;320(21):2270-2271
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30512095
PMC ID: not available

Simulation Modeling of Cancer Clinical Trials: Application to Omitting Radiotherapy in Low-risk Breast Cancer.

Jayasekera J,  Li Y,  Schechter CB,  Jagsi R,  Song J,  White J,  Luta G,  Chapman JW,  Feuer EJ,  Zellars RC,  Stout N,  Julian TB,  Whelan T,  Huang X,  Shelley Hwang E,  Hopkins JO,  Sparano JA,  Anderson SJ,  Fyles AW,  Gray R,  Sauerbrei W,  Mandelblatt J,  Berry DA,  CISNET-BOLD Collaborative Group
J Natl Cancer Inst 2018 Dec 1;110(12):1360-1369
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29718314
PMC ID: PMC6292816

Effects of Radiotherapy in Early-Stage, Low-Recurrence Risk, Hormone-Sensitive Breast Cancer.

Jayasekera J,  Schechter CB,  Sparano JA,  Jagsi R,  White J,  Chapman JW,  Whelan T,  Anderson SJ,  Fyles AW,  Sauerbrei W,  Zellars RC,  Li Y,  Song J,  Huang X,  Julian TB,  Luta G,  Berry DA,  Feuer EJ,  Mandelblatt J,  CISNET-BOLD Collaborative Group
J Natl Cancer Inst 2018 Dec 1;110(12):1370-1379
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30239794
PMC ID: PMC6292790

Multimedia psychoeducation for patients with cancer who are eligible for clinical trials: A randomized clinical trial.

Kamen CS,  Quinn GP,  Asare M,  Heckler CE,  Guido JJ,  Giguere JK,  Gilliland K,  Liu JJ,  Geer J,  Delacroix SE,  Morrow GR,  Jacobsen PB
Cancer 2018 Dec 1;124(23):4504-4511
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30291797
PMC ID: PMC6558986

Incorporating Digital Tools to Improve Clinical Trial Infrastructure: A White Paper From the Digital Engagement Committee of SWOG.

Dizon DS,  Sedrak MS,  Lewis MA,  Cook E,  Fisch MJ,  Klemp JR,  Sommers J,  Ciccarella A,  Gralow J,  Lawton W,  Nichols C,  SWOG Digital Engagement Committee
JCO Clin Cancer Inform 2018 Dec;2:1-8
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30652537
PMC ID: PMC6668704

A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: An NRG oncology/gynecologic oncology group study.

Monk BJ,  Kauderer JT,  Moxley KM,  Bonebrake AJ,  Dewdney SB,  Secord AA,  Ueland FR,  Johnston CM,  Aghajanian C
Gynecol Oncol 2018 Dec;151(3):422-427
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30309721
PMC ID: PMC6392076

Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927).

Shen S,  Unger JM,  Crew KD,  Till C,  Greenlee H,  Gralow J,  Dakhil SR,  Minasian LM,  Wade JL 3rd,  Fisch MJ,  Henry NL,  Hershman DL
Breast Cancer Res Treat 2018 Dec;172(3):603-610
Major Program(s) or Research Group(s): Office of the Director ;  NCI Community Oncology Research Program
PubMed ID: 30159789
PMC ID: PMC6681817

Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221).

Mongiovi JM,  Zirpoli GR,  Cannioto R,  Sucheston-Campbell LE,  Hershman DL,  Unger JM,  Moore HCF,  Stewart JA,  Isaacs C,  Hobday TJ,  Salim M,  Hortobagyi GN,  Gralow JR,  Thomas Budd G,  Albain KS,  Ambrosone CB,  McCann SE
Breast Cancer Res 2018 Nov 28;20(1):146
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30486865
PMC ID: PMC6264595

Germline variation at 8q24 and prostate cancer risk in men of European ancestry.

Matejcic M,  Saunders EJ,  Dadaev T,  Brook MN,  Wang K,  Sheng X,  Olama AAA,  Schumacher FR,  Ingles SA,  Govindasami K,  Benlloch S,  Berndt SI,  Albanes D,  Koutros S,  Muir K,  Stevens VL,  Gapstur SM,  Tangen CM,  Batra J,  Clements J,  Gronberg H,  Pashayan N,  Schleutker J,  Wolk A,  West C,  Mucci L,  Kraft P,  Cancel-Tassin G,  Sorensen KD,  Maehle L,  Grindedal EM,  Strom SS,  Neal DE,  Hamdy FC,  Donovan JL,  Travis RC,  Hamilton RJ,  Rosenstein B,  Lu YJ,  Giles GG,  Kibel AS,  Vega A,  Bensen JT,  Kogevinas M,  Penney KL,  Park JY,  Stanford JL,  Cybulski C,  Nordestgaard BG,  Brenner H,  Maier C,  Kim J,  Teixeira MR,  Neuhausen SL,  De Ruyck K,  Razack A,  Newcomb LF,  Lessel D,  Kaneva R,  Usmani N,  Claessens F,  Townsend PA,  Gago-Dominguez M,  Roobol MJ,  Menegaux F,  Khaw KT,  Cannon-Albright LA,  Pandha H,  Thibodeau SN,  Schaid DJ,  PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium,  Wiklund F,  Chanock SJ,  Easton DF,  Eeles RA,  Kote-Jarai Z,  Conti DV,  Haiman CA
Nat Commun 2018 Nov 5;9(1):4616
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialNCI Community Oncology Research Program
PubMed ID: 30397198
PMC ID: PMC6218483

Reduced Risk of Prostate Cancer With 5α-Reductase Inhibitors.

Thompson I Jr,  Goodman P,  Tangen C
J Natl Cancer Inst 2018 Nov 1;110(11):1159-1160
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29547919
PMC ID: PMC6454440

Using Medicare Claims to Examine Long-term Prostate Cancer Risk of Finasteride in the Prostate Cancer Prevention Trial.

Unger JM,  Hershman DL,  Till C,  Tangen CM,  Barlow WE,  Ramsey SD,  Goodman PJ,  Thompson IM Jr
J Natl Cancer Inst 2018 Nov 1;110(11):1208-1215
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29534197
PMC ID: PMC6235685

Quality of Life in Partners of Young and Old Breast Cancer Survivors.

Cohee AA,  Bigatti SM,  Shields CG,  Johns SA,  Stump T,  Monahan PO,  Champion VL
Cancer Nurs 2018 Nov-Dec;41(6):491-497
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29538019
PMC ID: PMC6136975

Conscious awareness is necessary for affective faces to influence social judgments.

Kleckner IR,  Anderson EC,  Betz NJ,  Wormwood JB,  Eskew RT Jr,  Barrett LF
J Exp Soc Psychol 2018 Nov;79:181-187
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31097841
PMC ID: PMC6511977

Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial.

Roach M,  Moughan J,  Lawton CAF,  Dicker AP,  Zeitzer KL,  Gore EM,  Kwok Y,  Seider MJ,  Hsu IC,  Hartford AC,  Horwitz EM,  Yamoah K,  Jones CU,  Michalski JM,  Lee WR,  Pisansky TM,  Rabinovitch R,  Rotman M,  Pryzant RM,  Kim HE,  Thomas CR Jr,  Shipley WU,  Sandler HM
Lancet Oncol 2018 Nov;19(11):1504-1515
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30316827
PMC ID: PMC6540797

Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective Studies.

Watts EL,  Appleby PN,  Perez-Cornago A,  Bueno-de-Mesquita HB,  Chan JM,  Chen C,  Cohn BA,  Cook MB,  Flicker L,  Freedman ND,  Giles GG,  Giovannucci E,  Gislefoss RE,  Hankey GJ,  Kaaks R,  Knekt P,  Kolonel LN,  Kubo T,  Le Marchand L,  Luben RN,  Luostarinen T,  Männistö S,  Metter EJ,  Mikami K,  Milne RL,  Ozasa K,  Platz EA,  Quirós JR,  Rissanen H,  Sawada N,  Stampfer M,  Stanczyk FZ,  Stattin P,  Tamakoshi A,  Tangen CM,  Thompson IM,  Tsilidis KK,  Tsugane S,  Ursin G,  Vatten L,  Weiss NS,  Yeap BB,  Allen NE,  Key TJ,  Travis RC
Eur Urol 2018 Nov;74(5):585-594
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30077399
PMC ID: PMC6195673

Novel mHealth App to Deliver Geriatric Assessment-Driven Interventions for Older Adults With Cancer: Pilot Feasibility and Usability Study.

Loh KP,  Ramsdale E,  Culakova E,  Mendler JH,  Liesveld JL,  O'Dwyer KM,  McHugh C,  Gilles M,  Lloyd T,  Goodman M,  Klepin HD,  Mustian KM,  Schnall R,  Mohile SG
JMIR Cancer 2018 Oct 29;4(2):e10296
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30373733
PMC ID: PMC6234352

Identification of a Genomic Region between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance).

Li M,  Mulkey F,  Jiang C,  O'Neil BH,  Schneider BP,  Shen F,  Friedman PN,  Momozawa Y,  Kubo M,  Niedzwiecki D,  Hochster HS,  Lenz HJ,  Atkins JN,  Rugo HS,  Halabi S,  Kelly WK,  McLeod HL,  Innocenti F,  Ratain MJ,  Venook AP,  Owzar K,  Kroetz DL
Clin Cancer Res 2018 Oct 1;24(19):4734-4744
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29871907
PMC ID: PMC6168379

Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer.

Lukka HR,  Pugh SL,  Bruner DW,  Bahary JP,  Lawton CAF,  Efstathiou JA,  Kudchadker RJ,  Ponsky LE,  Seaward SA,  Dayes IS,  Gopaul DD,  Michalski JM,  Delouya G,  Kaplan ID,  Horwitz EM,  Roach M 3rd,  Pinover WH,  Beyer DC,  Amanie JO,  Sandler HM,  Kachnic LA
Int J Radiat Oncol Biol Phys 2018 Oct 1;102(2):287-295
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29913254
PMC ID: PMC6248906

Chemoprevention in Prostate Cancer: Current Perspective and Future Directions.

Rivero JR Jr,  Thompson IM Jr,  Liss MA,  Kaushik D
Cold Spring Harb Perspect Med 2018 Oct 1;8(10)
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29311128
PMC ID: PMC6169981

Phase II Feasibility Study of a Weight Loss Intervention in Female Breast and Colorectal Cancer Survivors (SWOG S1008).

Greenlee H,  Lew DL,  Hershman DL,  Newman VA,  Hansen L,  Hartman SJ,  Korner J,  Shi Z,  Sardo Molmenti CL,  Sayegh A,  Fehrenbacher L,  Lo S,  Klemp J,  Rinn K,  Robertson JM,  Unger J,  Gralow J,  Albain K,  Krouse R,  Fabian C
Obesity (Silver Spring) 2018 Oct;26(10):1539-1549
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30272836
PMC ID: PMC6611675

More Frequent Surveillance Following Lung Cancer Resection Is Not Associated With Improved Survival: A Nationally Representative Cohort Study.

McMurry TL,  Stukenborg GJ,  Kessler LG,  Colditz GA,  Wong ML,  Francescatti AB,  Jones DR,  Schumacher JR,  Greenberg CC,  Chang GJ,  Winchester DP,  McKellar DP,  Kozower BD
Ann Surg 2018 Oct;268(4):632-639
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30004919
PMC ID: PMC6419100

The complicated 'Yes': Decision-making processes and receptivity to lung cancer screening among head and neck cancer survivors.

Seaman AT,  Dukes K,  Hoffman RM,  Christensen AJ,  Kendell N,  Sussman AL,  Veléz-Bermúdez M,  Volk RJ,  Pagedar NA
Patient Educ Couns 2018 Oct;101(10):1741-1747
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29709410
PMC ID: PMC6119119

Randomized phase III trial to evaluate radiopharmaceuticals and zoledronic acid in the palliation of osteoblastic metastases from lung, breast, and prostate cancer: report of the NRG Oncology RTOG 0517 trial.

Seider MJ,  Pugh SL,  Langer C,  Wyatt G,  Demas W,  Rashtian A,  Clausen CL,  Derdel JD,  Cleary SF,  Peters CA,  Ramalingam A,  Clarkson JE,  Tomblyn M,  Rabinovitch RA,  Kachnic LA,  Berk LB,  NRG Oncology
Ann Nucl Med 2018 Oct;32(8):553-560
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30094545
PMC ID: PMC6245542

Dietary Fat Intake after Colon Cancer Diagnosis in Relation to Cancer Recurrence and Survival: CALGB 89803 (Alliance).

Van Blarigan EL,  Ou FS,  Niedzwiecki D,  Zhang S,  Fuchs CS,  Saltz L,  Mayer RJ,  Venook A,  Ogino S,  Song M,  Benson A,  Hantel A,  Atkins JN,  Giovannucci EL,  Meyerhardt JA
Cancer Epidemiol Biomarkers Prev 2018 Oct;27(10):1227-1230
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30038051
PMC ID: PMC6170705

Longitudinal Trajectory and Characterization of Cancer-Related Cognitive Impairment in a Nationwide Cohort Study.

Janelsins MC,  Heckler CE,  Peppone LJ,  Ahles TA,  Mohile SG,  Mustian KM,  Palesh O,  O'Mara AM,  Minasian LM,  Williams AM,  Magnuson A,  Geer J,  Dakhil SR,  Hopkins JO,  Morrow GR
J Clin Oncol 2018 Sep 21 :JCO2018786624
Major Program(s) or Research Group(s): Office of the Director ;  NCI Community Oncology Research Program
PubMed ID: 30240328
PMC ID: PMC6225503

Effect of Levofloxacin Prophylaxis on Bacteremia in Children With Acute Leukemia or Undergoing Hematopoietic Stem Cell Transplantation: A Randomized Clinical Trial.

Alexander S,  Fisher BT,  Gaur AH,  Dvorak CC,  Villa Luna D,  Dang H,  Chen L,  Green M,  Nieder ML,  Fisher B,  Bailey LC,  Wiernikowski J,  Sung L,  Children's Oncology Group
JAMA 2018 Sep 11;320(10):995-1004
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30208456
PMC ID: PMC6143098

Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048.

Basch E,  Dueck AC,  Rogak LJ,  Mitchell SA,  Minasian LM,  Denicoff AM,  Wind JK,  Shaw MC,  Heon N,  Shi Q,  Ginos B,  Nelson GD,  Meyers JP,  Chang GJ,  Mamon HJ,  Weiser MR,  Kolevska T,  Reeve BB,  Bruner DW,  Schrag D
J Clin Oncol 2018 Sep 11 :JCO2018788620
Major Program(s) or Research Group(s): Office of the Director ;  NCI Community Oncology Research Program
PubMed ID: 30204536
PMC ID: PMC6209091

Association of Cardiovascular Risk Factors With Cardiac Events and Survival Outcomes Among Patients With Breast Cancer Enrolled in SWOG Clinical Trials.

Hershman DL,  Till C,  Shen S,  Wright JD,  Ramsey SD,  Barlow WE,  Unger JM
J Clin Oncol 2018 Sep 10;36(26):2710-2717
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29584550
PMC ID: PMC6127026

Prognostic value of contrast enhancement and FLAIR for survival in newly diagnosed glioblastoma treated with and without bevacizumab: results from ACRIN 6686.

Boxerman JL,  Zhang Z,  Safriel Y,  Rogg JM,  Wolf RL,  Mohan S,  Marques H,  Sorensen AG,  Gilbert MR,  Barboriak DP
Neuro Oncol 2018 Sep 3;20(10):1400-1410
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29590461
PMC ID: PMC6120359

Nurse-Delivered Symptom Assessment for Individuals With Advanced Lung Cancer.

Flannery M,  Stein KF,  Dougherty DW,  Mohile S,  Guido J,  Wells N
Oncol Nurs Forum 2018 Sep 1;45(5):619-630
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30118448
PMC ID: PMC6379074

Do older patients with non-small cell lung cancer also benefit from first-line platinum-based doublet chemotherapy? Observations from a pooled analysis of 730 prospectively-treated patients (Alliance Study A151622).

Feliciano JL,  Le-Rademacher JG,  Gajra A,  Edelman MJ,  Zemla T,  McMurray R,  Chen H,  Hurria A,  Muss H,  Cohen HJ,  Lilenbaum R,  Jatoi A
J Geriatr Oncol 2018 Sep;9(5):501-506
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29848457
PMC ID: PMC6233872

Promoting Accrual of Older Patients with Cancer to Clinical Trials: An Alliance for Clinical Trials in Oncology Member Survey (A171602).

Freedman RA,  Dockter TJ,  Lafky JM,  Hurria A,  Muss HJ,  Cohen HJ,  Jatoi A,  Kemeny MM,  Ruddy KJ
Oncologist 2018 Sep;23(9):1016-1023
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29674441
PMC ID: PMC6192613

Identification of risk factors for toxicity in patients with hormone receptor-positive advanced breast cancer treated with bevacizumab plus letrozole: a CALGB 40503 (alliance) correlative study.

Li D,  McCall LM,  Hahn OM,  Hudis CA,  Cohen HJ,  Muss HB,  Jatoi A,  Lafky JM,  Ballman KV,  Winer EP,  Tripathy D,  Schneider B,  Barry W,  Dickler MN,  Hurria A
Breast Cancer Res Treat 2018 Sep;171(2):325-334
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29789969
PMC ID: PMC6076849

Geriatric assessment-driven polypharmacy discussions between oncologists, older patients, and their caregivers.

Ramsdale E,  Lemelman T,  Loh KP,  Flannery M,  Kehoe L,  Mullaney T,  Wells M,  Gilmore N,  Plumb S,  Mohile S
J Geriatr Oncol 2018 Sep;9(5):534-539
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29530495
PMC ID: PMC6113101

Association Between Inflammatory Biomarker C-Reactive Protein and Radiotherapy-Induced Early Adverse Skin Reactions in a Multiracial/Ethnic Breast Cancer Population.

Hu JJ,  Urbanic JJ,  Case LD,  Takita C,  Wright JL,  Brown DR,  Langefeld CD,  Lively MO,  Mitchell SE,  Thakrar A,  Bryant D,  Baglan K,  Strasser J,  Baez-Diaz L,  Lesser GJ,  Shaw EG
J Clin Oncol 2018 Aug 20;36(24):2473-2482
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29989859
PMC ID: PMC6097833

Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203.

Klopp AH,  Yeung AR,  Deshmukh S,  Gil KM,  Wenzel L,  Westin SN,  Gifford K,  Gaffney DK,  Small W Jr,  Thompson S,  Doncals DE,  Cantuaria GHC,  Yaremko BP,  Chang A,  Kundapur V,  Mohan DS,  Haas ML,  Kim YB,  Ferguson CL,  Pugh SL,  Kachnic LA,  Bruner DW
J Clin Oncol 2018 Aug 20;36(24):2538-2544
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29989857
PMC ID: PMC6097832

The comparative effectiveness of decision aids in diverse populations with early stage prostate cancer: a study protocol for a cluster-randomized controlled trial in the NCI Community Oncology Research Program (NCORP), Alliance A191402CD.

Pacyna JE,  Kim S,  Yost K,  Sedlacek H,  Petereit D,  Kaur J,  Rapkin B,  Grubb R,  Paskett E,  Chang GJ,  Sloan J,  Basch E,  Major B,  Novotny P,  Taylor J,  Buckner J,  Parsons JK,  Morris M,  Tilburt JC
BMC Cancer 2018 Aug 6;18(1):788
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30081846
PMC ID: PMC6080528

Geographic Distribution and Survival Outcomes for Rural Patients With Cancer Treated in Clinical Trials.

Unger JM,  Moseley A,  Symington B,  Chavez-MacGregor M,  Ramsey SD,  Hershman DL
JAMA Netw Open 2018 Aug 3;1(4):e181235
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30646114
PMC ID: PMC6324281

Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology.

Mohile SG,  Dale W,  Somerfield MR,  Schonberg MA,  Boyd CM,  Burhenn PS,  Canin B,  Cohen HJ,  Holmes HM,  Hopkins JO,  Janelsins MC,  Khorana AA,  Klepin HD,  Lichtman SM,  Mustian KM,  Tew WP,  Hurria A
J Clin Oncol 2018 Aug 1;36(22):2326-2347
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29782209
PMC ID: PMC6063790

Pre-operative assessment and post-operative outcomes of elderly women with gynecologic cancers, primary analysis of NRG CC-002: An NRG oncology group/gynecologic oncology group study.

Ahmed A,  Deng W,  Tew W,  Bender D,  Mannel RS,  Littell RD,  DeNittis AS,  Edelson M,  Morgan M,  Carlson J,  Darus CJ,  Fleury AC,  Modesitt S,  Olawaiye A,  Evans A,  Fleming GF
Gynecol Oncol 2018 Aug;150(2):300-305
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29807694
PMC ID: PMC6387790

Predicting Cardiovascular Disease Among Testicular Cancer Survivors After Modern Cisplatin-based Chemotherapy: Application of the Framingham Risk Score.

Feldman DR,  Ardeshir-Rouhani-Fard S,  Monahan P,  Sesso HD,  Fung C,  Williams AM,  Hamilton RJ,  Vaughn DJ,  Beard CJ,  Cook R,  Zaid MA,  Lipshultz SE,  Einhorn LH,  Oeffinger KC,  Travis LB,  Fossa SD,  Platinum Study Group
Clin Genitourin Cancer 2018 Aug;16(4):e761-e769
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29534941
PMC ID: PMC6063791

Cardiovascular Magnetic Resonance in the Oncology Patient.

Jordan JH,  Todd RM,  Vasu S,  Hundley WG
JACC Cardiovasc Imaging 2018 Aug;11(8):1150-1172
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30092971
PMC ID: PMC6242266

Hyperglycemia during first-line R-CHOP or dose adjusted R-EPOCH chemotherapy for non-Hodgkin lymphoma is prevalent and associated with chemotherapy alteration - a retrospective study.

Lamar ZS,  Dothard A,  Kennedy L,  Isom S,  Robinson M,  Vaidya R,  Hurd D,  McClain D,  Lesser G
Leuk Lymphoma 2018 Aug;59(8):1871-1877
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29252084
PMC ID: PMC6005713

Feasibility and acceptability of brief behavioral therapy for cancer-related insomnia: effects on insomnia and circadian rhythm during chemotherapy: a phase II randomised multicentre controlled trial.

Palesh O,  Scheiber C,  Kesler S,  Janelsins MC,  Guido JJ,  Heckler C,  Cases MG,  Miller J,  Chrysson NG,  Mustian KM
Br J Cancer 2018 Aug;119(3):274-281
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30026614
PMC ID: PMC6068121

The effects of high-dose calcitriol and individualized exercise on bone metabolism in breast cancer survivors on hormonal therapy: a phase II feasibility trial.

Peppone LJ,  Ling M,  Huston AJ,  Reid ME,  Janelsins MC,  Puzas JE,  Kamen C,  Del Giglio A,  Asare M,  Peoples AR,  Mustian KM
Support Care Cancer 2018 Aug;26(8):2675-2683
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29470705
PMC ID: PMC6019129

The scientific impact and value of large, NCI-sponsored randomized phase III cancer chemoprevention trials.

Unger JM,  Barlow WE,  Tangen CM,  Ramsey SD,  Thompson IM Jr,  Klein EA,  LeBlanc M,  Blanke CD,  Goodman PJ,  Minasian LM,  Nghiem VT,  Hershman DL
Cancer Epidemiol 2018 Aug;55:117-122
Major Program(s) or Research Group(s): Office of the Director ;  NCI Community Oncology Research Program
PubMed ID: 29936140
PMC ID: PMC6625804

Surveillance for Late Effects in Childhood Cancer Survivors.

Landier W,  Skinner R,  Wallace WH,  Hjorth L,  Mulder RL,  Wong FL,  Yasui Y,  Bhakta N,  Constine LS,  Bhatia S,  Kremer LC,  Hudson MM
J Clin Oncol 2018 Jul 20;36(21):2216-2222
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29874139
PMC ID: PMC6804892

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.

Francis PA,  Pagani O,  Fleming GF,  Walley BA,  Colleoni M,  Láng I,  Gómez HL,  Tondini C,  Ciruelos E,  Burstein HJ,  Bonnefoi HR,  Bellet M,  Martino S,  Geyer CE Jr,  Goetz MP,  Stearns V,  Pinotti G,  Puglisi F,  Spazzapan S,  Climent MA,  Pavesi L,  Ruhstaller T,  Davidson NE,  Coleman R,  Debled M,  Buchholz S,  Ingle JN,  Winer EP,  Maibach R,  Rabaglio-Poretti M,  Ruepp B,  Di Leo A,  Coates AS,  Gelber RD,  Goldhirsch A,  Regan MM,  SOFT and TEXT Investigators and the International Breast Cancer Study Group
N Engl J Med 2018 Jul 12;379(2):122-137
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29863451
PMC ID: PMC6193457

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.

Sparano JA,  Gray RJ,  Makower DF,  Pritchard KI,  Albain KS,  Hayes DF,  Geyer CE Jr,  Dees EC,  Goetz MP,  Olson JA Jr,  Lively T,  Badve SS,  Saphner TJ,  Wagner LI,  Whelan TJ,  Ellis MJ,  Paik S,  Wood WC,  Ravdin PM,  Keane MM,  Gomez Moreno HL,  Reddy PS,  Goggins TF,  Mayer IA,  Brufsky AM,  Toppmeyer DL,  Kaklamani VG,  Berenberg JL,  Abrams J,  Sledge GW Jr
N Engl J Med 2018 Jul 12;379(2):111-121
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29860917
PMC ID: PMC6172658

Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial.

Hershman DL,  Unger JM,  Greenlee H,  Capodice JL,  Lew DL,  Darke AK,  Kengla AT,  Melnik MK,  Jorgensen CW,  Kreisle WH,  Minasian LM,  Fisch MJ,  Henry NL,  Crew KD
JAMA 2018 Jul 10;320(2):167-176
Major Program(s) or Research Group(s): Office of the Director ;  NCI Community Oncology Research Program
PubMed ID: 29998338
PMC ID: PMC6583520

Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trials.

Ailawadhi S,  Jacobus S,  Sexton R,  Stewart AK,  Dispenzieri A,  Hussein MA,  Zonder JA,  Crowley J,  Hoering A,  Barlogie B,  Orlowski RZ,  Rajkumar SV
Blood Cancer J 2018 Jul 6;8(7):67
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29980678
PMC ID: PMC6035273

Hidden Patients, Hidden Partners: Prostate Cancer Care for Gay and Bisexual Men.

Arthur EK,  Kamen CS
Oncol Nurs Forum 2018 Jul 2;45(4):435-438
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29947352
PMC ID: PMC6419741

Smoking, Sex, and Non-Small Cell Lung Cancer: Steroid Hormone Receptors in Tumor Tissue (S0424).

Cheng TD,  Darke AK,  Redman MW,  Zirpoli GR,  Davis W,  Payne Ondracek R,  Bshara W,  Omilian AR,  Kratzke R,  Reid ME,  Molina JR,  Kolesar JM,  Chen Y,  MacRae RM,  Moon J,  Mack P,  Gandara DR,  Kelly K,  Santella RM,  Albain KS,  Ambrosone CB
J Natl Cancer Inst 2018 Jul 1;110(7):734-742
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29346580
PMC ID: PMC6037104

Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data.

Lambertini M,  Moore HCF,  Leonard RCF,  Loibl S,  Munster P,  Bruzzone M,  Boni L,  Unger JM,  Anderson RA,  Mehta K,  Minton S,  Poggio F,  Albain KS,  Adamson DJA,  Gerber B,  Cripps A,  Bertelli G,  Seiler S,  Ceppi M,  Partridge AH,  Del Mastro L
J Clin Oncol 2018 Jul 1;36(19):1981-1990
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29718793
PMC ID: PMC6804855

Time-to-Treatment-Failure and Related Outcomes Among 1000+ Advanced Non-Small Cell Lung Cancer Patients: Comparisons Between Older Versus Younger Patients (Alliance A151711).

Gajra A,  Zemla TJ,  Jatoi A,  Feliciano JL,  Wong ML,  Chen H,  Maggiore R,  McMurray RP,  Hurria A,  Muss HB,  Cohen HJ,  Lafky J,  Edelman MJ,  Lilenbaum R,  Le-Rademacher JG
J Thorac Oncol 2018 Jul;13(7):996-1003
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29608967
PMC ID: PMC6015776

Can a gastric cancer risk survey identify high-risk patients for endoscopic screening? A pilot study.

In H,  Langdon-Embry M,  Gordon L,  Schechter CB,  Wylie-Rosett J,  Castle PE,  Margaret Kemeny M,  Rapkin BD
J Surg Res 2018 Jul;227:246-256
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29622399
PMC ID: PMC5972059

Simple, Transparent, and Flexible Automated Quality Assessment Procedures for Ambulatory Electrodermal Activity Data.

Kleckner IR,  Jones RM,  Wilder-Smith O,  Wormwood JB,  Akcakaya M,  Quigley KS,  Lord C,  Goodwin MS
IEEE Trans Biomed Eng 2018 Jul;65(7):1460-1467
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28976309
PMC ID: PMC5880745

Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology Summary.

Mohile SG,  Dale W,  Somerfield MR,  Hurria A
J Oncol Pract 2018 Jul;14(7):442-446
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29932846
PMC ID: PMC6041128

Physical Activity and Survival in Women With Advanced Breast Cancer.

Palesh O,  Kamen C,  Sharp S,  Golden A,  Neri E,  Spiegel D,  Koopman C
Cancer Nurs 2018 Jul-Aug;41(4):E31-E38
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28727578
PMC ID: PMC5775062

Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.

Rogers L,  Zhang P,  Vogelbaum MA,  Perry A,  Ashby LS,  Modi JM,  Alleman AM,  Galvin J,  Brachman D,  Jenrette JM,  De Groot J,  Bovi JA,  Werner-Wasik M,  Knisely JPS,  Mehta MP
J Neurosurg 2018 Jul;129(1):35-47
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28984517
PMC ID: PMC5889346

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.

Schumacher FR,  Al Olama AA,  Berndt SI,  Benlloch S,  Ahmed M,  Saunders EJ,  Dadaev T,  Leongamornlert D,  Anokian E,  Cieza-Borrella C,  Goh C,  Brook MN,  Sheng X,  Fachal L,  Dennis J,  Tyrer J,  Muir K,  Lophatananon A,  Stevens VL,  Gapstur SM,  Carter BD,  Tangen CM,  Goodman PJ,  Thompson IM Jr,  Batra J,  Chambers S,  Moya L,  Clements J,  Horvath L,  Tilley W,  Risbridger GP,  Gronberg H,  Aly M,  Nordström T,  Pharoah P,  Pashayan N,  Schleutker J,  Tammela TLJ,  Sipeky C,  Auvinen A,  Albanes D,  Weinstein S,  Wolk A,  HÃ¥kansson N,  West CML,  Dunning AM,  Burnet N,  Mucci LA,  Giovannucci E,  Andriole GL,  Cussenot O,  Cancel-Tassin G,  Koutros S,  Beane Freeman LE,  Sorensen KD,  Orntoft TF,  Borre M,  Maehle L,  Grindedal EM,  Neal DE,  Donovan JL,  Hamdy FC,  Martin RM,  Travis RC,  Key TJ,  Hamilton RJ,  Fleshner NE,  Finelli A,  Ingles SA,  Stern MC,  Rosenstein BS,  Kerns SL,  Ostrer H,  Lu YJ,  Zhang HW,  Feng N,  Mao X,  Guo X,  Wang G,  Sun Z,  Giles GG,  Southey MC,  MacInnis RJ,  FitzGerald LM,  Kibel AS,  Drake BF,  Vega A,  Gómez-Caamaño A,  Szulkin R,  Eklund M,  Kogevinas M,  Llorca J,  Castaño-Vinyals G,  Penney KL,  Stampfer M,  Park JY,  Sellers TA,  Lin HY,  Stanford JL,  Cybulski C,  Wokolorczyk D,  Lubinski J,  Ostrander EA,  Geybels MS,  Nordestgaard BG,  Nielsen SF,  Weischer M,  Bisbjerg R,  Røder MA,  Iversen P,  Brenner H,  Cuk K,  Holleczek B,  Maier C,  Luedeke M,  Schnoeller T,  Kim J,  Logothetis CJ,  John EM,  Teixeira MR,  Paulo P,  Cardoso M,  Neuhausen SL,  Steele L,  Ding YC,  De Ruyck K,  De Meerleer G,  Ost P,  Razack A,  Lim J,  Teo SH,  Lin DW,  Newcomb LF,  Lessel D,  Gamulin M,  Kulis T,  Kaneva R,  Usmani N,  Singhal S,  Slavov C,  Mitev V,  Parliament M,  Claessens F,  Joniau S,  Van den Broeck T,  Larkin S,  Townsend PA,  Aukim-Hastie C,  Gago-Dominguez M,  Castelao JE,  Martinez ME,  Roobol MJ,  Jenster G,  van Schaik RHN,  Menegaux F,  Truong T,  Koudou YA,  Xu J,  Khaw KT,  Cannon-Albright L,  Pandha H,  Michael A,  Thibodeau SN,  McDonnell SK,  Schaid DJ,  Lindstrom S,  Turman C,  Ma J,  Hunter DJ,  Riboli E,  Siddiq A,  Canzian F,  Kolonel LN,  Le Marchand L,  Hoover RN,  Machiela MJ,  Cui Z,  Kraft P,  Amos CI,  Conti DV,  Easton DF,  Wiklund F,  Chanock SJ,  Henderson BE,  Kote-Jarai Z,  Haiman CA,  Eeles RA,  Profile Study,  Australian Prostate Cancer BioResource (APCB),  IMPACT Study,  Canary PASS Investigators,  Breast and Prostate Cancer Cohort Consortium (BPC3),  PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium,  Cancer of the Prostate in Sweden (CAPS),  Prostate Cancer Genome-wide Association Study of Uncommon Susceptibility Loci (PEGASUS),  Genetic Associations and Mechanisms in Oncology (GAME-ON)/Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium
Nat Genet 2018 Jul;50(7):928-936
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialNCI Community Oncology Research Program
PubMed ID: 29892016
PMC ID: PMC6568012

Frequency and impact of grade three or four toxicities of novel agents on outcomes of older patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma (alliance A151611).

Tallarico M,  Foster JC,  Seisler D,  Lafky JM,  Hurria A,  Jatoi A,  Cohen HJ,  Muss HB,  Bartlett N,  Cheson BD,  Jung SH,  Leonard JP,  Byrd JC,  Nabhan C
J Geriatr Oncol 2018 Jul;9(4):321-328
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29673807
PMC ID: PMC6015785

Quality of life, symptoms and care needs in patients with persistent or recurrent platinum-resistant ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.

von Gruenigen VE,  Huang HQ,  Cella D,  Zevon M,  LaChance JA,  Walker JL,  Salani R,  Modesitt SC,  Morris RT,  Bradley WH,  Boente MP,  Wenzel L
Gynecol Oncol 2018 Jul;150(1):119-126
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29778506
PMC ID: PMC6874212

Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicities.

Xiao C,  Moughan J,  Movsas B,  Konski AA,  Hanks GE,  Cox JD,  Roach M 3rd,  Zeitzer KL,  Lawton CA,  Peters CA,  Rosenthal SA,  Hsu IJ,  Horwitz EM,  Mishra MV,  Michalski JM,  Parliament MB,  D'Souza DP,  Pugh SL,  Bruner DW
Adv Radiat Oncol 2018 Jul-Sep;3(3):405-411
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30202809
PMC ID: PMC6128023

Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial.

Michalski JM,  Moughan J,  Purdy J,  Bosch W,  Bruner DW,  Bahary JP,  Lau H,  Duclos M,  Parliament M,  Morton G,  Hamstra D,  Seider M,  Lock MI,  Patel M,  Gay H,  Vigneault E,  Winter K,  Sandler H
JAMA Oncol 2018 Jun 14;4(6):e180039
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29543933
PMC ID: PMC5885160

A New Framework for Patient Engagement in Cancer Clinical Trials Cooperative Group Studies.

Deverka PA,  Bangs R,  Kreizenbeck K,  Delaney DM,  Hershman DL,  Blanke CD,  Ramsey SD
J Natl Cancer Inst 2018 Jun 1;110(6):553-559
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29684151
PMC ID: PMC6005117

Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L-Carnitine (SWOG S0715).

Hershman DL,  Unger JM,  Crew KD,  Till C,  Greenlee H,  Minasian LM,  Moinpour CM,  Lew DL,  Fehrenbacher L,  Wade JL 3rd,  Wong SF,  Fisch MJ,  Lynn Henry N,  Albain KS
J Natl Cancer Inst 2018 Jun 1;110(6):669-676
Major Program(s) or Research Group(s): Office of the Director ;  NCI Community Oncology Research Program
PubMed ID: 29361042
PMC ID: PMC6005110

Questions About a Clinical Trial Evaluating the Addition of Cetuximab to Definitive Chemoradiation Therapy With Paclitaxel and Cisplatin for Patients With Esophageal Cancer-Reply.

Suntharalingam M,  Winter K,  Ilson D
JAMA Oncol 2018 Jun 1;4(6):888-889
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29596545
PMC ID: PMC6659110

Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis: The CALGB 89803/Alliance Trial.

Van Blarigan EL,  Fuchs CS,  Niedzwiecki D,  Zhang S,  Saltz LB,  Mayer RJ,  Mowat RB,  Whittom R,  Hantel A,  Benson A,  Atienza D,  Messino M,  Kindler H,  Venook A,  Ogino S,  Giovannucci EL,  Ng K,  Meyerhardt JA
JAMA Oncol 2018 Jun 1;4(6):783-790
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29710284
PMC ID: PMC6145685

Recruitment practices for U.S. minority and underserved populations in NRG oncology: Results of an online survey.

Cook ED,  Yeager KA,  Cecchini RS,  Boparai J,  Brown CL,  Duncan M,  Cronin WM,  Paskett ED
Contemp Clin Trials Commun 2018 Jun;10:100-104
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30023443
PMC ID: PMC6046466

Longitudinal and dynamic measurement invariance of the FACIT-Fatigue scale: an application of the measurement model of derivatives to ECOG-ACRIN study E2805.

Estabrook R,  Cella D,  Zhao F,  Manola J,  DiPaola RS,  Wagner LI,  Haas NB
Qual Life Res 2018 Jun;27(6):1589-1597
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29508208
PMC ID: PMC6004788

Germline genome-wide association studies in women receiving neoadjuvant chemotherapy with or without bevacizumab.

Ingle JN,  Kalari KR,  Wickerham DL,  von Minckwitz G,  Fasching PA,  Furukawa Y,  Mushiroda T,  Goetz MP,  Barman P,  Carlson EE,  Rastogi P,  Costantino JP,  Cairns J,  Paik S,  Bear HD,  Kubo M,  Wang L,  Wolmark N,  Weinshilboum RM
Pharmacogenet Genomics 2018 Jun;28(6):147-152
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29768301
PMC ID: PMC5965682

An Economic Analysis of Radiation Therapy Oncology Group 94-10: Cost-Efficacy of Concurrent vs. Sequential Chemoradiotherapy.

Konski A,  Bhargavan M,  Owen J,  Komaki R,  Langer CJ,  Gore E,  Paulus R,  Choy H,  Bruner DW,  Curran WJ
J Radiat Oncol 2018 Jun;7(2):195-201
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30559923
PMC ID: PMC6294122

Physical Activity and Outcomes in Patients with Stage III Colon Cancer: A Correlative Analysis of Phase III Trial NCCTG N0147 (Alliance).

Phipps AI,  Shi Q,  Zemla TJ,  Dotan E,  Gill S,  Goldberg RM,  Hardikar S,  Jahagirdar B,  Limburg PJ,  Newcomb PA,  Shields A,  Sinicrope FA,  Sargent DJ,  Alberts SR
Cancer Epidemiol Biomarkers Prev 2018 Jun;27(6):696-703
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29563133
PMC ID: PMC5984710

Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03).

Wagner LI,  Zhao F,  Goss PE,  Chapman JW,  Shepherd LE,  Whelan TJ,  Mattar BI,  Bufill JA,  Schultz WC,  LaFrancis IE,  Nagargoje GG,  Vemuri R,  Nikcevich DA,  Sledge GW,  Cella D
Breast Cancer Res Treat 2018 Jun;169(3):537-548
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29455298
PMC ID: PMC6092930

Fatigue among patients with renal cell carcinoma receiving adjuvant sunitinib or sorafenib: patient-reported outcomes of ECOG-ACRIN E2805 trial.

Zhao F,  Cella D,  Manola J,  DiPaola RS,  Wagner LI,  Haas NSB
Support Care Cancer 2018 Jun;26(6):1889-1895
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29274030
PMC ID: PMC5924580

Prevention of cisplatin-induced hearing loss in children: Informing the design of future clinical trials.

Minasian LM,  Frazier AL,  Sung L,  O'Mara A,  Kelaghan J,  Chang KW,  Krailo M,  Pollock BH,  Reaman G,  Freyer DR
Cancer Med 2018 May 30
Major Program(s) or Research Group(s): Office of the Director ;  NCI Community Oncology Research Program
PubMed ID: 29846043
PMC ID: PMC6051159

Housing and Food Insecurity, Care Access, and Health Status Among the Chronically Ill: An Analysis of the Behavioral Risk Factor Surveillance System.

Charkhchi P,  Fazeli Dehkordy S,  Carlos RC
J Gen Intern Med 2018 May;33(5):644-650
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29299816
PMC ID: PMC5910337

The preference to receive chemotherapy and cancer-related outcomes in older adults with breast cancer CALGB 49907 (Alliance).

Gajra A,  McCall L,  Muss HB,  Cohen HJ,  Jatoi A,  Ballman KV,  Partridge AH,  Sutton L,  Parker BA,  Magrinat G,  Klepin HD,  Lafky JM,  Hurria A
J Geriatr Oncol 2018 May;9(3):221-227
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29602735
PMC ID: PMC5967401

Medical Care Costs Were Similar Across the Low-dose Computed Tomography and Chest X-Ray Arms of the National Lung Screening Trial Despite Different Rates of Significant Incidental Findings.

Gareen IF,  Black WC,  Tosteson TD,  Wang Q,  Sicks JD,  Tosteson ANA
Med Care 2018 May;56(5):403-409
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29613874
PMC ID: PMC6085094

Dilator Use After Vaginal Brachytherapy for Endometrial Cancer: A Randomized Feasibility and Adherence Study.

Hanlon A,  Small W Jr,  Strauss J,  Lin LL,  Hanisch L,  Huang L,  Bai J,  Wells J,  Bruner DW
Cancer Nurs 2018 May-Jun;41(3):200-209
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28437283
PMC ID: PMC5650953

The impact of actual body weight-based chemotherapy dosing and body size on adverse events and outcome in older patients with breast cancer: Results from Cancer and Leukemia Group B (CALGB) trial 49907 (Alliance A151436).

Morrison VA,  McCall L,  Muss HB,  Jatoi A,  Cohen HJ,  Cirrincione CT,  Ligibel JA,  Lafky JM,  Hurria A
J Geriatr Oncol 2018 May;9(3):228-234
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29233548
PMC ID: PMC5936657

Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.

Rebbeck TR,  Friebel TM,  Friedman E,  Hamann U,  Huo D,  Kwong A,  Olah E,  Olopade OI,  Solano AR,  Teo SH,  Thomassen M,  Weitzel JN,  Chan TL,  Couch FJ,  Goldgar DE,  Kruse TA,  Palmero EI,  Park SK,  Torres D,  van Rensburg EJ,  McGuffog L,  Parsons MT,  Leslie G,  Aalfs CM,  Abugattas J,  Adlard J,  Agata S,  Aittomäki K,  Andrews L,  Andrulis IL,  Arason A,  Arnold N,  Arun BK,  Asseryanis E,  Auerbach L,  Azzollini J,  Balmaña J,  Barile M,  Barkardottir RB,  Barrowdale D,  Benitez J,  Berger A,  Berger R,  Blanco AM,  Blazer KR,  Blok MJ,  Bonadona V,  Bonanni B,  Bradbury AR,  Brewer C,  Buecher B,  Buys SS,  Caldes T,  Caliebe A,  Caligo MA,  Campbell I,  Caputo SM,  Chiquette J,  Chung WK,  Claes KBM,  Collée JM,  Cook J,  Davidson R,  de la Hoya M,  De Leeneer K,  de Pauw A,  Delnatte C,  Diez O,  Ding YC,  Ditsch N,  Domchek SM,  Dorfling CM,  Velazquez C,  Dworniczak B,  Eason J,  Easton DF,  Eeles R,  Ehrencrona H,  Ejlertsen B,  EMBRACE,  Engel C,  Engert S,  Evans DG,  Faivre L,  Feliubadaló L,  Ferrer SF,  Foretova L,  Fowler J,  Frost D,  Galvão HCR,  Ganz PA,  Garber J,  Gauthier-Villars M,  Gehrig A,  GEMO Study Collaborators,  Gerdes AM,  Gesta P,  Giannini G,  Giraud S,  Glendon G,  Godwin AK,  Greene MH,  Gronwald J,  Gutierrez-Barrera A,  Hahnen E,  Hauke J,  HEBON,  Henderson A,  Hentschel J,  Hogervorst FBL,  Honisch E,  Imyanitov EN,  Isaacs C,  Izatt L,  Izquierdo A,  Jakubowska A,  James P,  Janavicius R,  Jensen UB,  John EM,  Vijai J,  Kaczmarek K,  Karlan BY,  Kast K,  Investigators K,  Kim SW,  Konstantopoulou I,  Korach J,  Laitman Y,  Lasa A,  Lasset C,  Lázaro C,  Lee A,  Lee MH,  Lester J,  Lesueur F,  Liljegren A,  Lindor NM,  Longy M,  Loud JT,  Lu KH,  Lubinski J,  Machackova E,  Manoukian S,  Mari V,  Martínez-Bouzas C,  Matrai Z,  Mebirouk N,  Meijers-Heijboer HEJ,  Meindl A,  Mensenkamp AR,  Mickys U,  Miller A,  Montagna M,  Moysich KB,  Mulligan AM,  Musinsky J,  Neuhausen SL,  Nevanlinna H,  Ngeow J,  Nguyen HP,  Niederacher D,  Nielsen HR,  Nielsen FC,  Nussbaum RL,  Offit K,  Öfverholm A,  Ong KR,  Osorio A,  Papi L,  Papp J,  Pasini B,  Pedersen IS,  Peixoto A,  Peruga N,  Peterlongo P,  Pohl E,  Pradhan N,  Prajzendanc K,  Prieur F,  Pujol P,  Radice P,  Ramus SJ,  Rantala J,  Rashid MU,  Rhiem K,  Robson M,  Rodriguez GC,  Rogers MT,  Rudaitis V,  Schmidt AY,  Schmutzler RK,  Senter L,  Shah PD,  Sharma P,  Side LE,  Simard J,  Singer CF,  Skytte AB,  Slavin TP,  Snape K,  Sobol H,  Southey M,  Steele L,  Steinemann D,  Sukiennicki G,  Sutter C,  Szabo CI,  Tan YY,  Teixeira MR,  Terry MB,  Teulé A,  Thomas A,  Thull DL,  Tischkowitz M,  Tognazzo S,  Toland AE,  Topka S,  Trainer AH,  Tung N,  van Asperen CJ,  van der Hout AH,  van der Kolk LE,  van der Luijt RB,  Van Heetvelde M,  Varesco L,  Varon-Mateeva R,  Vega A,  Villarreal-Garza C,  von Wachenfeldt A,  Walker L,  Wang-Gohrke S,  Wappenschmidt B,  Weber BHF,  Yannoukakos D,  Yoon SY,  Zanzottera C,  Zidan J,  Zorn KK,  Hutten Selkirk CG,  Hulick PJ,  Chenevix-Trench G,  Spurdle AB,  Antoniou AC,  Nathanson KL
Hum Mutat 2018 May;39(5):593-620
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29446198
PMC ID: PMC5903938

Oral curcumin for radiation dermatitis: a URCC NCORP study of 686 breast cancer patients.

Ryan Wolf J,  Heckler CE,  Guido JJ,  Peoples AR,  Gewandter JS,  Ling M,  Vinciguerra VP,  Anderson T,  Evans L,  Wade J,  Pentland AP,  Morrow GR
Support Care Cancer 2018 May;26(5):1543-1552
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29192329
PMC ID: PMC5876157

Rationale, development, and design of the Altering Intake, Managing Symptoms (AIMS) dietary intervention for bowel dysfunction in rectal cancer survivors.

Sun V,  Crane TE,  Slack SD,  Yung A,  Wright S,  Sentovich S,  Melstrom K,  Fakih M,  Krouse RS,  Thomson CA
Contemp Clin Trials 2018 May;68:61-66
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29567283
PMC ID: PMC5899669

Survival by Hispanic ethnicity among patients with cancer participating in SWOG clinical trials.

Chavez-MacGregor M,  Unger JM,  Moseley A,  Ramsey SD,  Hershman DL
Cancer 2018 Apr 15;124(8):1760-1769
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29370458
PMC ID: PMC5963502

Nut Consumption and Survival in Patients With Stage III Colon Cancer: Results From CALGB 89803 (Alliance).

Fadelu T,  Zhang S,  Niedzwiecki D,  Ye X,  Saltz LB,  Mayer RJ,  Mowat RB,  Whittom R,  Hantel A,  Benson AB,  Atienza DM,  Messino M,  Kindler HL,  Venook A,  Ogino S,  Ng K,  Wu K,  Willett W,  Giovannucci E,  Meyerhardt J,  Bao Y,  Fuchs CS
J Clin Oncol 2018 Apr 10;36(11):1112-1120
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29489429
PMC ID: PMC5891130

Quality of Life During Treatment With Chemohormonal Therapy: Analysis of E3805 Chemohormonal Androgen Ablation Randomized Trial in Prostate Cancer.

Morgans AK,  Chen YH,  Sweeney CJ,  Jarrard DF,  Plimack ER,  Gartrell BA,  Carducci MA,  Hussain M,  Garcia JA,  Cella D,  DiPaola RS,  Patrick-Miller LJ
J Clin Oncol 2018 Apr 10;36(11):1088-1095
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29522362
PMC ID: PMC5891128

Efficacy of Chemotherapy for ER-Negative and ER-Positive Isolated Locoregional Recurrence of Breast Cancer: Final Analysis of the CALOR Trial.

Wapnir IL,  Price KN,  Anderson SJ,  Robidoux A,  Martín M,  Nortier JWR,  Paterson AHG,  Rimawi MF,  Láng I,  Baena-Cañada JM,  Thürlimann B,  Mamounas EP,  Geyer CE Jr,  Gelber S,  Coates AS,  Gelber RD,  Rastogi P,  Regan MM,  Wolmark N,  Aebi S,  International Breast Cancer Study Group,  NRG Oncology, GEICAM Spanish Breast Cancer Group, BOOG Dutch Breast Cancer Trialists' Group,  Breast International Group
J Clin Oncol 2018 Apr 10;36(11):1073-1079
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29443653
PMC ID: PMC5891132

Systemic and local effects of vaginal dehydroepiandrosterone (DHEA): NCCTG N10C1 (Alliance).

Barton DL,  Shuster LT,  Dockter T,  Atherton PJ,  Thielen J,  Birrell SN,  Sood R,  Griffin P,  Terstriep SA,  Mattar B,  Lafky JM,  Loprinzi CL
Support Care Cancer 2018 Apr;26(4):1335-1343
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29164377
PMC ID: PMC5823730

Identification of Distant Metastatic Disease in Uterine Cervical and Endometrial Cancers with FDG PET/CT: Analysis from the ACRIN 6671/GOG 0233 Multicenter Trial.

Gee MS,  Atri M,  Bandos AI,  Mannel RS,  Gold MA,  Lee SI
Radiology 2018 Apr;287(1):176-184
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29185901
PMC ID: PMC5881639

Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial.

Kleckner IR,  Kamen C,  Gewandter JS,  Mohile NA,  Heckler CE,  Culakova E,  Fung C,  Janelsins MC,  Asare M,  Lin PJ,  Reddy PS,  Giguere J,  Berenberg J,  Kesler SR,  Mustian KM
Support Care Cancer 2018 Apr;26(4):1019-1028
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29243164
PMC ID: PMC5823751

Diet Quality, Inflammation, and Quality of Life in Breast Cancer Survivors: A Cross-Sectional Analysis of Pilot Study Data.

Orchard TS,  Andridge RR,  Yee LD,  Lustberg MB
J Acad Nutr Diet 2018 Apr;118(4):578-588.e1
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29233615
PMC ID: PMC5869134

Men's Eating and Living (MEAL) study (CALGB 70807 [Alliance]): recruitment feasibility and baseline demographics of a randomized trial of diet in men on active surveillance for prostate cancer.

Parsons JK,  Pierce JP,  Mohler J,  Paskett E,  Jung SH,  Morris MJ,  Small E,  Hahn O,  Humphrey P,  Taylor J,  Marshall J
BJU Int 2018 Apr;121(4):534-539
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28437029
PMC ID: PMC5654696

Postresection CA19-9 and margin status as predictors of recurrence after adjuvant treatment for pancreatic carcinoma: Analysis of NRG oncology RTOG trial 9704.

Regine WF,  Winter K,  Abrams RA,  Safran H,  Kessel IL,  Chen Y,  Fugazzi JA,  Donnelly ED,  DiPetrillo TA,  Narayan S,  Plastaras JP,  Gaur R,  Delouya G,  Suh JH,  Meyer JE,  Haddock MG,  Didolkar MS,  Padula GDA,  Johnson D,  Hoffman JP,  Crane CH
Adv Radiat Oncol 2018 Apr-Jun;3(2):154-162
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29904740
PMC ID: PMC6000159

Utility of the ACE Inhibitor Captopril in Mitigating Radiation-associated Pulmonary Toxicity in Lung Cancer: Results From NRG Oncology RTOG 0123.

Small W Jr,  James JL,  Moore TD,  Fintel DJ,  Lutz ST,  Movsas B,  Suntharalingam M,  Garces YI,  Ivker R,  Moulder J,  Pugh S,  Berk LB
Am J Clin Oncol 2018 Apr;41(4):396-401
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27100959
PMC ID: PMC5073047

Marine ω-3 Polyunsaturated Fatty Acid and Fish Intake after Colon Cancer Diagnosis and Survival: CALGB 89803 (Alliance).

Van Blarigan EL,  Fuchs CS,  Niedzwiecki D,  Ye X,  Zhang S,  Song M,  Saltz LB,  Mayer RJ,  Mowat RB,  Whittom R,  Hantel A,  Benson A,  Atienza D,  Messino M,  Kindler H,  Venook A,  Ogino S,  Giovannucci EL,  Meyerhardt JA
Cancer Epidemiol Biomarkers Prev 2018 Apr;27(4):438-445
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29358223
PMC ID: PMC5939380

Phase 2 Study of Weekly Paclitaxel Plus Estramustine in Metastatic Hormone-Refractory Prostate Carcinoma: ECOG-ACRIN Cancer Research Group (E1898) Trial.

Wong YN,  Manola J,  Hudes GR,  Roth BJ,  Moul JW,  Barsevick AM,  Scher RM,  Volk MJ,  Vaughn DJ,  Williams SD,  Fisch MJ,  Cella D,  Carducci MA,  Wilding G
Clin Genitourin Cancer 2018 Apr;16(2):e315-e322
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29173976
PMC ID: PMC5975965

Acupressure bands do not improve chemotherapy-induced nausea control in pediatric patients receiving highly emetogenic chemotherapy: A single-blinded, randomized controlled trial.

Dupuis LL,  Kelly KM,  Krischer JP,  Langevin AM,  Tamura RN,  Xu P,  Chen L,  Kolb EA,  Ullrich NJ,  Sahler OJZ,  Hendershot E,  Stratton A,  Sung L,  McLean TW
Cancer 2018 Mar 15;124(6):1188-1196
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29266260
PMC ID: PMC5839969

Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study.

Felix AS,  Brasky TM,  Cohn DE,  Mutch DG,  Creasman WT,  Thaker PH,  Walker JL,  Moore RG,  Lele SB,  Guntupalli SR,  Downs LS,  Nagel C,  Boggess JF,  Pearl ML,  Ioffe OB,  Deng W,  Miller DS,  Brinton LA
Int J Cancer 2018 Mar 15;142(6):1102-1115
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29063589
PMC ID: PMC5798245

Improving Quality and Consistency in NRG Oncology Radiation Therapy Oncology Group 0631 for Spine Radiosurgery via Knowledge-Based Planning.

Younge KC,  Marsh RB,  Owen D,  Geng H,  Xiao Y,  Spratt DE,  Foy J,  Suresh K,  Wu QJ,  Yin FF,  Ryu S,  Matuszak MM
Int J Radiat Oncol Biol Phys 2018 Mar 15;100(4):1067-1074
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29485048
PMC ID: PMC5915303

Using Information Technology in the Assessment and Monitoring of Geriatric Oncology Patients.

Loh KP,  McHugh C,  Mohile SG,  Mustian K,  Flannery M,  Klepin H,  Schnall R,  Culakova E,  Ramsdale E
Curr Oncol Rep 2018 Mar 6;20(3):25
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29511850
PMC ID: PMC5878089

NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients.

Ali AN,  Zhang P,  Yung WKA,  Chen Y,  Movsas B,  Urtasun RC,  Jones CU,  Choi KN,  Michalski JM,  Fischbach AJ,  Markoe AM,  Schultz CJ,  Penas-Prado M,  Garg MK,  Hartford AC,  Kim HE,  Won M,  Curran WJ Jr
J Neurooncol 2018 Mar;137(1):39-47
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29404979
PMC ID: PMC6020014

Circadian genes and risk of prostate cancer in the prostate cancer prevention trial.

Chu LW,  Till C,  Yang B,  Tangen CM,  Goodman PJ,  Yu K,  Zhu Y,  Han S,  Hoque AM,  Ambrosone C,  Thompson I,  Leach R,  Hsing AW
Mol Carcinog 2018 Mar;57(3):462-466
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29318656
PMC ID: PMC5940353

A Randomized Double-Blind Placebo-Controlled Trial of Fruit and Vegetable Concentrates on Intermediate Biomarkers in Head and Neck Cancer.

Datta M,  Shaw EG,  Lesser GJ,  Case LD,  Vitolins MZ,  Schneider C,  Frizzell B,  Sullivan C,  Lively M,  Franzmann E,  Hu JJ
Integr Cancer Ther 2018 Mar;17(1):115-123
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28102098
PMC ID: PMC5501769

Echocardiography Core Laboratory Reproducibility of Cardiac Safety Assessments in Cardio-Oncology.

Khouri MG,  Ky B,  Dunn G,  Plappert T,  Englefield V,  Rabineau D,  Yow E,  Barnhart HX,  St John Sutton M,  Douglas PS
J Am Soc Echocardiogr 2018 Mar;31(3):361-371.e3
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29395626
PMC ID: PMC6722324

Community Oncologists' Decision-Making for Treatment of Older Patients With Cancer.

Mohile SG,  Magnuson A,  Pandya C,  Velarde C,  Duberstein P,  Hurria A,  Loh KP,  Wells M,  Plumb S,  Gilmore N,  Flannery M,  Wittink M,  Epstein R,  Heckler CE,  Janelsins M,  Mustian K,  Hopkins JO,  Liu J,  Peri S,  Dale W
J Natl Compr Canc Netw 2018 Mar;16(3):301-309
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29523669
PMC ID: PMC5878087

Clinical and Genetic Risk Factors for Adverse Metabolic Outcomes in North American Testicular Cancer Survivors.

Zaid MA,  Gathirua-Mwangi WG,  Fung C,  Monahan PO,  El-Charif O,  Williams AM,  Feldman DR,  Hamilton RJ,  Vaughn DJ,  Beard CJ,  Cook R,  Althouse SK,  Ardeshir-Rouhani-Fard S,  Dinh PC,  Sesso HD,  Einhorn LH,  Fossa SD,  Travis LB,  Platinum Study Group
J Natl Compr Canc Netw 2018 Mar;16(3):257-265
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29523664
PMC ID: PMC6345519

Pathways: patient-centred decision counselling for women at risk of cancer-related infertility: a protocol for a comparative effectiveness cluster randomised trial.

Woodard TL,  Hoffman AS,  Crocker LC,  Holman DA,  Hoffman DB,  Ma J,  Bassett RL Jr,  Leal VB,  Volk RJ
BMJ Open 2018 Feb 21;8(2):e019994
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29467138
PMC ID: PMC5855396

Quality of Life From Canadian Cancer Trials Group MA.17R: A Randomized Trial of Extending Adjuvant Letrozole to 10 Years.

Lemieux J,  Brundage MD,  Parulekar WR,  Goss PE,  Ingle JN,  Pritchard KI,  Celano P,  Muss H,  Gralow J,  Strasser-Weippl K,  Whelan K,  Tu D,  Whelan TJ
J Clin Oncol 2018 Feb 20;36(6):563-571
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29328860
PMC ID: PMC5815404

Estimating global treatment toxicity burden from adverse-event data.

Lee SM,  Hershman DL,  Miao J,  Zhong X,  Unger JM,  Cheung YKK
Cancer 2018 Feb 15;124(4):858-864
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29112232
PMC ID: PMC5801103

Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention Trial.

Tang L,  Platek ME,  Yao S,  Till C,  Goodman PJ,  Tangen CM,  Wu Y,  Platz EA,  Neuhouser ML,  Stanczyk FZ,  Reichardt JKV,  Santella RM,  Hsing A,  Figg WD,  Lippman SM,  Thompson IM,  Ambrosone CB
Carcinogenesis 2018 Feb 9;39(2):125-133
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29228205
PMC ID: PMC6075364

Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer.

Klein AP,  Wolpin BM,  Risch HA,  Stolzenberg-Solomon RZ,  Mocci E,  Zhang M,  Canzian F,  Childs EJ,  Hoskins JW,  Jermusyk A,  Zhong J,  Chen F,  Albanes D,  Andreotti G,  Arslan AA,  Babic A,  Bamlet WR,  Beane-Freeman L,  Berndt SI,  Blackford A,  Borges M,  Borgida A,  Bracci PM,  Brais L,  Brennan P,  Brenner H,  Bueno-de-Mesquita B,  Buring J,  Campa D,  Capurso G,  Cavestro GM,  Chaffee KG,  Chung CC,  Cleary S,  Cotterchio M,  Dijk F,  Duell EJ,  Foretova L,  Fuchs C,  Funel N,  Gallinger S,  M Gaziano JM,  Gazouli M,  Giles GG,  Giovannucci E,  Goggins M,  Goodman GE,  Goodman PJ,  Hackert T,  Haiman C,  Hartge P,  Hasan M,  Hegyi P,  Helzlsouer KJ,  Herman J,  Holcatova I,  Holly EA,  Hoover R,  Hung RJ,  Jacobs EJ,  Jamroziak K,  Janout V,  Kaaks R,  Khaw KT,  Klein EA,  Kogevinas M,  Kooperberg C,  Kulke MH,  Kupcinskas J,  Kurtz RJ,  Laheru D,  Landi S,  Lawlor RT,  Lee IM,  LeMarchand L,  Lu L,  Malats N,  Mambrini A,  Mannisto S,  Milne RL,  Mohelníková-Duchoňová B,  Neale RE,  Neoptolemos JP,  Oberg AL,  Olson SH,  Orlow I,  Pasquali C,  Patel AV,  Peters U,  Pezzilli R,  Porta M,  Real FX,  Rothman N,  Scelo G,  Sesso HD,  Severi G,  Shu XO,  Silverman D,  Smith JP,  Soucek P,  Sund M,  Talar-Wojnarowska R,  Tavano F,  Thornquist MD,  Tobias GS,  Van Den Eeden SK,  Vashist Y,  Visvanathan K,  Vodicka P,  Wactawski-Wende J,  Wang Z,  Wentzensen N,  White E,  Yu H,  Yu K,  Zeleniuch-Jacquotte A,  Zheng W,  Kraft P,  Li D,  Chanock S,  Obazee O,  Petersen GM,  Amundadottir LT
Nat Commun 2018 Feb 8;9(1):556
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialNCI Community Oncology Research Program
PubMed ID: 29422604
PMC ID: PMC5805680

Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30.

Bandos H,  Melnikow J,  Rivera DR,  Swain SM,  Sturtz K,  Fehrenbacher L,  Wade JL 3rd,  Brufsky AM,  Julian TB,  Margolese RG,  McCarron EC,  Ganz PA
J Natl Cancer Inst 2018 Feb 1;110(2)
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28954297
PMC ID: PMC5825682

Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202.

Henry NL,  Unger JM,  Schott AF,  Fehrenbacher L,  Flynn PJ,  Prow DM,  Sharer CW,  Burton GV,  Kuzma CS,  Moseley A,  Lew DL,  Fisch MJ,  Moinpour CM,  Hershman DL,  Wade JL 3rd
J Clin Oncol 2018 Feb 1;36(4):326-332
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29136387
PMC ID: PMC5805479

Expression of the DNA repair gene MLH1 correlates with survival in patients who have resected pancreatic cancer and have received adjuvant chemoradiation: NRG Oncology RTOG Study 9704.

Lawrence YR,  Moughan J,  Magliocco AM,  Klimowicz AC,  Regine WF,  Mowat RB,  DiPetrillo TA,  Small W Jr,  Simko JP,  Golan T,  Winter KA,  Guha C,  Crane CH,  Dicker AP
Cancer 2018 Feb 1;124(3):491-498
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29053185
PMC ID: PMC5780226

Yoga for the Management of Cancer Treatment-Related Toxicities.

Lin PJ,  Peppone LJ,  Janelsins MC,  Mohile SG,  Kamen CS,  Kleckner IR,  Fung C,  Asare M,  Cole CL,  Culakova E,  Mustian KM
Curr Oncol Rep 2018 Feb 1;20(1):5
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29388071
PMC ID: PMC5901971

Feasibility of a text-based smoking cessation intervention in rural older adults.

Noonan D,  Silva S,  Njuru J,  Bishop T,  Fish LJ,  Simmons LA,  Choi SH,  Pollak KI
Health Educ Res 2018 Feb 1;33(1):81-88
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29309599
PMC ID: PMC6279146

Longitudinal analysis of quality-of-life outcomes in children during treatment for acute lymphoblastic leukemia: A report from the Children's Oncology Group AALL0932 trial.

Zheng DJ,  Lu X,  Schore RJ,  Balsamo L,  Devidas M,  Winick NJ,  Raetz EA,  Loh ML,  Carroll WL,  Sung L,  Hunger SP,  Angiolillo AL,  Kadan-Lottick NS
Cancer 2018 Feb 1;124(3):571-579
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29112230
PMC ID: PMC5808870

Racial Differences in Information Needs During and After Cancer Treatment: a Nationwide, Longitudinal Survey by the University of Rochester Cancer Center National Cancer Institute Community Oncology Research Program.

Asare M,  Peppone LJ,  Roscoe JA,  Kleckner IR,  Mustian KM,  Heckler CE,  Guido JJ,  Sborov M,  Bushunow P,  Onitilo A,  Kamen C
J Cancer Educ 2018 Feb;33(1):95-101
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27097806
PMC ID: PMC5074918

Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance).

Barton DL,  Sloan JA,  Shuster LT,  Gill P,  Griffin P,  Flynn K,  Terstriep SA,  Rana FN,  Dockter T,  Atherton PJ,  Tsai M,  Sturtz K,  Lafky JM,  Riepl M,  Thielen J,  Loprinzi CL
Support Care Cancer 2018 Feb;26(2):643-650
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28921241
PMC ID: PMC5754227

Lesbian, Gay, Bisexual, and Transgender (LGBT) Survivorship.

Kamen C
Semin Oncol Nurs 2018 Feb;34(1):52-59
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29275016
PMC ID: PMC5811352

Randomized placebo-controlled pilot trial of omega 3 fatty acids for prevention of aromatase inhibitor-induced musculoskeletal pain.

Lustberg MB,  Orchard TS,  Reinbolt R,  Andridge R,  Pan X,  Belury M,  Cole R,  Logan A,  Layman R,  Ramaswamy B,  Wesolowski R,  Berger M,  Patterson E,  Loprinzi C,  Shapiro CL,  Yee L
Breast Cancer Res Treat 2018 Feb;167(3):709-718
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29101597
PMC ID: PMC5809189

Geriatric assessment with management intervention in older adults with cancer: a randomized pilot study.

Magnuson A,  Lemelman T,  Pandya C,  Goodman M,  Noel M,  Tejani M,  Doughtery D,  Dale W,  Hurria A,  Janelsins M,  Lin FV,  Heckler C,  Mohile S
Support Care Cancer 2018 Feb;26(2):605-613
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28914366
PMC ID: PMC5887127

21-Gene Recurrence Score for prognosis and prediction of taxane benefit after adjuvant chemotherapy plus endocrine therapy: results from NSABP B-28/NRG Oncology.

Mamounas EP,  Tang G,  Paik S,  Baehner FL,  Liu Q,  Jeong JH,  Kim SR,  Butler SM,  Jamshidian F,  Cherbavaz DB,  Sing AP,  Shak S,  Julian TB,  Lembersky BC,  Lawrence Wickerham D,  Costantino JP,  Wolmark N
Breast Cancer Res Treat 2018 Feb;168(1):69-77
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29128898
PMC ID: PMC5996978

Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci.

Sucheston-Campbell LE,  Clay-Gilmour AI,  Barlow WE,  Budd GT,  Stram DO,  Haiman CA,  Sheng X,  Yan L,  Zirpoli G,  Yao S,  Jiang C,  Owzar K,  Hershman D,  Albain KS,  Hayes DF,  Moore HC,  Hobday TJ,  Stewart JA,  Rizvi A,  Isaacs C,  Salim M,  Gralow JR,  Hortobagyi GN,  Livingston RB,  Kroetz DL,  Ambrosone CB
Pharmacogenet Genomics 2018 Feb;28(2):49-55
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29278617
PMC ID: PMC5824720

Pharmacogenomic Discovery to Function and Mechanism: Breast Cancer as a Case Study.

Wang L,  Ingle J,  Weinshilboum R
Clin Pharmacol Ther 2018 Feb;103(2):243-252
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29052219
PMC ID: PMC5760458

Impact of Prognostic Discussions on the Patient-Physician Relationship: Prospective Cohort Study.

Fenton JJ,  Duberstein PR,  Kravitz RL,  Xing G,  Tancredi DJ,  Fiscella K,  Mohile S,  Epstein RM
J Clin Oncol 2018 Jan 20;36(3):225-230
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29148892
PMC ID: PMC5773842

Associations between inflammatory markers and cognitive function in breast cancer patients receiving chemotherapy.

Williams AM,  Shah R,  Shayne M,  Huston AJ,  Krebs M,  Murray N,  Thompson BD,  Doyle K,  Korotkin J,  van Wijngaarden E,  Hyland S,  Moynihan JA,  Cory-Slechta DA,  Janelsins MC
J Neuroimmunol 2018 Jan 15;314:17-23
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29128118
PMC ID: PMC5768199

Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis.

Henderson TO,  Parsons SK,  Wroblewski KE,  Chen L,  Hong F,  Smith SM,  McNeer JL,  Advani RH,  Gascoyne RD,  Constine LS,  Horning S,  Bartlett NL,  Shah B,  Connors JM,  Leonard JI,  Kahl BS,  Kelly KM,  Schwartz CL,  Li H,  Friedberg JW,  Friedman DL,  Gordon LI,  Evens AM
Cancer 2018 Jan 1;124(1):136-144
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28902390
PMC ID: PMC5735034

Investigating the Effect of Reirradiation or Systemic Therapy in Patients With Glioblastoma After Tumor Progression: A Secondary Analysis of NRG Oncology/Radiation Therapy Oncology Group Trial 0525.

Shi W,  Scannell Bryan M,  Gilbert MR,  Mehta MP,  Blumenthal DT,  Brown PD,  Valeinis E,  Hopkins K,  Souhami L,  Andrews DW,  Tzuk-Shina T,  Howard SP,  Youssef EF,  Lessard N,  Dignam JJ,  Werner-Wasik M
Int J Radiat Oncol Biol Phys 2018 Jan 1;100(1):38-44
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29102648
PMC ID: PMC5742545

Surgical outcomes among elderly women with endometrial cancer treated by laparoscopic hysterectomy: a NRG/Gynecologic Oncology Group study.

Bishop EA,  Java JJ,  Moore KN,  Spirtos NM,  Pearl ML,  Zivanovic O,  Kushner DM,  Backes F,  Hamilton CA,  Geller MA,  Hurteau J,  Mathews C,  Wenham RM,  Ramirez PT,  Zweizig S,  Walker JL
Am J Obstet Gynecol 2018 Jan;218(1):109.e1-109.e11
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29037481
PMC ID: PMC5756682

Toxicities Associated with Cisplatin-Based Chemotherapy and Radiotherapy in Long-Term Testicular Cancer Survivors.

Fung C,  Dinh P Jr,  Ardeshir-Rouhani-Fard S,  Schaffer K,  Fossa SD,  Travis LB
Adv Urol 2018;2018:8671832
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29670654
PMC ID: PMC5835297

Associations of artificially sweetened beverage intake with disease recurrence and mortality in stage III colon cancer: Results from CALGB 89803 (Alliance).

Guercio BJ,  Zhang S,  Niedzwiecki D,  Li Y,  Babic A,  Morales-Oyarvide V,  Saltz LB,  Mayer RJ,  Mowat RB,  Whittom R,  Hantel A,  Benson A,  Atienza D,  Messino M,  Kindler H,  Venook A,  Ogino S,  Zoltick ES,  Stampfer M,  Ng K,  Wu K,  Willett WC,  Giovannucci EL,  Meyerhardt JA,  Fuchs CS
PLoS One 2018;13(7):e0199244
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30024889
PMC ID: PMC6053135

Exercise for Toxicity Management in Cancer-A Narrative Review.

Kleckner IR,  Dunne RF,  Asare M,  Cole C,  Fleming F,  Fung C,  Lin PJ,  Mustian KM
Oncol Hematol Rev 2018 Spring;14(1):28-37
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29713475
PMC ID: PMC5922767

Combining Survival and Toxicity Effect Sizes from Clinical Trials: NCCTG 89-20-52 (Alliance).

Major-Elechi BT,  Novotny PJ,  Singh JA,  Bonner JA,  Dueck AC,  Sargent DJ,  Grothey A,  Sloan JA
Int J Stat Med Res 2018;7(4):137-146
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31396297
PMC ID: PMC6686677

In vitro and ex-vivo evaluation of topical formulations designed to minimize transdermal absorption of Vitamin K1.

Nabiee R,  Dubois B,  Green L,  Sharma A,  Wong SF,  Montazeri Aliabadi H
PLoS One 2018;13(10):e0204531
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30289881
PMC ID: PMC6173387

Self-reported adherence and biomarker levels of CoQ10 and alpha-tocopherol.

Vitolins MZ,  Case LD,  Rapp SR,  Lively MO,  Shaw EG,  Naughton MJ,  Giguere J,  Lesser GJ
Patient Prefer Adherence 2018;12:637-646
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29731611
PMC ID: PMC5923253

E2112: randomized phase iii trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancer.

Yeruva SLH,  Zhao F,  Miller KD,  Tevaarwerk AJ,  Wagner LI,  Gray RJ,  Sparano JA,  Connolly RM
NPJ Breast Cancer 2018;4:1
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29354686
PMC ID: PMC5765007

Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer.

Fakhry C,  Zhang Q,  Nguyen-Tân PF,  Rosenthal DI,  Weber RS,  Lambert L,  Trotti AM 3rd,  Barrett WL,  Thorstad WL,  Jones CU,  Yom SS,  Wong SJ,  Ridge JA,  Rao SSD,  Bonner JA,  Vigneault E,  Raben D,  Kudrimoti MR,  Harris J,  Le QT,  Gillison ML
J Clin Oncol 2017 Dec 20;35(36):4057-4065
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28777690
PMC ID: PMC5736236

Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2.

Ganz PA,  Romond EH,  Cecchini RS,  Rastogi P,  Geyer CE Jr,  Swain SM,  Jeong JH,  Fehrenbacher L,  Gross HM,  Brufsky AM,  Flynn PJ,  Wahl TA,  Seay TE,  Wade JL 3rd,  Biggs DD,  Atkins JN,  Polikoff J,  Zapas JL,  Mamounas EP,  Wolmark N
J Clin Oncol 2017 Dec 10;35(35):3942-3948
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29072977
PMC ID: PMC5721228

Cost-Effectiveness Analysis of Monthly Zoledronic Acid, Zoledronic Acid Every 3 Months, and Monthly Denosumab in Women With Breast Cancer and Skeletal Metastases: CALGB 70604 (Alliance).

Shapiro CL,  Moriarty JP,  Dusetzina S,  Himelstein AL,  Foster JC,  Grubbs SS,  Novotny PJ,  Borah BJ
J Clin Oncol 2017 Dec 10;35(35):3949-3955
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29023215
PMC ID: PMC5721226

Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590).

Bhatia AK,  Lee JW,  Pinto HA,  Jacobs CD,  Limburg PJ,  Rubin P,  Arusell RM,  Dunphy EP,  Khandekar JD,  Reiner SA,  Baez-Diaz L,  Celano P,  Li S,  Li Y,  Burtness BA,  Adams GL,  Pandya KJ
Cancer 2017 Dec 1;123(23):4653-4662
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28786105
PMC ID: PMC5693641

Supplement Use and Chemotherapy-Induced Peripheral Neuropathy in a Cooperative Group Trial (S0221): The DELCaP Study.

Zirpoli GR,  McCann SE,  Sucheston-Campbell LE,  Hershman DL,  Ciupak G,  Davis W,  Unger JM,  Moore HCF,  Stewart JA,  Isaacs C,  Hobday TJ,  Salim M,  Hortobagyi GN,  Gralow JR,  Budd GT,  Albain KS,  Ambrosone CB
J Natl Cancer Inst 2017 Dec 1;109(12)
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29546345
PMC ID: PMC6075365

Deciding on breast cancer risk reduction: The role of counseling in individual decision-making - A qualitative study.

Blakeslee SB,  McCaskill-Stevens W,  Parker PA,  Gunn CM,  Bandos H,  Bevers TB,  Battaglia TA,  Fagerlin A,  Müller-Nordhorn J,  Holmberg C
Patient Educ Couns 2017 Dec;100(12):2346-2354
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsNCI Community Oncology Research Program
PubMed ID: 28734560
PMC ID: PMC5683919

Capacity for Cancer Care Delivery Research in National Cancer Institute Community Oncology Research Program Community Practices: Availability of Radiology and Primary Care Research Partners.

Carlos RC,  Sicks JD,  Chang GJ,  Lyss AP,  Stewart TL,  Sung L,  Weaver KE
J Am Coll Radiol 2017 Dec;14(12):1530-1537
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29055605
PMC ID: PMC5880209

Research priorities in cancer cachexia: The University of Rochester Cancer Center NCI Community Oncology Research Program Research Base Symposium on Cancer Cachexia and Sarcopenia.

Dunne RF,  Mustian KM,  Garcia JM,  Dale W,  Hayward R,  Roussel B,  Buschmann MM,  Caan BJ,  Cole CL,  Fleming FJ,  Chakkalakal JV,  Linehan DC,  Hezel AF,  Mohile SG
Curr Opin Support Palliat Care 2017 Dec;11(4):278-286
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28957880
PMC ID: PMC5658778

Lymphedema, musculoskeletal events and arm function in older patients receiving adjuvant chemotherapy for breast cancer (Alliance A171302).

Hopkins JO,  Allred J,  Hurria A,  Jatoi A,  Lafky JM,  Cohen H,  Hudis C,  Winer E,  Mandelblatt J,  Partridge A,  Carey L,  Muss HB
Breast Cancer Res Treat 2017 Dec;166(3):793-808
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28825227
PMC ID: PMC5771504

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.

Milne RL,  Kuchenbaecker KB,  Michailidou K,  Beesley J,  Kar S,  Lindström S,  Hui S,  Lemaçon A,  Soucy P,  Dennis J,  Jiang X,  Rostamianfar A,  Finucane H,  Bolla MK,  McGuffog L,  Wang Q,  Aalfs CM,  ABCTB Investigators,  Adams M,  Adlard J,  Agata S,  Ahmed S,  Ahsan H,  Aittomäki K,  Al-Ejeh F,  Allen J,  Ambrosone CB,  Amos CI,  Andrulis IL,  Anton-Culver H,  Antonenkova NN,  Arndt V,  Arnold N,  Aronson KJ,  Auber B,  Auer PL,  Ausems MGEM,  Azzollini J,  Bacot F,  Balmaña J,  Barile M,  Barjhoux L,  Barkardottir RB,  Barrdahl M,  Barnes D,  Barrowdale D,  Baynes C,  Beckmann MW,  Benitez J,  Bermisheva M,  Bernstein L,  Bignon YJ,  Blazer KR,  Blok MJ,  Blomqvist C,  Blot W,  Bobolis K,  Boeckx B,  Bogdanova NV,  Bojesen A,  Bojesen SE,  Bonanni B,  Børresen-Dale AL,  Bozsik A,  Bradbury AR,  Brand JS,  Brauch H,  Brenner H,  Bressac-de Paillerets B,  Brewer C,  Brinton L,  Broberg P,  Brooks-Wilson A,  Brunet J,  Brüning T,  Burwinkel B,  Buys SS,  Byun J,  Cai Q,  Caldés T,  Caligo MA,  Campbell I,  Canzian F,  Caron O,  Carracedo A,  Carter BD,  Castelao JE,  Castera L,  Caux-Moncoutier V,  Chan SB,  Chang-Claude J,  Chanock SJ,  Chen X,  Cheng TD,  Chiquette J,  Christiansen H,  Claes KBM,  Clarke CL,  Conner T,  Conroy DM,  Cook J,  Cordina-Duverger E,  Cornelissen S,  Coupier I,  Cox A,  Cox DG,  Cross SS,  Cuk K,  Cunningham JM,  Czene K,  Daly MB,  Damiola F,  Darabi H,  Davidson R,  De Leeneer K,  Devilee P,  Dicks E,  Diez O,  Ding YC,  Ditsch N,  Doheny KF,  Domchek SM,  Dorfling CM,  Dörk T,  Dos-Santos-Silva I,  Dubois S,  Dugué PA,  Dumont M,  Dunning AM,  Durcan L,  Dwek M,  Dworniczak B,  Eccles D,  Eeles R,  Ehrencrona H,  Eilber U,  Ejlertsen B,  Ekici AB,  Eliassen AH,  EMBRACE,  Engel C,  Eriksson M,  Fachal L,  Faivre L,  Fasching PA,  Faust U,  Figueroa J,  Flesch-Janys D,  Fletcher O,  Flyger H,  Foulkes WD,  Friedman E,  Fritschi L,  Frost D,  Gabrielson M,  Gaddam P,  Gammon MD,  Ganz PA,  Gapstur SM,  Garber J,  Garcia-Barberan V,  García-Sáenz JA,  Gaudet MM,  Gauthier-Villars M,  Gehrig A,  GEMO Study Collaborators,  Georgoulias V,  Gerdes AM,  Giles GG,  Glendon G,  Godwin AK,  Goldberg MS,  Goldgar DE,  González-Neira A,  Goodfellow P,  Greene MH,  Alnæs GIG,  Grip M,  Gronwald J,  Grundy A,  Gschwantler-Kaulich D,  Guénel P,  Guo Q,  Haeberle L,  Hahnen E,  Haiman CA,  HÃ¥kansson N,  Hallberg E,  Hamann U,  Hamel N,  Hankinson S,  Hansen TVO,  Harrington P,  Hart SN,  Hartikainen JM,  Healey CS,  HEBON,  Hein A,  Helbig S,  Henderson A,  Heyworth J,  Hicks B,  Hillemanns P,  Hodgson S,  Hogervorst FB,  Hollestelle A,  Hooning MJ,  Hoover B,  Hopper JL,  Hu C,  Huang G,  Hulick PJ,  Humphreys K,  Hunter DJ,  Imyanitov EN,  Isaacs C,  Iwasaki M,  Izatt L,  Jakubowska A,  James P,  Janavicius R,  Janni W,  Jensen UB,  John EM,  Johnson N,  Jones K,  Jones M,  Jukkola-Vuorinen A,  Kaaks R,  Kabisch M,  Kaczmarek K,  Kang D,  Kast K,  kConFab/AOCS Investigators,  Keeman R,  Kerin MJ,  Kets CM,  Keupers M,  Khan S,  Khusnutdinova E,  Kiiski JI,  Kim SW,  Knight JA,  Konstantopoulou I,  Kosma VM,  Kristensen VN,  Kruse TA,  Kwong A,  Lænkholm AV,  Laitman Y,  Lalloo F,  Lambrechts D,  Landsman K,  Lasset C,  Lazaro C,  Le Marchand L,  Lecarpentier J,  Lee A,  Lee E,  Lee JW,  Lee MH,  Lejbkowicz F,  Lesueur F,  Li J,  Lilyquist J,  Lincoln A,  Lindblom A,  Lissowska J,  Lo WY,  Loibl S,  Long J,  Loud JT,  Lubinski J,  Luccarini C,  Lush M,  MacInnis RJ,  Maishman T,  Makalic E,  Kostovska IM,  Malone KE,  Manoukian S,  Manson JE,  Margolin S,  Martens JWM,  Martinez ME,  Matsuo K,  Mavroudis D,  Mazoyer S,  McLean C,  Meijers-Heijboer H,  Menéndez P,  Meyer J,  Miao H,  Miller A,  Miller N,  Mitchell G,  Montagna M,  Muir K,  Mulligan AM,  Mulot C,  Nadesan S,  Nathanson KL,  NBSC Collaborators,  Neuhausen SL,  Nevanlinna H,  Nevelsteen I,  Niederacher D,  Nielsen SF,  Nordestgaard BG,  Norman A,  Nussbaum RL,  Olah E,  Olopade OI,  Olson JE,  Olswold C,  Ong KR,  Oosterwijk JC,  Orr N,  Osorio A,  Pankratz VS,  Papi L,  Park-Simon TW,  Paulsson-Karlsson Y,  Lloyd R,  Pedersen IS,  Peissel B,  Peixoto A,  Perez JIA,  Peterlongo P,  Peto J,  Pfeiler G,  Phelan CM,  Pinchev M,  Plaseska-Karanfilska D,  Poppe B,  Porteous ME,  Prentice R,  Presneau N,  Prokofieva D,  Pugh E,  Pujana MA,  Pylkäs K,  Rack B,  Radice P,  Rahman N,  Rantala J,  Rappaport-Fuerhauser C,  Rennert G,  Rennert HS,  Rhenius V,  Rhiem K,  Richardson A,  Rodriguez GC,  Romero A,  Romm J,  Rookus MA,  Rudolph A,  Ruediger T,  Saloustros E,  Sanders J,  Sandler DP,  Sangrajrang S,  Sawyer EJ,  Schmidt DF,  Schoemaker MJ,  Schumacher F,  Schürmann P,  Schwentner L,  Scott C,  Scott RJ,  Seal S,  Senter L,  Seynaeve C,  Shah M,  Sharma P,  Shen CY,  Sheng X,  Shimelis H,  Shrubsole MJ,  Shu XO,  Side LE,  Singer CF,  Sohn C,  Southey MC,  Spinelli JJ,  Spurdle AB,  Stegmaier C,  Stoppa-Lyonnet D,  Sukiennicki G,  Surowy H,  Sutter C,  Swerdlow A,  Szabo CI,  Tamimi RM,  Tan YY,  Taylor JA,  Tejada MI,  Tengström M,  Teo SH,  Terry MB,  Tessier DC,  Teulé A,  Thöne K,  Thull DL,  Tibiletti MG,  Tihomirova L,  Tischkowitz M,  Toland AE,  Tollenaar RAEM,  Tomlinson I,  Tong L,  Torres D,  Tranchant M,  Truong T,  Tucker K,  Tung N,  Tyrer J,  Ulmer HU,  Vachon C,  van Asperen CJ,  Van Den Berg D,  van den Ouweland AMW,  van Rensburg EJ,  Varesco L,  Varon-Mateeva R,  Vega A,  Viel A,  Vijai J,  Vincent D,  Vollenweider J,  Walker L,  Wang Z,  Wang-Gohrke S,  Wappenschmidt B,  Weinberg CR,  Weitzel JN,  Wendt C,  Wesseling J,  Whittemore AS,  Wijnen JT,  Willett W,  Winqvist R,  Wolk A,  Wu AH,  Xia L,  Yang XR,  Yannoukakos D,  Zaffaroni D,  Zheng W,  Zhu B,  Ziogas A,  Ziv E,  Zorn KK,  Gago-Dominguez M,  Mannermaa A,  Olsson H,  Teixeira MR,  Stone J,  Offit K,  Ottini L,  Park SK,  Thomassen M,  Hall P,  Meindl A,  Schmutzler RK,  Droit A,  Bader GD,  Pharoah PDP,  Couch FJ,  Easton DF,  Kraft P,  Chenevix-Trench G,  García-Closas M,  Schmidt MK,  Antoniou AC,  Simard J
Nat Genet 2017 Dec;49(12):1767-1778
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29058716
PMC ID: PMC5808456

Cultural Competency Training to Increase Minority Enrollment into Radiation Therapy Clinical Trials-an NRG Oncology RTOG Study.

Wells JS,  Pugh S,  Boparai K,  Rearden J,  Yeager KA,  Bruner DW
J Cancer Educ 2017 Dec;32(4):721-727
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27209044
PMC ID: PMC5118189

Clinical and Genetic Risk Prediction of Subsequent CNS Tumors in Survivors of Childhood Cancer: A Report From the COG ALTE03N1 Study.

Wang X,  Sun CL,  Hageman L,  Smith K,  Singh P,  Desai S,  Hawkins DS,  Hudson MM,  Mascarenhas L,  Neglia JP,  Oeffinger KC,  Ritchey AK,  Robison LL,  Villaluna D,  Landier W,  Bhatia S
J Clin Oncol 2017 Nov 10;35(32):3688-3696
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28976792
PMC ID: PMC5678343

Comparative "nocebo effects" in older patients enrolled in cancer therapeutic trials: Observations from a 446-patient cohort.

Foster JC,  Le-Rademacher JG,  Feliciano JL,  Gajra A,  Seisler DK,  DeMatteo R,  Lafky JM,  Hurria A,  Muss HB,  Cohen HJ,  Jatoi A
Cancer 2017 Nov 1;123(21):4193-4198
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28700816
PMC ID: PMC5735997

Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical Trial.

Suntharalingam M,  Winter K,  Ilson D,  Dicker AP,  Kachnic L,  Konski A,  Chakravarthy AB,  Anker CJ,  Thakrar H,  Horiba N,  Dubey A,  Greenberger JS,  Raben A,  Giguere J,  Roof K,  Videtic G,  Pollock J,  Safran H,  Crane CH
JAMA Oncol 2017 Nov 1;3(11):1520-1528
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28687830
PMC ID: PMC5710193

Gene Methylation Biomarkers in Sputum and Plasma as Predictors for Lung Cancer Recurrence.

Belinsky SA,  Leng S,  Wu G,  Thomas CL,  Picchi MA,  Lee SJ,  Aisner S,  Ramalingam S,  Khuri FR,  Karp DD
Cancer Prev Res (Phila) 2017 Nov;10(11):635-640
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28904059
PMC ID: PMC5668184

Access to Lung Cancer Screening Services: Preliminary Analysis of Geographic Service Distribution Using the ACR Lung Cancer Screening Registry.

Charkhchi P,  Kolenic GE,  Carlos RC
J Am Coll Radiol 2017 Nov;14(11):1388-1395
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29101972
PMC ID: PMC5893937

Personality, coping, and social support as predictors of long-term quality-of-life trajectories in older breast cancer survivors: CALGB protocol 369901 (Alliance).

Durá-Ferrandis E,  Mandelblatt JS,  Clapp J,  Luta G,  Faul L,  Kimmick G,  Cohen HJ,  Yung RL,  Hurria A
Psychooncology 2017 Nov;26(11):1914-1921
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28219113
PMC ID: PMC5563496

The Resilience in Illness Model Part 2: Confirmatory Evaluation in Adolescents and Young Adults With Cancer.

Haase JE,  Kintner EK,  Robb SL,  Stump TE,  Monahan PO,  Phillips C,  Stegenga KA,  Burns DS
Cancer Nurs 2017 Nov-Dec;40(6):454-463
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27984241
PMC ID: PMC5471133

History of Diabetes and Survival Outcome Among Participants 65 Years or Older in SWOG Clinical Trials.

Hershman DL,  Till C,  Wright JD,  Ramsey S,  Barlow WE,  Unger JM
JCO Clin Cancer Inform 2017 Nov;1:1-12
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30657402
PMC ID: PMC6640843

NRG Oncology/National Surgical Adjuvant Breast and Bowel Project Decision-Making Project-1 Results: Decision Making in Breast Cancer Risk Reduction.

Holmberg C,  Bandos H,  Fagerlin A,  Bevers TB,  Battaglia TA,  Wickerham DL,  McCaskill-Stevens WJ
Cancer Prev Res (Phila) 2017 Nov;10(11):625-634
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsNCI Community Oncology Research Program
PubMed ID: 28978566
PMC ID: PMC5848501

Patient-reported (EORTC QLQ-CIPN20) versus physician-reported (CTCAE) quantification of oxaliplatin- and paclitaxel/carboplatin-induced peripheral neuropathy in NCCTG/Alliance clinical trials.

Le-Rademacher J,  Kanwar R,  Seisler D,  Pachman DR,  Qin R,  Abyzov A,  Ruddy KJ,  Banck MS,  Lavoie Smith EM,  Dorsey SG,  Aaronson NK,  Sloan J,  Loprinzi CL,  Beutler AS
Support Care Cancer 2017 Nov;25(11):3537-3544
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28634656
PMC ID: PMC5693734

Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240).

Tewari KS,  Sill MW,  Penson RT,  Huang H,  Ramondetta LM,  Landrum LM,  Oaknin A,  Reid TJ,  Leitao MM,  Michael HE,  DiSaia PJ,  Copeland LJ,  Creasman WT,  Stehman FB,  Brady MF,  Burger RA,  Thigpen JT,  Birrer MJ,  Waggoner SE,  Moore DH,  Look KY,  Koh WJ,  Monk BJ
Lancet 2017 Oct 7;390(10103):1654-1663
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28756902
PMC ID: PMC5714293

Characterizing 18 Years of the Death With Dignity Act in Oregon.

Blanke C,  LeBlanc M,  Hershman D,  Ellis L,  Meyskens F
JAMA Oncol 2017 Oct 1;3(10):1403-1406
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28384683
PMC ID: PMC5824315

Association between patients' perception of the comorbidity burden and symptoms in outpatients with common solid tumors.

Ritchie CS,  Zhao F,  Patel K,  Manola J,  Kvale EA,  Snyder CF,  Fisch MJ
Cancer 2017 Oct 1;123(19):3835-3842
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28608952
PMC ID: PMC5610613

The Effect of Positive SWOG Treatment Trials on Survival of Patients With Cancer in the US Population.

Unger JM,  LeBlanc M,  Blanke CD
JAMA Oncol 2017 Oct 1;3(10):1345-1351
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28586789
PMC ID: PMC5710507

A systematic review of patient perspectives on surveillance after colorectal cancer treatment.

Berian JR,  Cuddy A,  Francescatti AB,  O'Dwyer L,  Nancy You Y,  Volk RJ,  Chang GJ
J Cancer Surviv 2017 Oct;11(5):542-552
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28639159
PMC ID: PMC5744251

Cognitive function and discontinuation of adjuvant hormonal therapy in older breast cancer survivors: CALGB 369901 (Alliance).

Bluethmann SM,  Alfano CM,  Clapp JD,  Luta G,  Small BJ,  Hurria A,  Cohen HJ,  Sugarman S,  B Muss H,  Isaacs C,  Mandelblatt JS
Breast Cancer Res Treat 2017 Oct;165(3):677-686
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28653250
PMC ID: PMC5709158

Spirituality, emotional distress, and post-traumatic growth in breast cancer survivors and their partners: an actor-partner interdependence modeling approach.

Gesselman AN,  Bigatti SM,  Garcia JR,  Coe K,  Cella D,  Champion VL
Psychooncology 2017 Oct;26(10):1691-1699
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27280320
PMC ID: PMC5148716

Flexible modeling of the hazard rate and treatment effects in long-term survival studies.

Hagar Y,  Dignam JJ,  Dukic V
Stat Methods Med Res 2017 Oct;26(5):2455-2480
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28150523
PMC ID: PMC5651995

Effects of childhood trauma exposure and cortisol levels on cognitive functioning among breast cancer survivors.

Kamen C,  Scheiber C,  Janelsins M,  Jo B,  Shen H,  Palesh O
Child Abuse Negl 2017 Oct;72:163-171
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28818733
PMC ID: PMC5659913

Associations of sleep disturbance with physical function and cognition in older adults with cancer.

Loh KP,  Pandya C,  Zittel J,  Kadambi S,  Flannery M,  Reizine N,  Magnuson A,  Braganza G,  Mustian K,  Dale W,  Duberstein P,  Mohile SG
Support Care Cancer 2017 Oct;25(10):3161-3169
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28455547
PMC ID: PMC5660663

Hippocampal dose volume histogram predicts Hopkins Verbal Learning Test scores after brain irradiation.

Okoukoni C,  McTyre ER,  Ayala Peacock DN,  Peiffer AM,  Strowd R,  Cramer C,  Hinson WH,  Rapp S,  Metheny-Barlow L,  Shaw EG,  Chan MD
Adv Radiat Oncol 2017 Oct-Dec;2(4):624-629
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29204530
PMC ID: PMC5707405

Does biomarker information impact breast cancer patients' preferences and physician recommendation for adjuvant chemotherapy?

Partridge AH,  Sepucha K,  O'Neill A,  Miller KD,  Baker E,  Dang CT,  Northfelt DW,  Sledge GW,  Schneider BP
Breast Cancer Res Treat 2017 Oct;165(3):545-553
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28646344
PMC ID: PMC5837858

Quality of life is significantly associated with survival in women with advanced epithelial ovarian cancer: An ancillary data analysis of the NRG Oncology/Gynecologic Oncology Group (GOG-0218) study.

Phippen NT,  Secord AA,  Wolf S,  Samsa G,  Davidson B,  Abernethy AP,  Cella D,  Havrilesky LJ,  Burger RA,  Monk BJ,  Leath CA 3rd
Gynecol Oncol 2017 Oct;147(1):98-103
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28743369
PMC ID: PMC5605439

A Prospective Study of Chronic Inflammation in Benign Prostate Tissue and Risk of Prostate Cancer: Linked PCPT and SELECT Cohorts.

Platz EA,  Kulac I,  Barber JR,  Drake CG,  Joshu CE,  Nelson WG,  Lucia MS,  Klein EA,  Lippman SM,  Parnes HL,  Thompson IM,  Goodman PJ,  Tangen CM,  De Marzo AM
Cancer Epidemiol Biomarkers Prev 2017 Oct;26(10):1549-1557
Major Program(s) or Research Group(s): Prostate and Urologic CancerNCI Community Oncology Research Program
PubMed ID: 28754796
PMC ID: PMC5626618

Responding to Patient Requests for Hastened Death: Physician Aid in Dying and the Clinical Oncologist.

Spence RA,  Blanke CD,  Keating TJ,  Taylor LP
J Oncol Pract 2017 Oct;13(10):693-699
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28915075
PMC ID: PMC5946710

Gene methylation biomarkers in sputum as a classifier for lung cancer risk.

Leng S,  Wu G,  Klinge DM,  Thomas CL,  Casas E,  Picchi MA,  Stidley CA,  Lee SJ,  Aisner S,  Siegfried JM,  Ramalingam S,  Khuri FR,  Karp DD,  Belinsky SA
Oncotarget 2017 Sep 8;8(38):63978-63985
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28969046
PMC ID: PMC5609978

Advance Care Planning and Palliative Care Integration for Patients Undergoing Hematopoietic Stem-Cell Transplantation.

Wang WS,  Ma JD,  Nelson SH,  Revta C,  Buckholz GT,  Mulroney CM,  Roeland EJ
J Oncol Pract 2017 Sep;13(9):e721-e728
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28644706
PMC ID: PMC6366810

Novel Molecular Targets for Chemoprevention in Malignancies of the Head and Neck.

Bhatia A,  Burtness B
Cancers (Basel) 2017 Aug 31;9(9)
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28858212
PMC ID: PMC5615328

Chemotherapy-induced peripheral neuropathy clinical trials: Review and recommendations.

Gewandter JS,  Freeman R,  Kitt RA,  Cavaletti G,  Gauthier LR,  McDermott MP,  Mohile NA,  Mohlie SG,  Smith AG,  Tejani MA,  Turk DC,  Dworkin RH
Neurology 2017 Aug 22;89(8):859-869
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28747442
PMC ID: not available

Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology).

Blum JL,  Flynn PJ,  Yothers G,  Asmar L,  Geyer CE Jr,  Jacobs SA,  Robert NJ,  Hopkins JO,  O'Shaughnessy JA,  Dang CT,  Gómez HL,  Fehrenbacher L,  Vukelja SJ,  Lyss AP,  Paul D,  Brufsky AM,  Jeong JH,  Colangelo LH,  Swain SM,  Mamounas EP,  Jones SE,  Wolmark N
J Clin Oncol 2017 Aug 10;35(23):2647-2655
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28398846
PMC ID: PMC5549453

NRG Oncology-Radiation Therapy Oncology Group Study 1014: 1-Year Toxicity Report From a Phase 2 Study of Repeat Breast-Preserving Surgery and 3-Dimensional Conformal Partial-Breast Reirradiation for In-Breast Recurrence.

Arthur DW,  Winter KA,  Kuerer HM,  Haffty BG,  Cuttino LW,  Todor DA,  Simone NL,  Hayes SB,  Woodward WA,  McCormick B,  Cohen RJ,  Sahijdak WM,  Canaday DJ,  Brown DR,  Currey AD,  Fisher CM,  Jagsi R,  White J
Int J Radiat Oncol Biol Phys 2017 Aug 1;98(5):1028-1035
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28721885
PMC ID: PMC5572128

Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials.

Basch E,  Dueck AC,  Rogak LJ,  Minasian LM,  Kelly WK,  O'Mara AM,  Denicoff AM,  Seisler D,  Atherton PJ,  Paskett E,  Carey L,  Dickler M,  Heist RS,  Himelstein A,  Rugo HS,  Sikov WM,  Socinski MA,  Venook AP,  Weckstein DJ,  Lake DE,  Biggs DD,  Freedman RA,  Kuzma C,  Kirshner JJ,  Schrag D
JAMA Oncol 2017 Aug 1;3(8):1043-1050
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials ;  Office of the Director ;  Supportive Care and Symptom ManagementNCI Community Oncology Research Program
PubMed ID: 28208174
PMC ID: PMC5553624

A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial.

Jatoi A,  Steen PD,  Atherton PJ,  Moore DF,  Rowland KM,  Le-Lindqwister NA,  Adonizio CS,  Jaslowski AJ,  Sloan J,  Loprinzi C
Ann Oncol 2017 Aug 1;28(8):1957-1963
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28475678
PMC ID: PMC5808669

Survival benefit needed to undergo chemotherapy: Patient and physician preferences.

Vaz-Luis I,  O'Neill A,  Sepucha K,  Miller KD,  Baker E,  Dang CT,  Northfelt DW,  Winer EP,  Sledge GW,  Schneider B,  Partridge AH
Cancer 2017 Aug 1;123(15):2821-2828
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28323331
PMC ID: PMC5517352

Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.

Brown PD,  Ballman KV,  Cerhan JH,  Anderson SK,  Carrero XW,  Whitton AC,  Greenspoon J,  Parney IF,  Laack NNI,  Ashman JB,  Bahary JP,  Hadjipanayis CG,  Urbanic JJ,  Barker FG 2nd,  Farace E,  Khuntia D,  Giannini C,  Buckner JC,  Galanis E,  Roberge D
Lancet Oncol 2017 Aug;18(8):1049-1060
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28687377
PMC ID: PMC5568757

A stakeholder-driven approach to improve the informed consent process for palliative chemotherapy.

Enzinger AC,  Wind JK,  Frank E,  McCleary NJ,  Porter L,  Cushing H,  Abbott C,  Cronin C,  Enzinger PC,  Meropol NJ,  Schrag D
Patient Educ Couns 2017 Aug;100(8):1527-1536
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28359659
PMC ID: PMC5492511

Patterns of growth factor usage and febrile neutropenia among older patients with diffuse large B-cell non-Hodgkin lymphoma treated with CHOP or R-CHOP: the Intergroup experience (CALGB 9793; ECOG-SWOG 4494).

Morrison VA,  Weller EA,  Habermann TM,  Li S,  Fisher RI,  Cheson BD,  Peterson BA
Leuk Lymphoma 2017 Aug;58(8):1814-1822
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27967294
PMC ID: PMC5502834

A Pooled Analysis of 15 Prospective Cohort Studies on the Association between Fruit, Vegetable, and Mature Bean Consumption and Risk of Prostate Cancer.

Petimar J,  Wilson KM,  Wu K,  Wang M,  Albanes D,  van den Brandt PA,  Cook MB,  Giles GG,  Giovannucci EL,  Goodman GE,  Goodman PJ,  HÃ¥kansson N,  Helzlsouer K,  Key TJ,  Kolonel LN,  Liao LM,  Männistö S,  McCullough ML,  Milne RL,  Neuhouser ML,  Park Y,  Platz EA,  Riboli E,  Sawada N,  Schenk JM,  Tsugane S,  Verhage B,  Wang Y,  Wilkens LR,  Wolk A,  Ziegler RG,  Smith-Warner SA
Cancer Epidemiol Biomarkers Prev 2017 Aug;26(8):1276-1287
Major Program(s) or Research Group(s): NCI Community Oncology Research ProgramProstate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 28446545
PMC ID: PMC5540798

Cure modeling in real-time prediction: How much does it help?

Ying GS,  Zhang Q,  Lan Y,  Li Y,  Heitjan DF
Contemp Clin Trials 2017 Aug;59:30-37
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28545934
PMC ID: PMC5571982

CT Perfusion as an Early Biomarker of Treatment Efficacy in Advanced Ovarian Cancer: An ACRIN and GOG Study.

Ng CS,  Zhang Z,  Lee SI,  Marques HS,  Burgers K,  Su F,  Bauza J,  Mannel RS,  Walker JL,  Huh WK,  Rubin SC,  DiSilvestro P,  Martin LP,  Chan JK,  Bookman MA,  Coleman RL,  Lee TY
Clin Cancer Res 2017 Jul 15;23(14):3684-3691
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28174234
PMC ID: PMC5720368

Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials.

Skates SJ,  Greene MH,  Buys SS,  Mai PL,  Brown P,  Piedmonte M,  Rodriguez G,  Schorge JO,  Sherman M,  Daly MB,  Rutherford T,  Brewster WR,  O'Malley DM,  Partridge E,  Boggess J,  Drescher CW,  Isaacs C,  Berchuck A,  Domchek S,  Davidson SA,  Edwards R,  Elg SA,  Wakeley K,  Phillips KA,  Armstrong D,  Horowitz I,  Fabian CJ,  Walker J,  Sluss PM,  Welch W,  Minasian L,  Horick NK,  Kasten CH,  Nayfield S,  Alberts D,  Finkelstein DM,  Lu KH
Clin Cancer Res 2017 Jul 15;23(14):3628-3637
Major Program(s) or Research Group(s): Breast and Gynecologic CancerEarly Detection ;  Office of the Director ;  NCI Community Oncology Research Program
PubMed ID: 28143870
PMC ID: PMC5726402

Words matter: Restoring respect and dignity when referring to individuals with cancer.

Ellis LM,  Blanke CD,  Kohn EC
Cancer 2017 Jul 1;123(13):2390-2391
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28182266
PMC ID: not available

Adjuvant radiation therapy, androgen deprivation, and docetaxel for high-risk prostate cancer postprostatectomy: Results of NRG Oncology/RTOG study 0621.

Hurwitz MD,  Harris J,  Sartor O,  Xiao Y,  Shayegan B,  Sperduto PW,  Badiozamani KR,  Lawton CAF,  Horwitz EM,  Michalski JM,  Roof K,  Beyer DC,  Zhang Q,  Sandler HM
Cancer 2017 Jul 1;123(13):2489-2496
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28323339
PMC ID: PMC5474197

Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers.

Kuchenbaecker KB,  McGuffog L,  Barrowdale D,  Lee A,  Soucy P,  Dennis J,  Domchek SM,  Robson M,  Spurdle AB,  Ramus SJ,  Mavaddat N,  Terry MB,  Neuhausen SL,  Schmutzler RK,  Simard J,  Pharoah PDP,  Offit K,  Couch FJ,  Chenevix-Trench G,  Easton DF,  Antoniou AC
J Natl Cancer Inst 2017 Jul 1;109(7)
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28376175
PMC ID: PMC5408990

Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue: A Meta-analysis.

Mustian KM,  Alfano CM,  Heckler C,  Kleckner AS,  Kleckner IR,  Leach CR,  Mohr D,  Palesh OG,  Peppone LJ,  Piper BF,  Scarpato J,  Smith T,  Sprod LK,  Miller SM
JAMA Oncol 2017 Jul 1;3(7):961-968
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28253393
PMC ID: PMC5557289

Avoidant coping and self-efficacy mediate relationships between perceived social constraints and symptoms among long-term breast cancer survivors.

Adams RN,  Mosher CE,  Cohee AA,  Stump TE,  Monahan PO,  Sledge GW Jr,  Cella D,  Champion VL
Psychooncology 2017 Jul;26(7):982-990
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 26969374
PMC ID: PMC5018239

A stakeholder-informed randomized, controlled comparative effectiveness study of an order prescribing intervention to improve colony stimulating factor use for cancer patients receiving myelosuppressive chemotherapy: the TrACER study.

Bansal A,  Sullivan SD,  Hershman DL,  Lyman GH,  Barlow WE,  McCune JS,  Ramsey SD
J Comp Eff Res 2017 Jul;6(5):461-470
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28686055
PMC ID: PMC5827800

The Effect on Surgical Complications of Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer: NRG Oncology/NSABP Protocol B-40.

Bear HD,  Tang G,  Rastogi P,  Geyer CE Jr,  Zoon CK,  Kidwell KM,  Robidoux A,  Baez-Diaz L,  Brufsky AM,  Mehta RS,  Fehrenbacher L,  Young JA,  Senecal FM,  Gaur R,  Margolese RG,  Adams PT,  Gross HM,  Costantino JP,  Paik S,  Swain SM,  Mamounas EP,  Wolmark N
Ann Surg Oncol 2017 Jul;24(7):1853-1860
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27864694
PMC ID: PMC5821429

MR spectroscopy of breast cancer for assessing early treatment response: Results from the ACRIN 6657 MRS trial.

Bolan PJ,  Kim E,  Herman BA,  Newstead GM,  Rosen MA,  Schnall MD,  Pisano ED,  Weatherall PT,  Morris EA,  Lehman CD,  Garwood M,  Nelson MT,  Yee D,  Polin SM,  Esserman LJ,  Gatsonis CA,  Metzger GJ,  Newitt DC,  Partridge SC,  Hylton NM,  ACRIN Trial team ISPY-1 Investigators
J Magn Reson Imaging 2017 Jul;46(1):290-302
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27981651
PMC ID: PMC5464996

Real-time Fatigue and Free-Living Physical Activity in Hematopoietic Stem Cell Transplantation Cancer Survivors and Healthy Controls: A Preliminary Examination of the Temporal, Dynamic Relationship.

Hacker ED,  Kim I,  Park C,  Peters T
Cancer Nurs 2017 Jul-Aug;40(4):259-268
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27922918
PMC ID: PMC5459685

Stories and Music for Adolescent/Young Adult Resilience During Transplant Partnerships: Strategies to Support Academic-Clinical Nurse Collaborations in Behavioral Intervention Studies.

Hendricks-Ferguson VL,  Barnes YJ,  Cherven B,  Stegenga K,  Roll L,  Docherty SL,  Haase JE
Clin Nurse Spec 2017 Jul-Aug;31(4):195-200
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28594670
PMC ID: PMC5918340

Frailty and long-term mortality of older breast cancer patients: CALGB 369901 (Alliance).

Mandelblatt JS,  Cai L,  Luta G,  Kimmick G,  Clapp J,  Isaacs C,  Pitcher B,  Barry W,  Winer E,  Sugarman S,  Hudis C,  Muss H,  Cohen HJ,  Hurria A
Breast Cancer Res Treat 2017 Jul;164(1):107-117
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28364214
PMC ID: PMC5479131

Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial.

Basch E,  Pugh SL,  Dueck AC,  Mitchell SA,  Berk L,  Fogh S,  Rogak LJ,  Gatewood M,  Reeve BB,  Mendoza TR,  O'Mara AM,  Denicoff AM,  Minasian LM,  Bennett AV,  Setser A,  Schrag D,  Roof K,  Moore JK,  Gergel T,  Stephans K,  Rimner A,  DeNittis A,  Bruner DW
Int J Radiat Oncol Biol Phys 2017 Jun 1;98(2):409-418
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials ;  Office of the Director ;  Supportive Care and Symptom ManagementNCI Community Oncology Research Program
PubMed ID: 28463161
PMC ID: PMC5557037

Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525.

Bell EH,  Pugh SL,  McElroy JP,  Gilbert MR,  Mehta M,  Klimowicz AC,  Magliocco A,  Bredel M,  Robe P,  Grosu AL,  Stupp R,  Curran W Jr,  Becker AP,  Salavaggione AL,  Barnholtz-Sloan JS,  Aldape K,  Blumenthal DT,  Brown PD,  Glass J,  Souhami L,  Lee RJ,  Brachman D,  Flickinger J,  Won M,  Chakravarti A
JAMA Oncol 2017 Jun 1;3(6):784-792
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28097324
PMC ID: PMC5464982

Predicted vitamin D status and colon cancer recurrence and mortality in CALGB 89803 (Alliance).

Fuchs MA,  Yuan C,  Sato K,  Niedzwiecki D,  Ye X,  Saltz LB,  Mayer RJ,  Mowat RB,  Whittom R,  Hantel A,  Benson A,  Atienza D,  Messino M,  Kindler H,  Venook A,  Innocenti F,  Warren RS,  Bertagnolli MM,  Ogino S,  Giovannucci EL,  Horvath E,  Meyerhardt JA,  Ng K
Ann Oncol 2017 Jun 1;28(6):1359-1367
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28327908
PMC ID: PMC5789809

Predictors of Radiation Therapy-Related Gastrointestinal Toxicity From Anal Cancer Dose-Painted Intensity Modulated Radiation Therapy: Secondary Analysis of NRG Oncology RTOG 0529.

Olsen JR,  Moughan J,  Myerson R,  Abitbol A,  Doncals DE,  Johnson D,  Schefter TE,  Chen Y,  Fisher B,  Michalski J,  Narayan S,  Chang A,  Crane CH,  Kachnic L
Int J Radiat Oncol Biol Phys 2017 Jun 1;98(2):400-408
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28463160
PMC ID: PMC5639877

Lack of Patient-Clinician Concordance in Cancer Patients: Its Relation With Patient Variables.

Chandwani KD,  Zhao F,  Morrow GR,  Deshields TL,  Minasian LM,  Manola J,  Fisch MJ
J Pain Symptom Manage 2017 Jun;53(6):988-998
Major Program(s) or Research Group(s): Office of the Director ;  NCI Community Oncology Research Program
PubMed ID: 28185892
PMC ID: PMC5474148

Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial.

Coleman RL,  Brady MF,  Herzog TJ,  Sabbatini P,  Armstrong DK,  Walker JL,  Kim BG,  Fujiwara K,  Tewari KS,  O'Malley DM,  Davidson SA,  Rubin SC,  DiSilvestro P,  Basen-Engquist K,  Huang H,  Chan JK,  Spirtos NM,  Ashfaq R,  Mannel RS
Lancet Oncol 2017 Jun;18(6):779-791
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28438473
PMC ID: PMC5715461

Minority stress, psychosocial resources, and psychological distress among sexual minority breast cancer survivors.

Kamen C,  Jabson JM,  Mustian KM,  Boehmer U
Health Psychol 2017 Jun;36(6):529-537
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28165265
PMC ID: PMC5444950

Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503).

Kimmick GG,  Major B,  Clapp J,  Sloan J,  Pitcher B,  Ballman K,  Barginear M,  Freedman RA,  Artz A,  Klepin HD,  Lafky JM,  Hopkins J,  Winer E,  Hudis C,  Muss H,  Cohen H,  Jatoi A,  Hurria A,  Mandelblatt J
Breast Cancer Res Treat 2017 Jun;163(2):391-398
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28283904
PMC ID: PMC5508575

Effects of cognitive behavioral therapy for insomnia and armodafinil on quality of life in cancer survivors: a randomized placebo-controlled trial.

Peoples AR,  Garland SN,  Perlis ML,  Savard J,  Heckler CE,  Kamen CS,  Ryan JL,  Mustian KM,  Janelsins MC,  Peppone LJ,  Morrow GR,  Roscoe JA
J Cancer Surviv 2017 Jun;11(3):401-409
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28105576
PMC ID: PMC5437869

Feasibility of a Centralized Clinical Trials Coverage Analysis: A Joint Initiative of the American Society of Clinical Oncology and the National Cancer Institute.

Szczepanek CM,  Hurley P,  Good MJ,  Denicoff A,  Willenberg K,  Dawson C,  Kurbegov D
J Oncol Pract 2017 Jun;13(6):395-400
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsNCI Community Oncology Research Program
PubMed ID: 28481681
PMC ID: not available

Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial.

Winchester DA,  Till C,  Goodman PJ,  Tangen CM,  Santella RM,  Johnson-Pais TL,  Leach RJ,  Xu J,  Zheng SL,  Thompson IM,  Lucia MS,  Lippman SM,  Parnes HL,  Isaacs WB,  De Marzo AM,  Drake CG,  Platz EA
Prostate 2017 Jun;77(8):908-919
Major Program(s) or Research Group(s): Prostate and Urologic CancerNCI Community Oncology Research Program
PubMed ID: 28317149
PMC ID: PMC5400704

Genetic landscape of extreme responders with anaplastic oligodendroglioma.

Holdhoff M,  Cairncross GJ,  Kollmeyer TM,  Zhang M,  Zhang P,  Mehta MP,  Werner-Wasik M,  Souhami L,  Bahary JP,  Kwok Y,  Hartford AC,  Chakravarti A,  Yegnasubramanian S,  Vogelstein B,  Papadopoulos N,  Kinzler K,  Jenkins RB,  Bettegowda C
Oncotarget 2017 May 30;8(22):35523-35531
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28388591
PMC ID: PMC5482595

Mercaptopurine Ingestion Habits, Red Cell Thioguanine Nucleotide Levels, and Relapse Risk in Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group Study AALL03N1.

Landier W,  Hageman L,  Chen Y,  Kornegay N,  Evans WE,  Bostrom BC,  Casillas J,  Dickens DS,  Angiolillo AL,  Lew G,  Maloney KW,  Mascarenhas L,  Ritchey AK,  Termuhlen AM,  Carroll WL,  Relling MV,  Wong FL,  Bhatia S
J Clin Oncol 2017 May 20;35(15):1730-1736
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28339328
PMC ID: PMC5455766

Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials.

Taylor C,  Correa C,  Duane FK,  Aznar MC,  Anderson SJ,  Bergh J,  Dodwell D,  Ewertz M,  Gray R,  Jagsi R,  Pierce L,  Pritchard KI,  Swain S,  Wang Z,  Wang Y,  Whelan T,  Peto R,  McGale P,  Early Breast Cancer Trialists' Collaborative Group
J Clin Oncol 2017 May 20;35(15):1641-1649
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28319436
PMC ID: PMC5548226

Impact of ethnicity on the outcome of men with metastatic, hormone-sensitive prostate cancer.

Bernard B,  Muralidhar V,  Chen YH,  Sridhar SS,  Mitchell EP,  Pettaway CA,  Carducci MA,  Nguyen PL,  Sweeney CJ
Cancer 2017 May 1;123(9):1536-1544
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28055108
PMC ID: PMC5400707

An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825.

Gittleman H,  Lim D,  Kattan MW,  Chakravarti A,  Gilbert MR,  Lassman AB,  Lo SS,  Machtay M,  Sloan AE,  Sulman EP,  Tian D,  Vogelbaum MA,  Wang TJC,  Penas-Prado M,  Youssef E,  Blumenthal DT,  Zhang P,  Mehta MP,  Barnholtz-Sloan JS
Neuro Oncol 2017 May 1;19(5):669-677
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28453749
PMC ID: PMC5464437

Association of Antioxidant Supplement Use and Dementia in the Prevention of Alzheimer's Disease by Vitamin E and Selenium Trial (PREADViSE).

Kryscio RJ,  Abner EL,  Caban-Holt A,  Lovell M,  Goodman P,  Darke AK,  Yee M,  Crowley J,  Schmitt FA
JAMA Neurol 2017 May 1;74(5):567-573
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28319243
PMC ID: PMC5506489

Pathologic and Treatment Outcomes Among a Geriatric Population of Endometrial Cancer Patients: An NRG Oncology/Gynecologic Oncology Group Ancillary Data Analysis of LAP2.

Bishop EA,  Java JJ,  Moore KN,  Walker JL
Int J Gynecol Cancer 2017 May;27(4):730-737
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28399028
PMC ID: PMC5407305

Persistent Fatigue in Hematopoietic Stem Cell Transplantation Survivors.

Hacker ED,  Fink AM,  Peters T,  Park C,  Fantuzzi G,  Rondelli D
Cancer Nurs 2017 May-Jun;40(3):174-183
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27333126
PMC ID: PMC5177539

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.

Phelan CM,  Kuchenbaecker KB,  Tyrer JP,  Kar SP,  Lawrenson K,  Winham SJ,  Dennis J,  Pirie A,  Riggan MJ,  Chornokur G,  Earp MA,  Lyra PC Jr,  Lee JM,  Coetzee S,  Beesley J,  McGuffog L,  Soucy P,  Dicks E,  Lee A,  Barrowdale D,  Lecarpentier J,  Leslie G,  Aalfs CM,  Aben KKH,  Adams M,  Adlard J,  Andrulis IL,  Anton-Culver H,  Antonenkova N,  AOCS study group,  Aravantinos G,  Arnold N,  Arun BK,  Arver B,  Azzollini J,  Balmaña J,  Banerjee SN,  Barjhoux L,  Barkardottir RB,  Bean Y,  Beckmann MW,  Beeghly-Fadiel A,  Benitez J,  Bermisheva M,  Bernardini MQ,  Birrer MJ,  Bjorge L,  Black A,  Blankstein K,  Blok MJ,  Bodelon C,  Bogdanova N,  Bojesen A,  Bonanni B,  Borg Å,  Bradbury AR,  Brenton JD,  Brewer C,  Brinton L,  Broberg P,  Brooks-Wilson A,  Bruinsma F,  Brunet J,  Buecher B,  Butzow R,  Buys SS,  Caldes T,  Caligo MA,  Campbell I,  Cannioto R,  Carney ME,  Cescon T,  Chan SB,  Chang-Claude J,  Chanock S,  Chen XQ,  Chiew YE,  Chiquette J,  Chung WK,  Claes KBM,  Conner T,  Cook LS,  Cook J,  Cramer DW,  Cunningham JM,  D'Aloisio AA,  Daly MB,  Damiola F,  Damirovna SD,  Dansonka-Mieszkowska A,  Dao F,  Davidson R,  DeFazio A,  Delnatte C,  Doheny KF,  Diez O,  Ding YC,  Doherty JA,  Domchek SM,  Dorfling CM,  Dörk T,  Dossus L,  Duran M,  Dürst M,  Dworniczak B,  Eccles D,  Edwards T,  Eeles R,  Eilber U,  Ejlertsen B,  Ekici AB,  Ellis S,  Elvira M,  EMBRACE Study,  Eng KH,  Engel C,  Evans DG,  Fasching PA,  Ferguson S,  Ferrer SF,  Flanagan JM,  Fogarty ZC,  Fortner RT,  Fostira F,  Foulkes WD,  Fountzilas G,  Fridley BL,  Friebel TM,  Friedman E,  Frost D,  Ganz PA,  Garber J,  García MJ,  Garcia-Barberan V,  Gehrig A,  GEMO Study Collaborators,  Gentry-Maharaj A,  Gerdes AM,  Giles GG,  Glasspool R,  Glendon G,  Godwin AK,  Goldgar DE,  Goranova T,  Gore M,  Greene MH,  Gronwald J,  Gruber S,  Hahnen E,  Haiman CA,  HÃ¥kansson N,  Hamann U,  Hansen TVO,  Harrington PA,  Harris HR,  Hauke J,  HEBON Study,  Hein A,  Henderson A,  Hildebrandt MAT,  Hillemanns P,  Hodgson S,  Høgdall CK,  Høgdall E,  Hogervorst FBL,  Holland H,  Hooning MJ,  Hosking K,  Huang RY,  Hulick PJ,  Hung J,  Hunter DJ,  Huntsman DG,  Huzarski T,  Imyanitov EN,  Isaacs C,  Iversen ES,  Izatt L,  Izquierdo A,  Jakubowska A,  James P,  Janavicius R,  Jernetz M,  Jensen A,  Jensen UB,  John EM,  Johnatty S,  Jones ME,  Kannisto P,  Karlan BY,  Karnezis A,  Kast K,  KConFab Investigators,  Kennedy CJ,  Khusnutdinova E,  Kiemeney LA,  Kiiski JI,  Kim SW,  Kjaer SK,  Köbel M,  Kopperud RK,  Kruse TA,  Kupryjanczyk J,  Kwong A,  Laitman Y,  Lambrechts D,  Larrañaga N,  Larson MC,  Lazaro C,  Le ND,  Le Marchand L,  Lee JW,  Lele SB,  Leminen A,  Leroux D,  Lester J,  Lesueur F,  Levine DA,  Liang D,  Liebrich C,  Lilyquist J,  Lipworth L,  Lissowska J,  Lu KH,  Lubinński J,  Luccarini C,  Lundvall L,  Mai PL,  Mendoza-Fandiño G,  Manoukian S,  Massuger LFAG,  May T,  Mazoyer S,  McAlpine JN,  McGuire V,  McLaughlin JR,  McNeish I,  Meijers-Heijboer H,  Meindl A,  Menon U,  Mensenkamp AR,  Merritt MA,  Milne RL,  Mitchell G,  Modugno F,  Moes-Sosnowska J,  Moffitt M,  Montagna M,  Moysich KB,  Mulligan AM,  Musinsky J,  Nathanson KL,  Nedergaard L,  Ness RB,  Neuhausen SL,  Nevanlinna H,  Niederacher D,  Nussbaum RL,  Odunsi K,  Olah E,  Olopade OI,  Olsson H,  Olswold C,  O'Malley DM,  Ong KR,  Onland-Moret NC,  OPAL study group,  Orr N,  Orsulic S,  Osorio A,  Palli D,  Papi L,  Park-Simon TW,  Paul J,  Pearce CL,  Pedersen IS,  Peeters PHM,  Peissel B,  Peixoto A,  Pejovic T,  Pelttari LM,  Permuth JB,  Peterlongo P,  Pezzani L,  Pfeiler G,  Phillips KA,  Piedmonte M,  Pike MC,  Piskorz AM,  Poblete SR,  Pocza T,  Poole EM,  Poppe B,  Porteous ME,  Prieur F,  Prokofyeva D,  Pugh E,  Pujana MA,  Pujol P,  Radice P,  Rantala J,  Rappaport-Fuerhauser C,  Rennert G,  Rhiem K,  Rice P,  Richardson A,  Robson M,  Rodriguez GC,  Rodríguez-Antona C,  Romm J,  Rookus MA,  Rossing MA,  Rothstein JH,  Rudolph A,  Runnebaum IB,  Salvesen HB,  Sandler DP,  Schoemaker MJ,  Senter L,  Setiawan VW,  Severi G,  Sharma P,  Shelford T,  Siddiqui N,  Side LE,  Sieh W,  Singer CF,  Sobol H,  Song H,  Southey MC,  Spurdle AB,  Stadler Z,  Steinemann D,  Stoppa-Lyonnet D,  Sucheston-Campbell LE,  Sukiennicki G,  Sutphen R,  Sutter C,  Swerdlow AJ,  Szabo CI,  Szafron L,  Tan YY,  Taylor JA,  Tea MK,  Teixeira MR,  Teo SH,  Terry KL,  Thompson PJ,  Thomsen LCV,  Thull DL,  Tihomirova L,  Tinker AV,  Tischkowitz M,  Tognazzo S,  Toland AE,  Tone A,  Trabert B,  Travis RC,  Trichopoulou A,  Tung N,  Tworoger SS,  van Altena AM,  Van Den Berg D,  van der Hout AH,  van der Luijt RB,  Van Heetvelde M,  Van Nieuwenhuysen E,  van Rensburg EJ,  Vanderstichele A,  Varon-Mateeva R,  Vega A,  Edwards DV,  Vergote I,  Vierkant RA,  Vijai J,  Vratimos A,  Walker L,  Walsh C,  Wand D,  Wang-Gohrke S,  Wappenschmidt B,  Webb PM,  Weinberg CR,  Weitzel JN,  Wentzensen N,  Whittemore AS,  Wijnen JT,  Wilkens LR,  Wolk A,  Woo M,  Wu X,  Wu AH,  Yang H,  Yannoukakos D,  Ziogas A,  Zorn KK,  Narod SA,  Easton DF,  Amos CI,  Schildkraut JM,  Ramus SJ,  Ottini L,  Goodman MT,  Park SK,  Kelemen LE,  Risch HA,  Thomassen M,  Offit K,  Simard J,  Schmutzler RK,  Hazelett D,  Monteiro AN,  Couch FJ,  Berchuck A,  Chenevix-Trench G,  Goode EL,  Sellers TA,  Gayther SA,  Antoniou AC,  Pharoah PDP
Nat Genet 2017 May;49(5):680-691
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28346442
PMC ID: PMC5612337

A stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study.

Rader JS,  Sill MW,  Beumer JH,  Lankes HA,  Benbrook DM,  Garcia F,  Trimble C,  Tate Thigpen J,  Lieberman R,  Zuna RE,  Leath CA 3rd,  Spirtos NM,  Byron J,  Thaker PH,  Lele S,  Alberts D
Gynecol Oncol 2017 May;145(2):291-297
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28285845
PMC ID: PMC5794341

Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer.

Taieb J,  Le Malicot K,  Shi Q,  Penault-Llorca F,  Bouché O,  Tabernero J,  Mini E,  Goldberg RM,  Folprecht G,  Luc Van Laethem J,  Sargent DJ,  Alberts SR,  Emile JF,  Laurent Puig P,  Sinicrope FA
J Natl Cancer Inst 2017 May;109(5)
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28040692
PMC ID: PMC6075212

Integrative Development of a TLR8 Agonist for Ovarian Cancer Chemoimmunotherapy.

Monk BJ,  Facciabene A,  Brady WE,  Aghajanian CA,  Fracasso PM,  Walker JL,  Lankes HA,  Manjarrez KL,  Danet-Desnoyers GH,  Bell-McGuinn KM,  McCourt CK,  Malykhin A,  Hershberg RM,  Coukos G
Clin Cancer Res 2017 Apr 15;23(8):1955-1966
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27702821
PMC ID: PMC5437973

Interactions of the Insulin-Like Growth Factor Axis and Vitamin D in Prostate Cancer Risk in the Prostate Cancer Prevention Trial.

Miles FL,  Goodman PJ,  Tangen C,  Torkko KC,  Schenk JM,  Song X,  Pollak M,  Thompson IM,  Neuhouser ML
Nutrients 2017 Apr 12;9(4)
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28417914
PMC ID: PMC5409717

Comparison of self-report and electronic monitoring of 6MP intake in childhood ALL: a Children's Oncology Group study.

Landier W,  Chen Y,  Hageman L,  Kim H,  Bostrom BC,  Casillas JN,  Dickens DS,  Evans WE,  Maloney KW,  Mascarenhas L,  Ritchey AK,  Termuhlen AM,  Carroll WL,  Relling MV,  Wong FL,  Bhatia S
Blood 2017 Apr 6;129(14):1919-1926
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28153823
PMC ID: PMC5383868

Association of DNA Mismatch Repair and Mutations in BRAF and KRAS With Survival After Recurrence in Stage III Colon Cancers : A Secondary Analysis of 2 Randomized Clinical Trials.

Sinicrope FA,  Shi Q,  Allegra CJ,  Smyrk TC,  Thibodeau SN,  Goldberg RM,  Meyers JP,  Pogue-Geile KL,  Yothers G,  Sargent DJ,  Alberts SR
JAMA Oncol 2017 Apr 1;3(4):472-480
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28006055
PMC ID: PMC5498991

The KRAS-Variant and Cetuximab Response in Head and Neck Squamous Cell Cancer: A Secondary Analysis of a Randomized Clinical Trial.

Weidhaas JB,  Harris J,  Schaue D,  Chen AM,  Chin R,  Axelrod R,  El-Naggar AK,  Singh AK,  Galloway TJ,  Raben D,  Wang D,  Matthiesen C,  Avizonis VN,  Manon RR,  Yumen O,  Nguyen-Tan PF,  Trotti A,  Skinner H,  Zhang Q,  Ferris RL,  Sidransky D,  Chung CH
JAMA Oncol 2017 Apr 1;3(4):483-491
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28006059
PMC ID: PMC5470422

The importance of evidence-based supportive care practice guidelines in childhood cancer-a plea for their development and implementation.

Loeffen EAH,  Kremer LCM,  Mulder RL,  Font-Gonzalez A,  Dupuis LL,  Sung L,  Robinson PD,  van de Wetering MD,  Tissing WJE
Support Care Cancer 2017 Apr;25(4):1121-1125
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27928642
PMC ID: PMC5321691

Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group study.

Mai PL,  Piedmonte M,  Han PK,  Moser RP,  Walker JL,  Rodriguez G,  Boggess J,  Rutherford TJ,  Zivanovic O,  Cohn DE,  Thigpen JT,  Wenham RM,  Friedlander ML,  Hamilton CA,  Bakkum-Gamez J,  Olawaiye AB,  Hensley ML,  Greene MH,  Huang HQ,  Wenzel L
Gynecol Oncol 2017 Apr;145(1):122-129
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28190649
PMC ID: PMC5359045

Discovery and fine-mapping of adiposity loci using high density imputation of genome-wide association studies in individuals of African ancestry: African Ancestry Anthropometry Genetics Consortium.

Ng MCY,  Graff M,  Lu Y,  Justice AE,  Mudgal P,  Liu CT,  Young K,  Yanek LR,  Feitosa MF,  Wojczynski MK,  Rand K,  Brody JA,  Cade BE,  Dimitrov L,  Duan Q,  Guo X,  Lange LA,  Nalls MA,  Okut H,  Tajuddin SM,  Tayo BO,  Vedantam S,  Bradfield JP,  Chen G,  Chen WM,  Chesi A,  Irvin MR,  Padhukasahasram B,  Smith JA,  Zheng W,  Allison MA,  Ambrosone CB,  Bandera EV,  Bartz TM,  Berndt SI,  Bernstein L,  Blot WJ,  Bottinger EP,  Carpten J,  Chanock SJ,  Chen YI,  Conti DV,  Cooper RS,  Fornage M,  Freedman BI,  Garcia M,  Goodman PJ,  Hsu YH,  Hu J,  Huff CD,  Ingles SA,  John EM,  Kittles R,  Klein E,  Li J,  McKnight B,  Nayak U,  Nemesure B,  Ogunniyi A,  Olshan A,  Press MF,  Rohde R,  Rybicki BA,  Salako B,  Sanderson M,  Shao Y,  Siscovick DS,  Stanford JL,  Stevens VL,  Stram A,  Strom SS,  Vaidya D,  Witte JS,  Yao J,  Zhu X,  Ziegler RG,  Zonderman AB,  Adeyemo A,  Ambs S,  Cushman M,  Faul JD,  Hakonarson H,  Levin AM,  Nathanson KL,  Ware EB,  Weir DR,  Zhao W,  Zhi D,  Bone Mineral Density in Childhood Study (BMDCS) Group,  Arnett DK,  Grant SFA,  Kardia SLR,  Oloapde OI,  Rao DC,  Rotimi CN,  Sale MM,  Williams LK,  Zemel BS,  Becker DM,  Borecki IB,  Evans MK,  Harris TB,  Hirschhorn JN,  Li Y,  Patel SR,  Psaty BM,  Rotter JI,  Wilson JG,  Bowden DW,  Cupples LA,  Haiman CA,  Loos RJF,  North KE
PLoS Genet 2017 Apr;13(4):e1006719
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28430825
PMC ID: PMC5419579

Nausea and disturbed sleep as predictors of cancer-related fatigue in breast cancer patients: a multicenter NCORP study.

Peoples AR,  Roscoe JA,  Block RC,  Heckler CE,  Ryan JL,  Mustian KM,  Janelsins MC,  Peppone LJ,  Moore DF Jr,  Coles C,  Hoelzer KL,  Morrow GR,  Dozier AM
Support Care Cancer 2017 Apr;25(4):1271-1278
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27995318
PMC ID: PMC5323277

Dental health status and patient-reported outcomes at baseline in patients participating in the osteonecrosis of the jaw registry study, SWOG S0702.

Van Poznak CH,  Darke A,  Moinpour CM,  Bagramian RA,  Schubert MM,  Gralow JR,  Wade JL 3rd,  Unger JM
Support Care Cancer 2017 Apr;25(4):1191-1199
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27928641
PMC ID: PMC5323355

The Behavior Rating Inventory of Executive Function (BRIEF) to Identify Pediatric Acute Lymphoblastic Leukemia (ALL) Survivors At Risk for Neurocognitive Impairment.

Viola A,  Balsamo L,  Neglia JP,  Brouwers P,  Ma X,  Kadan-Lottick NS
J Pediatr Hematol Oncol 2017 Apr;39(3):174-178
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28085741
PMC ID: PMC5364064

A Randomized Phase 2 Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy-Induced Esophagitis During the Treatment of Lung Cancer: Results of NRG Oncology RTOG 1012.

Fogh SE,  Deshmukh S,  Berk LB,  Dueck AC,  Roof K,  Yacoub S,  Gergel T,  Stephans K,  Rimner A,  DeNittis A,  Pablo J,  Rineer J,  Williams TM,  Bruner D
Int J Radiat Oncol Biol Phys 2017 Mar 15;97(4):786-796
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28244415
PMC ID: PMC5673256

Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Locally Advanced Head and Neck Carcinoma: NRG Oncology Radiation Therapy Oncology Group 0522.

Truong MT,  Zhang Q,  Rosenthal DI,  List M,  Axelrod R,  Sherman E,  Weber R,  Nguyen-Tân PF,  El-Naggar A,  Konski A,  Galvin J,  Schwartz D,  Trotti A,  Silverman C,  Singh A,  Godette K,  Bonner JA,  Jones CU,  Garden AS,  Shenouda G,  Matthiesen C,  Le QT,  Bruner D
Int J Radiat Oncol Biol Phys 2017 Mar 15;97(4):687-699
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27727066
PMC ID: PMC5303682

Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Standard Radiation Versus Accelerated Radiation Plus Cisplatin for Locally Advanced Head and Neck Carcinoma: NRG Oncology RTOG 0129.

Xiao C,  Zhang Q,  Nguyen-Tân PF,  List M,  Weber RS,  Ang KK,  Rosenthal D,  Filion EJ,  Kim H,  Silverman C,  Raben A,  Galloway T,  Fortin A,  Gore E,  Winquist E,  Jones CU,  Robinson W,  Raben D,  Le QT,  Bruner D
Int J Radiat Oncol Biol Phys 2017 Mar 15;97(4):667-677
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27727063
PMC ID: PMC5266672

Phase III Randomized Study of 4 Weeks of High-Dose Interferon-α-2b in Stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E1697).

Agarwala SS,  Lee SJ,  Yip W,  Rao UN,  Tarhini AA,  Cohen GI,  Reintgen DS,  Evans TL,  Brell JM,  Albertini MR,  Atkins MB,  Dakhil SR,  Conry RM,  Sosman JA,  Flaherty LE,  Sondak VK,  Carson WE,  Smylie MG,  Pappo AS,  Kefford RF,  Kirkwood JM
J Clin Oncol 2017 Mar 10;35(8):885-892
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28135150
PMC ID: PMC5455684

Tailoring Palliative Care to the Changing Needs of People Facing Cancer.

Roeland EJ
J Clin Oncol 2017 Mar 10;35(8):813-815
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28113031
PMC ID: not available

Significance of Co-expression of Epidermal Growth Factor Receptor and Ki67 on Clinical Outcome in Patients With Anal Cancer Treated With Chemoradiotherapy: An Analysis of NRG Oncology RTOG 9811.

Doll CM,  Moughan J,  Klimowicz A,  Ho CK,  Kornaga EN,  Lees-Miller SP,  Ajani JA,  Crane CH,  Kachnic LA,  Okawara GS,  Berk LB,  Roof KS,  Becker MJ,  Grisell DL,  Ellis RJ,  Sperduto PW,  Marsa GW,  Guha C,  Magliocco AM
Int J Radiat Oncol Biol Phys 2017 Mar 1;97(3):554-562
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28126304
PMC ID: PMC5687248

Association of Polymorphisms in FCGR2A and FCGR3A With Degree of Trastuzumab Benefit in the Adjuvant Treatment of ERBB2/HER2-Positive Breast Cancer: Analysis of the NSABP B-31 Trial.

Gavin PG,  Song N,  Kim SR,  Lipchik C,  Johnson NL,  Bandos H,  Finnigan M,  Rastogi P,  Fehrenbacher L,  Mamounas EP,  Swain SM,  Wickerham DL,  Geyer CE Jr,  Jeong JH,  Costantino JP,  Wolmark N,  Paik S,  Pogue-Geile KL
JAMA Oncol 2017 Mar 1;3(3):335-341
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27812689
PMC ID: PMC5344747

Effect of Long-Term Hormonal Therapy (vs Short-Term Hormonal Therapy): A Secondary Analysis of Intermediate-Risk Prostate Cancer Patients Treated on NRG Oncology RTOG 9202.

Mirhadi AJ,  Zhang Q,  Hanks GE,  Lepor H,  Grignon DJ,  Peters CA,  Rosenthal SA,  Zeitzer K,  Radwan JS,  Lawton C,  Parliament MB,  Reznik RS,  Sandler HM
Int J Radiat Oncol Biol Phys 2017 Mar 1;97(3):511-515
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28126300
PMC ID: PMC5485922

Reduced Expiratory Flow Rate among Heavy Smokers Increases Lung Cancer Risk. Results from the National Lung Screening Trial-American College of Radiology Imaging Network Cohort.

Hopkins RJ,  Duan F,  Chiles C,  Greco EM,  Gamble GD,  Aberle D,  Young RP
Ann Am Thorac Soc 2017 Mar;14(3):392-402
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28076701
PMC ID: PMC5686299

Genomewide Approach Validates Thiopurine Methyltransferase Activity Is a Monogenic Pharmacogenomic Trait.

Liu C,  Yang W,  Pei D,  Cheng C,  Smith C,  Landier W,  Hageman L,  Chen Y,  Yang JJ,  Crews KR,  Kornegay N,  Karol SE,  Wong FL,  Jeha S,  Sandlund JT,  Ribeiro RC,  Rubnitz JE,  Metzger ML,  Pui CH,  Evans WE,  Bhatia S,  Relling MV
Clin Pharmacol Ther 2017 Mar;101(3):373-381
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27564568
PMC ID: PMC5309133

Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601.

Smith EM,  Pang H,  Ye C,  Cirrincione C,  Fleishman S,  Paskett ED,  Ahles T,  Bressler LR,  Le-Lindqwister N,  Fadul CE,  Loprinzi C,  Shapiro CL,  Alliance for Clinical Trials in Oncology
Eur J Cancer Care (Engl) 2017 Mar;26(2)
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 26603828
PMC ID: PMC4879099

Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer - An NRG oncology/Gynecologic Oncology Group study.

von Gruenigen VE,  Huang HQ,  Beumer JH,  Lankes HA,  Tew W,  Herzog T,  Hurria A,  Mannel RS,  Rizack T,  Landrum LM,  Rose PG,  Salani R,  Bradley WH,  Rutherford TJ,  Higgins RV,  Secord AA,  Fleming G
Gynecol Oncol 2017 Mar;144(3):459-467
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28089376
PMC ID: PMC5570471

Evaluation of treatment-related mortality among paediatric cancer deaths: a population based analysis.

Pole JD,  Gibson P,  Ethier MC,  Lazor T,  Johnston DL,  Portwine C,  Silva M,  Alexander S,  Sung L
Br J Cancer 2017 Feb 14;116(4):540-545
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28095399
PMC ID: PMC5318976

Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study.

Janelsins MC,  Heckler CE,  Peppone LJ,  Kamen C,  Mustian KM,  Mohile SG,  Magnuson A,  Kleckner IR,  Guido JJ,  Young KL,  Conlin AK,  Weiselberg LR,  Mitchell JW,  Ambrosone CA,  Ahles TA,  Morrow GR
J Clin Oncol 2017 Feb 10;35(5):506-514
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28029304
PMC ID: PMC5455314

E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group.

Marur S,  Li S,  Cmelak AJ,  Gillison ML,  Zhao WJ,  Ferris RL,  Westra WH,  Gilbert J,  Bauman JE,  Wagner LI,  Trevarthen DR,  Balkrishna J,  Murphy BA,  Agrawal N,  Colevas AD,  Chung CH,  Burtness B
J Clin Oncol 2017 Feb 10;35(5):490-497
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28029303
PMC ID: PMC5455313

Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer.

Shipley WU,  Seiferheld W,  Lukka HR,  Major PP,  Heney NM,  Grignon DJ,  Sartor O,  Patel MP,  Bahary JP,  Zietman AL,  Pisansky TM,  Zeitzer KL,  Lawton CA,  Feng FY,  Lovett RD,  Balogh AG,  Souhami L,  Rosenthal SA,  Kerlin KJ,  Dignam JJ,  Pugh SL,  Sandler HM,  NRG Oncology RTOG
N Engl J Med 2017 Feb 2;376(5):417-428
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28146658
PMC ID: PMC5444881

Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813.

Chang S,  Zhang P,  Cairncross JG,  Gilbert MR,  Bahary JP,  Dolinskas CA,  Chakravarti A,  Aldape KD,  Bell EH,  Schiff D,  Jaeckle K,  Brown PD,  Barger GR,  Werner-Wasik M,  Shih H,  Brachman D,  Penas-Prado M,  Robins HI,  Belanger K,  Schultz C,  Hunter G,  Mehta M
Neuro Oncol 2017 Feb 1;19(2):252-258
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27994066
PMC ID: PMC5463834

Screening for depression in cancer patients receiving radiotherapy: Feasibility and identification of effective tools in the NRG Oncology RTOG 0841 trial.

Wagner LI,  Pugh SL,  Small W Jr,  Kirshner J,  Sidhu K,  Bury MJ,  DeNittis AS,  Alpert TE,  Tran B,  Bloom BF,  Mai J,  Yeh A,  Sarma K,  Becker M,  James J,  Bruner DW
Cancer 2017 Feb 1;123(3):485-493
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27861753
PMC ID: PMC5258778

Accrual of Older Patients With Breast Cancer to Alliance Systemic Therapy Trials Over Time: Protocol A151527.

Freedman RA,  Foster JC,  Seisler DK,  Lafky JM,  Muss HB,  Cohen HJ,  Mandelblatt J,  Winer EP,  Hudis CA,  Partridge AH,  Carey LA,  Cirrincione C,  Moreno-Aspitia A,  Kimmick G,  Jatoi A,  Hurria A
J Clin Oncol 2017 Feb;35(4):421-431
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27992272
PMC ID: PMC5455700

Family history of colorectal cancer and its impact on survival in patients with resected stage III colon cancer: results from NCCTG Trial N0147 (Alliance).

Jansson-Knodell CL,  Foster NR,  Sargent DJ,  Limburg PJ,  Thibodeau SN,  Smyrk TC,  Sinicrope FA,  Jahagirdar B,  Goldberg RM,  Alberts SR
J Gastrointest Oncol 2017 Feb;8(1):1-11
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28280603
PMC ID: PMC5334054

Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy (ACCL05C1): A Report From the Children's Oncology Group.

Knight KR,  Chen L,  Freyer D,  Aplenc R,  Bancroft M,  Bliss B,  Dang H,  Gillmeister B,  Hendershot E,  Kraemer DF,  Lindenfeld L,  Meza J,  Neuwelt EA,  Pollock BH,  Sung L
J Clin Oncol 2017 Feb;35(4):440-445
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27937095
PMC ID: PMC5455699

Quality of life and symptoms in long-term survivors of colorectal cancer: results from NSABP protocol LTS-01.

Kunitake H,  Russell MM,  Zheng P,  Yothers G,  Land SR,  Petersen L,  Fehrenbacher L,  Giguere JK,  Wickerham DL,  Ko CY,  Ganz PA
J Cancer Surviv 2017 Feb;11(1):111-118
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27562475
PMC ID: PMC5269418

Seven-year follow-up for energy/vitality outcomes in early stage Hodgkin's disease patients treated with subtotal lymphoid irradiation versus chemotherapy plus radiation: SWOG S9133 and its QOL companion study, S9208.

Moinpour CM,  Unger JM,  Ganz PA,  Kornblith AB,  Gaynor ER,  Bowers MA,  Gatti GS,  Kaminski MS,  Erba HP,  Wang T,  Yoon J,  Press OW,  Fisher RI
J Cancer Surviv 2017 Feb;11(1):32-40
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27405732
PMC ID: PMC5233644

Wide variations in blood product transfusion practices among providers who care for patients with acute leukemia in the United States.

Pine AB,  Lee EJ,  Sekeres M,  Steensma DP,  Zelterman D,  Prebet T,  DeZern A,  Komrokji R,  Litzow M,  Luger S,  Stone R,  Erba HP,  Garcia-Manero G,  Lee AI,  Podoltsev NA,  Barbarotta L,  Kasberg S,  Hendrickson JE,  Gore SD,  Zeidan AM
Transfusion 2017 Feb;57(2):289-295
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27878822
PMC ID: PMC5309168

Milestone clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP).

Rastogi P,  Wickerham DL,  Geyer CE Jr,  Mamounas EP,  Julian TB,  Wolmark N
Chin Clin Oncol 2017 Feb;6(1):7
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28285537
PMC ID: PMC5731663

Final Results of NRG Oncology RTOG 0246: An Organ-Preserving Selective Resection Strategy in Esophageal Cancer Patients Treated with Definitive Chemoradiation.

Swisher SG,  Moughan J,  Komaki RU,  Ajani JA,  Wu TT,  Hofstetter WL,  Konski AA,  Willett CG
J Thorac Oncol 2017 Feb;12(2):368-374
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27729298
PMC ID: PMC5263046

Poor Prognosis After Second Locoregional Recurrences in the CALOR Trial.

Wapnir IL,  Gelber S,  Anderson SJ,  Mamounas EP,  Robidoux A,  Martín M,  Nortier JW,  Geyer CE Jr,  Paterson AH,  Láng I,  Price KN,  Coates AS,  Gelber RD,  Rastogi P,  Regan MM,  Wolmark N,  Aebi S,  CALOR trial investigators
Ann Surg Oncol 2017 Feb;24(2):398-406
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27663567
PMC ID: PMC5215961

Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial.

Himelstein AL,  Foster JC,  Khatcheressian JL,  Roberts JD,  Seisler DK,  Novotny PJ,  Qin R,  Go RS,  Grubbs SS,  O'Connor T,  Velasco MR Jr,  Weckstein D,  O'Mara A,  Loprinzi CL,  Shapiro CL
JAMA 2017 Jan 3;317(1):48-58
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsNCI Community Oncology Research Program
PubMed ID: 28030702
PMC ID: PMC5321662

Caphosol for prevention of oral mucositis in pediatric myeloablative haematopoietic cell transplantation.

Treister N,  Nieder M,  Baggott C,  Olson E,  Chen L,  Dang H,  Krailo M,  August A,  Sung L
Br J Cancer 2017 Jan 3;116(1):21-27
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27875526
PMC ID: PMC5220147

Social Determinants of Health: A Framework for Studying Cancer Health Disparities and Minority Participation in Research

Asare M,  Flannery M,  Kamen C
Oncol Nurs Forum 2017 Jan 2;44(1):20-23
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28060469
PMC ID: PMC5583708

Relationship Between Depressive Symptoms and Social Cognitive Processing in Partners of Long-Term Breast Cancer Survivors.

Cohee AA,  Adams RN,  Fife BL,  Von Ah DM,  Monahan PO,  Zoppi KA,  Cella D,  Champion VL
Oncol Nurs Forum 2017 Jan 1;44(1):44-51
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27991603
PMC ID: PMC5181790

Genome-Wide Association Study for Anthracycline-Induced Congestive Heart Failure.

Schneider BP,  Shen F,  Gardner L,  Radovich M,  Li L,  Miller KD,  Jiang G,  Lai D,  O'Neill A,  Sparano JA,  Davidson NE,  Cameron D,  Gradus-Pizlo I,  Mastouri RA,  Suter TM,  Foroud T,  Sledge GW Jr
Clin Cancer Res 2017 Jan 1;23(1):43-51
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27993963
PMC ID: PMC5215621

The impact of age on complications, survival, and cause of death following colon cancer surgery.

Aquina CT,  Mohile SG,  Tejani MA,  Becerra AZ,  Xu Z,  Hensley BJ,  Arsalani-Zadeh R,  Boscoe FP,  Schymura MJ,  Noyes K,  Monson JR,  Fleming FJ
Br J Cancer 2017 Jan;116(3):389-397
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28056465
PMC ID: PMC5294480

Metabolic tumor volume predicts overall survival and local control in patients with stage III non-small cell lung cancer treated in ACRIN 6668/RTOG 0235.

Bazan JG,  Duan F,  Snyder BS,  Horng D,  Graves EE,  Siegel BA,  Machtay M,  Loo BW Jr
Eur J Nucl Med Mol Imaging 2017 Jan;44(1):17-24
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27645692
PMC ID: PMC5121029

Long-term fear of recurrence in young breast cancer survivors and partners.

Cohee AA,  Adams RN,  Johns SA,  Von Ah D,  Zoppi K,  Fife B,  Monahan PO,  Stump T,  Cella D,  Champion VL
Psychooncology 2017 Jan;26(1):22-28
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 26490953
PMC ID: PMC4840075

Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511).

Freedman RA,  Seisler DK,  Foster JC,  Sloan JA,  Lafky JM,  Kimmick GG,  Hurria A,  Cohen HJ,  Winer EP,  Hudis CA,  Partridge AH,  Carey LA,  Jatoi A,  Klepin HD,  Citron M,  Berry DA,  Shulman LN,  Buzdar AU,  Suman VJ,  Muss HB
Breast Cancer Res Treat 2017 Jan;161(2):363-373
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27866278
PMC ID: PMC5226883

Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial.

Freyer DR,  Chen L,  Krailo MD,  Knight K,  Villaluna D,  Bliss B,  Pollock BH,  Ramdas J,  Lange B,  Van Hoff D,  VanSoelen ML,  Wiernikowski J,  Neuwelt EA,  Sung L
Lancet Oncol 2017 Jan;18(1):63-74
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27914822
PMC ID: PMC5520988

Association between Body Mass Index and Cancer Survival in a Pooled Analysis of 22 Clinical Trials.

Greenlee H,  Unger JM,  LeBlanc M,  Ramsey S,  Hershman DL
Cancer Epidemiol Biomarkers Prev 2017 Jan;26(1):21-29
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27986655
PMC ID: PMC5370550

Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3.

Hamdi Y,  Soucy P,  Kuchenbaeker KB,  Pastinen T,  Droit A,  Lemaçon A,  Adlard J,  Aittomäki K,  Andrulis IL,  Arason A,  Arnold N,  Arun BK,  Azzollini J,  Bane A,  Barjhoux L,  Barrowdale D,  Benitez J,  Berthet P,  Blok MJ,  Bobolis K,  Bonadona V,  Bonanni B,  Bradbury AR,  Brewer C,  Buecher B,  Buys SS,  Caligo MA,  Chiquette J,  Chung WK,  Claes KB,  Daly MB,  Damiola F,  Davidson R,  De la Hoya M,  De Leeneer K,  Diez O,  Ding YC,  Dolcetti R,  Domchek SM,  Dorfling CM,  Eccles D,  Eeles R,  Einbeigi Z,  Ejlertsen B,  EMBRACE,  Engel C,  Gareth Evans D,  Feliubadalo L,  Foretova L,  Fostira F,  Foulkes WD,  Fountzilas G,  Friedman E,  Frost D,  Ganschow P,  Ganz PA,  Garber J,  Gayther SA,  GEMO Study Collaborators,  Gerdes AM,  Glendon G,  Godwin AK,  Goldgar DE,  Greene MH,  Gronwald J,  Hahnen E,  Hamann U,  Hansen TV,  Hart S,  Hays JL,  HEBON,  Hogervorst FB,  Hulick PJ,  Imyanitov EN,  Isaacs C,  Izatt L,  Jakubowska A,  James P,  Janavicius R,  Jensen UB,  John EM,  Joseph V,  Just W,  Kaczmarek K,  Karlan BY,  KConFab Investigators,  Kets CM,  Kirk J,  Kriege M,  Laitman Y,  Laurent M,  Lazaro C,  Leslie G,  Lester J,  Lesueur F,  Liljegren A,  Loman N,  Loud JT,  Manoukian S,  Mariani M,  Mazoyer S,  McGuffog L,  Meijers-Heijboer HE,  Meindl A,  Miller A,  Montagna M,  Mulligan AM,  Nathanson KL,  Neuhausen SL,  Nevanlinna H,  Nussbaum RL,  Olah E,  Olopade OI,  Ong KR,  Oosterwijk JC,  Osorio A,  Papi L,  Park SK,  Pedersen IS,  Peissel B,  Segura PP,  Peterlongo P,  Phelan CM,  Radice P,  Rantala J,  Rappaport-Fuerhauser C,  Rennert G,  Richardson A,  Robson M,  Rodriguez GC,  Rookus MA,  Schmutzler RK,  Sevenet N,  Shah PD,  Singer CF,  Slavin TP,  Snape K,  Sokolowska J,  Sønderstrup IM,  Southey M,  Spurdle AB,  Stadler Z,  Stoppa-Lyonnet D,  Sukiennicki G,  Sutter C,  Tan Y,  Tea MK,  Teixeira MR,  Teulé A,  Teo SH,  Terry MB,  Thomassen M,  Tihomirova L,  Tischkowitz M,  Tognazzo S,  Toland AE,  Tung N,  van den Ouweland AM,  van der Luijt RB,  van Engelen K,  van Rensburg EJ,  Varon-Mateeva R,  Wappenschmidt B,  Wijnen JT,  Rebbeck T,  Chenevix-Trench G,  Offit K,  Couch FJ,  Nord S,  Easton DF,  Antoniou AC,  Simard J
Breast Cancer Res Treat 2017 Jan;161(1):117-134
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27796716
PMC ID: PMC5222911

Colorectal Adenomas in Participants of the SELECT Randomized Trial of Selenium and Vitamin E for Prostate Cancer Prevention.

Lance P,  Alberts DS,  Thompson PA,  Fales L,  Wang F,  San Jose J,  Jacobs ET,  Goodman PJ,  Darke AK,  Yee M,  Minasian L,  Thompson IM,  Roe DJ
Cancer Prev Res (Phila) 2017 Jan;10(1):45-54
Major Program(s) or Research Group(s): Office of the Director ;  NCI Community Oncology Research Program
PubMed ID: 27777235
PMC ID: PMC5510661

21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy.

Mamounas EP,  Liu Q,  Paik S,  Baehner FL,  Tang G,  Jeong JH,  Kim SR,  Butler SM,  Jamshidian F,  Cherbavaz DB,  Sing AP,  Shak S,  Julian TB,  Lembersky BC,  Wickerham DL,  Costantino JP,  Wolmark N
J Natl Cancer Inst 2017 Jan;109(4)
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28122895
PMC ID: PMC5721938

Exploratory Factor Analysis of NRG Oncology's University of Washington Quality of Life Questionnaire-RTOG Modification.

Pugh SL,  Wyatt G,  Wong RK,  Sagar SM,  Yueh B,  Singh AK,  Yao M,  Nguyen-Tan PF,  Yom SS,  Cardinale FS,  Sultanem K,  Hodson DI,  Krempl GA,  Chavez A,  Yeh AM,  Bruner DW
J Pain Symptom Manage 2017 Jan;53(1):139-145.e2
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27899312
PMC ID: PMC5191964

Antibiotic resistance among Helicobacter pylori clinical isolates in Lima, Peru.

Boehnke KF,  Valdivieso M,  Bussalleu A,  Sexton R,  Thompson KC,  Osorio S,  Novoa Reyes I,  Crowley JJ,  Baker LH,  Xi C
Infect Drug Resist 2017;10:85-90
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28331349
PMC ID: PMC5354526

How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention?

Crew KD,  Albain KS,  Hershman DL,  Unger JM,  Lo SS
NPJ Breast Cancer 2017;3:20
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28649660
PMC ID: PMC5460136

National Institute on Aging /Alzheimer's Association criteria for Mild Cognitive Impairment applied to chemotherapy treated breast cancer survivors.

Gifford AR,  Lawrence JA,  Baker LD,  Balcueva EP,  Case D,  Craft S,  Curtis AE,  Griffin L,  Groteluschen DL,  Klepin HD,  Lesser GJ,  Messino MJ,  Naughton M,  Samuel TA,  Rapp S,  Sachs B,  Sink KM,  Williamson J,  Shaw EG
J Oncol Research 2017;1(1)
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29873324
PMC ID: PMC5985141

Evidence for a Large-Scale Brain System Supporting Allostasis and Interoception in Humans.

Kleckner IR,  Zhang J,  Touroutoglou A,  Chanes L,  Xia C,  Simmons WK,  Quigley KS,  Dickerson BC,  Barrett LF
Nat Hum Behav 2017;1
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28983518
PMC ID: PMC5624222

Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design.

Ligibel JA,  Barry WT,  Alfano C,  Hershman DL,  Irwin M,  Neuhouser M,  Thomson CA,  Delahanty L,  Frank E,  Spears P,  Paskett ED,  Hopkins J,  Bernstein V,  Stearns V,  White J,  Hahn O,  Hudis C,  Winer EP,  Wadden TA,  Goodwin PJ
NPJ Breast Cancer 2017;3:37
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28948213
PMC ID: PMC5608692

Breast cancer chemoprevention pharmacogenomics: Deep sequencing and functional genomics of the ZNF423 and CTSO genes.

Liu D,  Ho MF,  Schaid DJ,  Scherer SE,  Kalari K,  Liu M,  Biernacka J,  Yee V,  Evans J,  Carlson E,  Goetz MP,  Kubo M,  Wickerham DL,  Wang L,  Ingle JN,  Weinshilboum RM
NPJ Breast Cancer 2017;3:30
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28856246
PMC ID: PMC5566425

Cardiac mechanics and dysfunction with anthracyclines in the community: results from the PREDICT study.

Narayan HK,  Wei W,  Feng Z,  Lenihan D,  Plappert T,  Englefield V,  Fisch M,  Ky B
Open Heart 2017;4(1):e000524
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28123764
PMC ID: PMC5255565

Association of fatigue and depression with circulating levels of proinflammatory cytokines and epidermal growth factor receptor ligands: a correlative study of a placebo-controlled fatigue trial.

Rich T,  Zhao F,  Cruciani RA,  Cella D,  Manola J,  Fisch MJ
Cancer Manag Res 2017;9:1-10
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28203105
PMC ID: PMC5295802

Impact of Genetic Ancestry on Outcomes in ECOG-ACRIN-E5103.

Schneider BP,  Shen F,  Jiang G,  O'Neill A,  Radovich M,  Li L,  Gardner L,  Lai D,  Foroud T,  Sparano JA,  Sledge GW Jr,  Miller KD
JCO Precis Oncol 2017;2017
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29333527
PMC ID: PMC5765553

Patient-reported outcomes for patients with metastatic castration-resistant prostate cancer receiving docetaxel and Atrasentan versus docetaxel and placebo in a randomized phase III clinical trial (SWOG S0421).

Unger JM,  Griffin K,  Donaldson GW,  Baranowski KM,  Good MJ,  Reburiano E,  Hussain M,  Monk PJ,  Van Veldhuizen PJ,  Carducci MA,  Higano CS,  Lara PN,  Tangen CM,  Quinn DI,  Wade JL III,  Vogelzang NJ,  Thompson IM Jr,  Moinpour CM
J Patient Rep Outcomes 2017;2:27
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29951640
PMC ID: PMC5997724

Diabetes mitigates the role of memory complaint in predicting dementia risk: Results from the Prevention of Alzheimer's Disease with Vitamin E and Selenium Study.

Zhang X,  Schmitt FA,  Caban-Holt AM,  Ding X,  Kryscio RJ,  Abner E
J Prev Alzheimers Dis 2017;4(3):143-148
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 28944218
PMC ID: PMC5607951

The American Society of Hematology Clinical Research Training Institute is associated with high retention in academic hematology.

King AA,  Vesely SK,  Elwood J,  Basso J,  Carson K,  Sung L
Blood 2016 Dec 22;128(25):2881-2885
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27784672
PMC ID: PMC5179335

Biases in Recommendations for and Acceptance of Prostate Biopsy Significantly Affect Assessment of Prostate Cancer Risk Factors: Results From Two Large Randomized Clinical Trials.

Tangen CM,  Goodman PJ,  Till C,  Schenk JM,  Lucia MS,  Thompson IM Jr
J Clin Oncol 2016 Dec 20;34(36):4338-4344
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27998216
PMC ID: PMC5455311

Charcot-Marie-Tooth gene, SBF2, associated with taxane-induced peripheral neuropathy in African Americans.

Schneider BP,  Lai D,  Shen F,  Jiang G,  Radovich M,  Li L,  Gardner L,  Miller KD,  O'Neill A,  Sparano JA,  Xue G,  Foroud T,  Sledge GW Jr
Oncotarget 2016 Dec 13;7(50):82244-82253
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27732968
PMC ID: PMC5347688

Long-Term Update of NRG Oncology RTOG 0319: A Phase 1 and 2 Trial to Evaluate 3-Dimensional Conformal Radiation Therapy Confined to the Region of the Lumpectomy Cavity for Stage I and II Breast Carcinoma.

Rabinovitch R,  Moughan J,  Vicini F,  Pass H,  Wong J,  Chafe S,  Petersen I,  Arthur DW,  White J
Int J Radiat Oncol Biol Phys 2016 Dec 1;96(5):1054-1059
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27869081
PMC ID: PMC5226218

Patient-reported outcomes questionnaire compliance in Cancer Cooperative Group Trials (Alliance N0992).

Atherton PJ,  Burger KN,  Pederson LD,  Kaggal S,  Sloan JA
Clin Trials 2016 Dec;13(6):612-620
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27365012
PMC ID: PMC5133154

Self-Reported Sleep Apnea and Dementia Risk: Findings from the Prevention of Alzheimer's Disease with Vitamin E and Selenium Trial.

Ding X,  Kryscio RJ,  Turner J,  Jicha GA,  Cooper G,  Caban-Holt A,  Schmitt FA,  Abner EL
J Am Geriatr Soc 2016 Dec;64(12):2472-2478
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27801937
PMC ID: PMC5173398

Impact of histology and surgical approach on survival among women with early-stage, high-grade uterine cancer: An NRG Oncology/Gynecologic Oncology Group ancillary analysis.

Fader AN,  Java J,  Tenney M,  Ricci S,  Gunderson CC,  Temkin SM,  Spirtos N,  Kushnir CL,  Pearl ML,  Zivanovic O,  Tewari KS,  O'Malley D,  Hartenbach EM,  Hamilton CA,  Gould NS,  Mannel RS,  Rodgers W,  Walker JL
Gynecol Oncol 2016 Dec;143(3):460-465
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27743738
PMC ID: PMC5116702

Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic Oncology Group study ancillary study.

Garcia-Soto AE,  Java JJ,  Nieves Neira W,  Pearson JM,  Cohn DE,  Lele SB,  Tewari KS,  Walker JL,  Alvarez Secord A,  Armstrong DK,  Copeland LJ
Gynecol Oncol 2016 Dec;143(3):484-489
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27726923
PMC ID: PMC5116405

Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505).

Pachman DR,  Qin R,  Seisler D,  Smith EM,  Kaggal S,  Novotny P,  Ruddy KJ,  Lafky JM,  Ta LE,  Beutler AS,  Wagner-Johnston ND,  Staff NP,  Grothey A,  Dougherty PM,  Cavaletti G,  Loprinzi CL
Support Care Cancer 2016 Dec;24(12):5059-5068
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27534963
PMC ID: PMC5439148

A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci.

Rand KA,  Song C,  Dean E,  Serie DJ,  Curtin K,  Sheng X,  Hu D,  Huff CA,  Bernal-Mizrachi L,  Tomasson MH,  Ailawadhi S,  Singhal S,  Pawlish K,  Peters ES,  Bock CH,  Stram A,  Van Den Berg DJ,  Edlund CK,  Conti DV,  Zimmerman T,  Hwang AE,  Huntsman S,  Graff J,  Nooka A,  Kong Y,  Pregja SL,  Berndt SI,  Blot WJ,  Carpten J,  Casey G,  Chu L,  Diver WR,  Stevens VL,  Lieber MR,  Goodman PJ,  Hennis AJ,  Hsing AW,  Mehta J,  Kittles RA,  Kolb S,  Klein EA,  Leske C,  Murphy AB,  Nemesure B,  Neslund-Dudas C,  Strom SS,  Vij R,  Rybicki BA,  Stanford JL,  Signorello LB,  Witte JS,  Ambrosone CB,  Bhatti P,  John EM,  Bernstein L,  Zheng W,  Olshan AF,  Hu JJ,  Ziegler RG,  Nyante SJ,  Bandera EV,  Birmann BM,  Ingles SA,  Press MF,  Atanackovic D,  Glenn MJ,  Cannon-Albright LA,  Jones B,  Tricot G,  Martin TG,  Kumar SK,  Wolf JL,  Deming Halverson SL,  Rothman N,  Brooks-Wilson AR,  Rajkumar SV,  Kolonel LN,  Chanock SJ,  Slager SL,  Severson RK,  Janakiraman N,  Terebelo HR,  Brown EE,  De Roos AJ,  Mohrbacher AF,  Colditz GA,  Giles GG,  Spinelli JJ,  Chiu BC,  Munshi NC,  Anderson KC,  Levy J,  Zonder JA,  Orlowski RZ,  Lonial S,  Camp NJ,  Vachon CM,  Ziv E,  Stram DO,  Hazelett DJ,  Haiman CA,  Cozen W
Cancer Epidemiol Biomarkers Prev 2016 Dec;25(12):1609-1618
Major Program(s) or Research Group(s): Cancer Prevention Fellowship ProgramNCI Community Oncology Research Program
PubMed ID: 27587788
PMC ID: PMC5524541

Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer Treatment Group N0147 (Alliance).

Singh PP,  Shi Q,  Foster NR,  Grothey A,  Nair SG,  Chan E,  Shields AF,  Goldberg RM,  Gill S,  Kahlenberg MS,  Sinicrope FA,  Sargent DJ,  Alberts SR
Oncologist 2016 Dec;21(12):1509-1521
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27881709
PMC ID: PMC5153338

Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial.

Unger JM,  Till C,  Thompson IM Jr,  Tangen CM,  Goodman PJ,  Wright JD,  Barlow WE,  Ramsey SD,  Minasian LM,  Hershman DL
J Natl Cancer Inst 2016 Dec;108(12)
Major Program(s) or Research Group(s): Office of the Director ;  NCI Community Oncology Research Program
PubMed ID: 27565902
PMC ID: PMC5241895

Radiology as the Point of Cancer Patient and Care Team Engagement: Applying the 4R Model at a Patient's Breast Cancer Care Initiation.

Weldon CB,  Friedewald SM,  Kulkarni SA,  Simon MA,  Carlos RC,  Strauss JB,  Bunce MM,  Small A,  Trosman JR
J Am Coll Radiol 2016 Dec;13(12 Pt B):1579-1589
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27888945
PMC ID: PMC5127438

Impact of age and comorbidity on treatment of non-small cell lung cancer recurrence following complete resection: A nationally representative cohort study.

Wong ML,  McMurry TL,  Stukenborg GJ,  Francescatti AB,  Amato-Martz C,  Schumacher JR,  Chang GJ,  Greenberg CC,  Winchester DP,  McKellar DP,  Walter LC,  Kozower BD
Lung Cancer 2016 Dec;102:108-117
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27987578
PMC ID: PMC5172386

Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234).

Divi V,  Harris J,  Harari PM,  Cooper JS,  McHugh J,  Bell D,  Sturgis EM,  Cmelak AJ,  Suntharalingam M,  Raben D,  Kim H,  Spencer SA,  Laramore GE,  Trotti A,  Foote RL,  Schultz C,  Thorstad WL,  Zhang QE,  Le QT,  Holsinger FC
Cancer 2016 Nov 15;122(22):3464-3471
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27419843
PMC ID: PMC5237619

Long-term trajectories of self-reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance).

Mandelblatt JS,  Clapp JD,  Luta G,  Faul LA,  Tallarico MD,  McClendon TD,  Whitley JA,  Cai L,  Ahles TA,  Stern RA,  Jacobsen PB,  Small BJ,  Pitcher BN,  Dura-Fernandis E,  Muss HB,  Hurria A,  Cohen HJ,  Isaacs C
Cancer 2016 Nov 15;122(22):3555-3563
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27447359
PMC ID: PMC5113662

Tobacco assessment in completed lung cancer treatment trials.

Peters EN,  Warren GW,  Sloan JA,  Marshall JR
Cancer 2016 Nov 15;122(21):3260-3262
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27459400
PMC ID: PMC5338464

Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women.

Rebbeck TR,  Friebel TM,  Mitra N,  Wan F,  Chen S,  Andrulis IL,  Apostolou P,  Arnold N,  Arun BK,  Barrowdale D,  Benitez J,  Berger R,  Berthet P,  Borg A,  Buys SS,  Caldes T,  Carter J,  Chiquette J,  Claes KB,  Couch FJ,  Cybulski C,  Daly MB,  de la Hoya M,  Diez O,  Domchek SM,  Nathanson KL,  Durda K,  Ellis S,  EMBRACE,  Evans DG,  Foretova L,  Friedman E,  Frost D,  Ganz PA,  Garber J,  Glendon G,  Godwin AK,  Greene MH,  Gronwald J,  Hahnen E,  Hallberg E,  Hamann U,  Hansen TV,  HEBON,  Imyanitov EN,  Isaacs C,  Jakubowska A,  Janavicius R,  Jaworska-Bieniek K,  John EM,  Karlan BY,  Kaufman B,  Investigators K,  Kwong A,  Laitman Y,  Lasset C,  Lazaro C,  Lester J,  Loman N,  Lubinski J,  Manoukian S,  Mitchell G,  Montagna M,  Neuhausen SL,  Nevanlinna H,  Niederacher D,  Nussbaum RL,  Offit K,  Olah E,  Olopade OI,  Park SK,  Piedmonte M,  Radice P,  Rappaport-Fuerhauser C,  Rookus MA,  Seynaeve C,  Simard J,  Singer CF,  Soucy P,  Southey M,  Stoppa-Lyonnet D,  Sukiennicki G,  Szabo CI,  Tancredi M,  Teixeira MR,  Teo SH,  Terry MB,  Thomassen M,  Tihomirova L,  Tischkowitz M,  Toland AE,  Toloczko-Grabarek A,  Tung N,  van Rensburg EJ,  Villano D,  Wang-Gohrke S,  Wappenschmidt B,  Weitzel JN,  Zidan J,  Zorn KK,  McGuffog L,  Easton D,  Chenevix-Trench G,  Antoniou AC,  Ramus SJ
Breast Cancer Res 2016 Nov 11;18(1):112
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27836010
PMC ID: PMC5106833

Shorter Remission Telomere Length Predicts Delayed Neutrophil Recovery After Acute Myeloid Leukemia Therapy: A Report From the Children's Oncology Group.

Gerbing RB,  Alonzo TA,  Sung L,  Gamis AS,  Meshinchi S,  Plon SE,  Bertuch AA,  Gramatges MM
J Clin Oncol 2016 Nov 1;34(31):3766-3772
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27354474
PMC ID: PMC5446304

Determinants of Patient-Oncologist Prognostic Discordance in Advanced Cancer.

Gramling R,  Fiscella K,  Xing G,  Hoerger M,  Duberstein P,  Plumb S,  Mohile S,  Fenton JJ,  Tancredi DJ,  Kravitz RL,  Epstein RM
JAMA Oncol 2016 Nov 1;2(11):1421-1426
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27415765
PMC ID: PMC5896571

Association between prolonged neutropenia and reduced relapse risk in pediatric AML: A report from the children's oncology group.

Sung L,  Aplenc R,  Alonzo TA,  Gerbing RB,  Wang YC,  Meshinchi S,  Gamis AS
Int J Cancer 2016 Nov 1;139(9):1930-5
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27312107
PMC ID: PMC4990479

Measuring the Real Clinical Impact of Randomized Clinical Trials in Oncology-Reply: Beyond Citation Counts.

Unger JM,  Barlow WE,  Hershman DL
JAMA Oncol 2016 Nov 1;2(11):1511
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27355398
PMC ID: not available

Selenium and Prostate Cancer: Analysis of Individual Participant Data From Fifteen Prospective Studies.

Allen NE,  Travis RC,  Appleby PN,  Albanes D,  Barnett MJ,  Black A,  Bueno-de-Mesquita HB,  Deschasaux M,  Galan P,  Goodman GE,  Goodman PJ,  Gunter MJ,  Heliövaara M,  Helzlsouer KJ,  Henderson BE,  Hercberg S,  Knekt P,  Kolonel LN,  Lasheras C,  Linseisen J,  Metter EJ,  Neuhouser ML,  Olsen A,  Pala V,  Platz EA,  Rissanen H,  Reid ME,  Schenk JM,  Stampfer MJ,  Stattin P,  Tangen CM,  Touvier M,  Trichopoulou A,  van den Brandt PA,  Key TJ,  Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group
J Natl Cancer Inst 2016 Nov;108(11)
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27385803
PMC ID: PMC5241899

Bone loss after oophorectomy among high-risk women: an NRG oncology/gynecologic oncology group study.

Hibler EA,  Kauderer J,  Greene MH,  Rodriguez GC,  Alberts DS
Menopause 2016 Nov;23(11):1228-1232
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27433858
PMC ID: PMC5079806

Peripheral Zone Inflammation Is Not Strongly Associated With Lower Urinary Tract Symptom Incidence and Progression in the Placebo Arm of the Prostate Cancer Prevention Trial .

Kulac I,  Gumuskaya B,  Drake CG,  Gonzalez B,  Arnold KB,  Goodman PJ,  Kristal AR,  Lucia MS,  Thompson IM,  Isaacs WB,  De Marzo AM,  Platz EA
Prostate 2016 Nov;76(15):1399-408
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27325488
PMC ID: PMC5497457

Which better predicts mortality among older men, a prostate cancer (PCa) diagnosis or vulnerability on the Vulnerable Elders Survey (VES-13)? A retrospective cohort study.

Lowenstein LM,  Mohile SG,  Gil HH,  Pandya C,  Hemmerich J,  Rodin M,  Dale W
J Geriatr Oncol 2016 Nov;7(6):437-443
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27480793
PMC ID: PMC5159296

Shared Goal Setting in Team-Based Geriatric Oncology.

Magnuson A,  Wallace J,  Canin B,  Chow S,  Dale W,  Mohile SG,  Hamel LM
J Oncol Pract 2016 Nov;12(11):1115-1122
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27624949
PMC ID: PMC5455415

Exercise Recommendations for the Management of Symptoms Clusters Resulting From Cancer and Cancer Treatments.

Mustian KM,  Cole CL,  Lin PJ,  Asare M,  Fung C,  Janelsins MC,  Kamen CS,  Peppone LJ,  Magnuson A
Semin Oncol Nurs 2016 Nov;32(4):383-393
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27776835
PMC ID: PMC5512003

Validity of Adjuvant! Online in older patients with stage III colon cancer based on 2967 patients from the ACCENT database.

Papamichael D,  Renfro LA,  Matthaiou C,  Yothers G,  Saltz L,  Guthrie KA,  Van Cutsem E,  Schmoll HJ,  Labianca R,  André T,  O'Connell M,  Alberts SR,  Haller DG,  Kountourakis P,  Sargent DJ,  Adjuvant Colon Cancer Endpoints (ACCENT) Group
J Geriatr Oncol 2016 Nov;7(6):422-429
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27468630
PMC ID: PMC5159186

Care for a Patient With Cancer As a Project: Management of Complex Task Interdependence in Cancer Care Delivery.

Trosman JR,  Carlos RC,  Simon MA,  Madden DL,  Gradishar WJ,  Benson AB 3rd,  Rapkin BD,  Weiss ES,  Gareen IF,  Wagner LI,  Khan SA,  Bunce MM,  Small A,  Weldon CB
J Oncol Pract 2016 Nov;12(11):1101-1113
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27577619
PMC ID: PMC5455414

Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21.

Zhang M,  Wang Z,  Obazee O,  Jia J,  Childs EJ,  Hoskins J,  Figlioli G,  Mocci E,  Collins I,  Chung CC,  Hautman C,  Arslan AA,  Beane-Freeman L,  Bracci PM,  Buring J,  Duell EJ,  Gallinger S,  Giles GG,  Goodman GE,  Goodman PJ,  Kamineni A,  Kolonel LN,  Kulke MH,  Malats N,  Olson SH,  Sesso HD,  Visvanathan K,  White E,  Zheng W,  Abnet CC,  Albanes D,  Andreotti G,  Brais L,  Bueno-de-Mesquita HB,  Basso D,  Berndt SI,  Boutron-Ruault MC,  Bijlsma MF,  Brenner H,  Burdette L,  Campa D,  Caporaso NE,  Capurso G,  Cavestro GM,  Cotterchio M,  Costello E,  Elena J,  Boggi U,  Gaziano JM,  Gazouli M,  Giovannucci EL,  Goggins M,  Gross M,  Haiman CA,  Hassan M,  Helzlsouer KJ,  Hu N,  Hunter DJ,  Iskierka-Jazdzewska E,  Jenab M,  Kaaks R,  Key TJ,  Khaw KT,  Klein EA,  Kogevinas M,  Krogh V,  Kupcinskas J,  Kurtz RC,  Landi MT,  Landi S,  Le Marchand L,  Mambrini A,  Mannisto S,  Milne RL,  Neale RE,  Oberg AL,  Panico S,  Patel AV,  Peeters PH,  Peters U,  Pezzilli R,  Porta M,  Purdue M,  Quiros JR,  Riboli E,  Rothman N,  Scarpa A,  Scelo G,  Shu XO,  Silverman DT,  Soucek P,  Strobel O,  Sund M,  Małecka-Panas E,  Taylor PR,  Tavano F,  Travis RC,  Thornquist M,  Tjønneland A,  Tobias GS,  Trichopoulos D,  Vashist Y,  Vodicka P,  Wactawski-Wende J,  Wentzensen N,  Yu H,  Yu K,  Zeleniuch-Jacquotte A,  Kooperberg C,  Risch HA,  Jacobs EJ,  Li D,  Fuchs C,  Hoover R,  Hartge P,  Chanock SJ,  Petersen GM,  Stolzenberg-Solomon RS,  Wolpin BM,  Kraft P,  Klein AP,  Canzian F,  Amundadottir LT
Oncotarget 2016 Oct 11;7(41):66328-66343
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialNCI Community Oncology Research Program
PubMed ID: 27579533
PMC ID: PMC5340084

Rationale and design of the Children's Oncology Group (COG) study ALTE1621: a randomized, placebo-controlled trial to determine if low-dose carvedilol can prevent anthracycline-related left ventricular remodeling in childhood cancer survivors at high risk for developing heart failure.

Armenian SH,  Hudson MM,  Chen MH,  Colan SD,  Lindenfeld L,  Mills G,  Siyahian A,  Gelehrter S,  Dang H,  Hein W,  Green DM,  Robison LL,  Wong FL,  Douglas PS,  Bhatia S
BMC Cardiovasc Disord 2016 Oct 4;16(1):187
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27716152
PMC ID: PMC5050602

Patient-Reported Measures of Hearing Loss and Tinnitus in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review.

Stark D,  Rosenberg AR,  Johnston D,  Knight K,  Caperon L,  Uleryk E,  Frazier AL,  Sung L
J Speech Lang Hear Res 2016 Oct 1;59(5):1247-1252
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27603148
PMC ID: PMC5962920

Recommendations for Premature Ovarian Insufficiency Surveillance for Female Survivors of Childhood, Adolescent, and Young Adult Cancer: A Report From the International Late Effects of Childhood Cancer Guideline Harmonization Group in Collaboration With the PanCareSurFup Consortium.

van Dorp W,  Mulder RL,  Kremer LC,  Hudson MM,  van den Heuvel-Eibrink MM,  van den Berg MH,  Levine JM,  van Dulmen-den Broeder E,  di Iorgi N,  Albanese A,  Armenian SH,  Bhatia S,  Constine LS,  Corrias A,  Deans R,  Dirksen U,  Gracia CR,  Hjorth L,  Kroon L,  Lambalk CB,  Landier W,  Levitt G,  Leiper A,  Meacham L,  Mussa A,  Neggers SJ,  Oeffinger KC,  Revelli A,  van Santen HM,  Skinner R,  Toogood A,  Wallace WH,  Haupt R
J Clin Oncol 2016 Oct 1;34(28):3440-50
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27458300
PMC ID: PMC5569686

Isolating the Role of Bevacizumab in Elderly Patients With Previously Untreated Nonsquamous Non-Small Cell Lung Cancer: Secondary Analyses of the ECOG 4599 and PointBreak Trials.

Langer CJ,  Socinski MA,  Patel JD,  Sandler AB,  Schiller JH,  Leon L,  Hazard SJ,  Ramalingam SS
Am J Clin Oncol 2016 Oct;39(5):441-7
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 25628268
PMC ID: PMC5016219

The Association of Multiple Identities with Self-Directed Violence and Depression among Transgender Individuals.

Lytle MC,  Blosnich JR,  Kamen C
Suicide Life Threat Behav 2016 Oct;46(5):535-544
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 26916366
PMC ID: PMC5087282

An integrative view of cisplatin-induced renal and cardiac toxicities: Molecular mechanisms, current treatment challenges and potential protective measures.

Dugbartey GJ,  Peppone LJ,  de Graaf IA
Toxicology 2016 Sep 14;371:58-66
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27717837
PMC ID: PMC5586594

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

Lawrenson K,  Kar S,  McCue K,  Kuchenbaeker K,  Michailidou K,  Tyrer J,  Beesley J,  Ramus SJ,  Li Q,  Delgado MK,  Lee JM,  Aittomäki K,  Andrulis IL,  Anton-Culver H,  Arndt V,  Arun BK,  Arver B,  Bandera EV,  Barile M,  Barkardottir RB,  Barrowdale D,  Beckmann MW,  Benitez J,  Berchuck A,  Bisogna M,  Bjorge L,  Blomqvist C,  Blot W,  Bogdanova N,  Bojesen A,  Bojesen SE,  Bolla MK,  Bonanni B,  Børresen-Dale AL,  Brauch H,  Brennan P,  Brenner H,  Bruinsma F,  Brunet J,  Buhari SA,  Burwinkel B,  Butzow R,  Buys SS,  Cai Q,  Caldes T,  Campbell I,  Canniotto R,  Chang-Claude J,  Chiquette J,  Choi JY,  Claes KB,  GEMO Study Collaborators,  Cook LS,  Cox A,  Cramer DW,  Cross SS,  Cybulski C,  Czene K,  Daly MB,  Damiola F,  Dansonka-Mieszkowska A,  Darabi H,  Dennis J,  Devilee P,  Diez O,  Doherty JA,  Domchek SM,  Dorfling CM,  Dörk T,  Dumont M,  Ehrencrona H,  Ejlertsen B,  Ellis S,  EMBRACE,  Engel C,  Lee E,  Evans DG,  Fasching PA,  Feliubadalo L,  Figueroa J,  Flesch-Janys D,  Fletcher O,  Flyger H,  Foretova L,  Fostira F,  Foulkes WD,  Fridley BL,  Friedman E,  Frost D,  Gambino G,  Ganz PA,  Garber J,  García-Closas M,  Gentry-Maharaj A,  Ghoussaini M,  Giles GG,  Glasspool R,  Godwin AK,  Goldberg MS,  Goldgar DE,  González-Neira A,  Goode EL,  Goodman MT,  Greene MH,  Gronwald J,  Guénel P,  Haiman CA,  Hall P,  Hallberg E,  Hamann U,  Hansen TV,  Harrington PA,  Hartman M,  Hassan N,  Healey S,  Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON),  Heitz F,  Herzog J,  Høgdall E,  Høgdall CK,  Hogervorst FB,  Hollestelle A,  Hopper JL,  Hulick PJ,  Huzarski T,  Imyanitov EN,  KConFab Investigators,  Australian Ovarian Cancer Study Group,  Isaacs C,  Ito H,  Jakubowska A,  Janavicius R,  Jensen A,  John EM,  Johnson N,  Kabisch M,  Kang D,  Kapuscinski M,  Karlan BY,  Khan S,  Kiemeney LA,  Kjaer SK,  Knight JA,  Konstantopoulou I,  Kosma VM,  Kristensen V,  Kupryjanczyk J,  Kwong A,  de la Hoya M,  Laitman Y,  Lambrechts D,  Le N,  De Leeneer K,  Lester J,  Levine DA,  Li J,  Lindblom A,  Long J,  Lophatananon A,  Loud JT,  Lu K,  Lubinski J,  Mannermaa A,  Manoukian S,  Le Marchand L,  Margolin S,  Marme F,  Massuger LF,  Matsuo K,  Mazoyer S,  McGuffog L,  McLean C,  McNeish I,  Meindl A,  Menon U,  Mensenkamp AR,  Milne RL,  Montagna M,  Moysich KB,  Muir K,  Mulligan AM,  Nathanson KL,  Ness RB,  Neuhausen SL,  Nevanlinna H,  Nord S,  Nussbaum RL,  Odunsi K,  Offit K,  Olah E,  Olopade OI,  Olson JE,  Olswold C,  O'Malley D,  Orlow I,  Orr N,  Osorio A,  Park SK,  Pearce CL,  Pejovic T,  Peterlongo P,  Pfeiler G,  Phelan CM,  Poole EM,  Pylkäs K,  Radice P,  Rantala J,  Rashid MU,  Rennert G,  Rhenius V,  Rhiem K,  Risch HA,  Rodriguez G,  Rossing MA,  Rudolph A,  Salvesen HB,  Sangrajrang S,  Sawyer EJ,  Schildkraut JM,  Schmidt MK,  Schmutzler RK,  Sellers TA,  Seynaeve C,  Shah M,  Shen CY,  Shu XO,  Sieh W,  Singer CF,  Sinilnikova OM,  Slager S,  Song H,  Soucy P,  Southey MC,  Stenmark-Askmalm M,  Stoppa-Lyonnet D,  Sutter C,  Swerdlow A,  Tchatchou S,  Teixeira MR,  Teo SH,  Terry KL,  Terry MB,  Thomassen M,  Tibiletti MG,  Tihomirova L,  Tognazzo S,  Toland AE,  Tomlinson I,  Torres D,  Truong T,  Tseng CC,  Tung N,  Tworoger SS,  Vachon C,  van den Ouweland AM,  van Doorn HC,  van Rensburg EJ,  Van't Veer LJ,  Vanderstichele A,  Vergote I,  Vijai J,  Wang Q,  Wang-Gohrke S,  Weitzel JN,  Wentzensen N,  Whittemore AS,  Wildiers H,  Winqvist R,  Wu AH,  Yannoukakos D,  Yoon SY,  Yu JC,  Zheng W,  Zheng Y,  Khanna KK,  Simard J,  Monteiro AN,  French JD,  Couch FJ,  Freedman ML,  Easton DF,  Dunning AM,  Pharoah PD,  Edwards SL,  Chenevix-Trench G,  Antoniou AC,  Gayther SA
Nat Commun 2016 Sep 7;7:12675
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27601076
PMC ID: PMC5023955

Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials.

Hershman DL,  Till C,  Wright JD,  Awad D,  Ramsey SD,  Barlow WE,  Minasian LM,  Unger J
J Clin Oncol 2016 Sep 1;34(25):3014-22
Major Program(s) or Research Group(s): Office of the Director ;  NCI Community Oncology Research Program
PubMed ID: 27325863
PMC ID: PMC5012713

Alcohol consumption and colon cancer prognosis among participants in north central cancer treatment group phase III trial N0147.

Phipps AI,  Shi Q,  Limburg PJ,  Nelson GD,  Sargent DJ,  Sinicrope FA,  Chan E,  Gill S,  Goldberg RM,  Kahlenberg M,  Nair S,  Shields AF,  Newcomb PA,  Alberts SR,  Alliance for Clinical Trials in Oncology
Int J Cancer 2016 Sep 1;139(5):986-95
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27060850
PMC ID: PMC4911257

Clinical Outcome From Oxaliplatin Treatment in Stage II/III Colon Cancer According to Intrinsic Subtypes: Secondary Analysis of NSABP C-07/NRG Oncology Randomized Clinical Trial.

Song N,  Pogue-Geile KL,  Gavin PG,  Yothers G,  Kim SR,  Johnson NL,  Lipchik C,  Allegra CJ,  Petrelli NJ,  O'Connell MJ,  Wolmark N,  Paik S
JAMA Oncol 2016 Sep 1;2(9):1162-9
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27270348
PMC ID: PMC5065181

Utility of PET-CT to evaluate retroperitoneal lymph node metastasis in advanced cervical cancer: Results of ACRIN6671/GOG0233 trial.

Atri M,  Zhang Z,  Dehdashti F,  Lee SI,  Ali S,  Marques H,  Koh WJ,  Moore K,  Landrum L,  Kim JW,  DiSilvestro P,  Eisenhauer E,  Schnell F,  Gold M
Gynecol Oncol 2016 Sep;142(3):413-9
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27178725
PMC ID: PMC4993667

Exercise Promotion in Geriatric Oncology.

Burhenn PS,  Bryant AL,  Mustian KM
Curr Oncol Rep 2016 Sep;18(9):58
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27484061
PMC ID: PMC5839509

Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trial.

Chen H,  Liu X,  Brendler CB,  Ankerst DP,  Leach RJ,  Goodman PJ,  Lucia MS,  Tangen CM,  Wang L,  Hsu FC,  Sun J,  Kader AK,  Isaacs WB,  Helfand BT,  Zheng SL,  Thompson IM,  Platz EA,  Xu J
Prostate 2016 Sep;76(12):1120-9
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27197965
PMC ID: PMC5501387

Institutional Enrollment and Survival Among NSCLC Patients Receiving Chemoradiation: NRG Oncology Radiation Therapy Oncology Group (RTOG) 0617.

Eaton BR,  Pugh SL,  Bradley JD,  Masters G,  Kavadi VS,  Narayan S,  Nedzi L,  Robinson C,  Wynn RB,  Koprowski C,  Johnson DW,  Meng J,  Curran WJ Jr
J Natl Cancer Inst 2016 Sep;108(9)
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27206636
PMC ID: PMC6059090

Early discharge as a mediator of greater ICU-level care requirements in patients not enrolled on the AAML0531 clinical trial: a Children's Oncology Group report.

Getz KD,  Miller TP,  Seif AE,  Li Y,  Huang YS,  Alonzo T,  Gerbing R,  Sung L,  Hall M,  Bagatell R,  Gamis A,  Fisher BT,  Aplenc R
Cancer Med 2016 Sep;5(9):2412-6
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27474232
PMC ID: PMC5055162

Nurse-Led Programs to Facilitate Enrollment to Children's Oncology Group Cancer Control Trials.

Haugen M,  Kelly KP,  Leonard M,  Mills D,  Sung L,  Mowbray C,  Landier W
J Pediatr Oncol Nurs 2016 Sep;33(5):387-91
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 26611754
PMC ID: PMC5013656

Development and psychometric evaluation of the Decisional Engagement Scale (DES-10): A patient-reported psychosocial survey for quality cancer care.

Hoerger M,  Chapman BP,  Mohile SG,  Duberstein PR
Psychol Assess 2016 Sep;28(9):1087-100
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27537003
PMC ID: PMC4991547

YOCAS©® Yoga Reduces Self-reported Memory Difficulty in Cancer Survivors in a Nationwide Randomized Clinical Trial: Investigating Relationships Between Memory and Sleep.

Janelsins MC,  Peppone LJ,  Heckler CE,  Kesler SR,  Sprod LK,  Atkins J,  Melnik M,  Kamen C,  Giguere J,  Messino MJ,  Mohile SG,  Mustian KM
Integr Cancer Ther 2016 Sep;15(3):263-71
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 26621521
PMC ID: PMC4884662

A systematic review of patient-reported outcome measures of neuropathy in children, adolescents and young adults.

Johnston DL,  Sung L,  Stark D,  Frazier AL,  Rosenberg AR
Support Care Cancer 2016 Sep;24(9):3723-8
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27037813
PMC ID: PMC5241023

Cognition and Cognitive Impairment in Older Adults with Cancer.

Magnuson A,  Mohile S,  Janelsins M
Curr Geriatr Rep 2016 Sep;5(3):213-219
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27547701
PMC ID: PMC4988403

Normative reference values of thoracic aortic diameter in American College of Radiology Imaging Network (ACRIN 6654) arm of National Lung Screening Trial.

McComb BL,  Munden RF,  Duan F,  Jain AA,  Tuite C,  Chiles C
Clin Imaging 2016 Sep-Oct;40(5):936-43
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27203287
PMC ID: PMC5361888

Polypharmacy and potentially inappropriate medication use in geriatric oncology.

Sharma M,  Loh KP,  Nightingale G,  Mohile SG,  Holmes HM
J Geriatr Oncol 2016 Sep;7(5):346-53
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27498305
PMC ID: PMC5037024

Repeated measures analyses of dermatitis symptom evolution in breast cancer patients receiving radiotherapy in a phase 3 randomized trial of mometasone furoate vs placebo (N06C4 [alliance]).

Sio TT,  Atherton PJ,  Birckhead BJ,  Schwartz DJ,  Sloan JA,  Seisler DK,  Martenson JA,  Loprinzi CL,  Griffin PC,  Morton RF,  Anders JC,  Stoffel TJ,  Haselow RE,  Mowat RB,  Wittich MA,  Bearden JD 3rd,  Miller RC
Support Care Cancer 2016 Sep;24(9):3847-55
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27075674
PMC ID: PMC4967382

Xerostomia health-related quality of life: NRG oncology RTOG 0537.

Wyatt G,  Pugh SL,  Wong RK,  Sagar S,  Singh AK,  Koyfman SA,  Nguyen-Tân PF,  Yom SS,  Cardinale FS,  Sultanem K,  Hodson I,  Krempl GA,  Lukaszczyk B,  Yeh AM,  Berk L
Qual Life Res 2016 Sep;25(9):2323-33
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 26914104
PMC ID: PMC4982852

Improving the quality of survivorship for older adults with cancer.

Mohile SG,  Hurria A,  Cohen HJ,  Rowland JH,  Leach CR,  Arora NK,  Canin B,  Muss HB,  Magnuson A,  Flannery M,  Lowenstein L,  Allore HG,  Mustian KM,  Demark-Wahnefried W,  Extermann M,  Ferrell B,  Inouye SK,  Studenski SA,  Dale W
Cancer 2016 Aug 15;122(16):2459-568
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27172129
PMC ID: PMC4974133

Opportunities and challenges in incorporating ancillary studies into a cancer prevention randomized clinical trial.

Goodman PJ,  Tangen CM,  Darke AK,  Arnold KB,  Hartline J,  Yee M,  Anderson K,  Caban-Holt A,  Christen WG,  Cassano PA,  Lance P,  Klein EA,  Crowley JJ,  Minasian LM,  Meyskens FL
Trials 2016 Aug 12;17:400
Major Program(s) or Research Group(s): Office of the Director ;  NCI Community Oncology Research Program
PubMed ID: 27519183
PMC ID: PMC4983010

Lack of Effectiveness of Neutropenic Diet and Social Restrictions as Anti-Infective Measures in Children With Acute Myeloid Leukemia: An Analysis of the AML-BFM 2004 Trial.

Tramsen L,  Salzmann-Manrique E,  Bochennek K,  Klingebiel T,  Reinhardt D,  Creutzig U,  Sung L,  Lehrnbecher T
J Clin Oncol 2016 Aug 10;34(23):2776-83
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27269945
PMC ID: PMC5019758

Correlation Between the Severity of Cetuximab-Induced Skin Rash and Clinical Outcome for Head and Neck Cancer Patients: The RTOG Experience.

Bar-Ad V,  Zhang QE,  Harari PM,  Axelrod R,  Rosenthal DI,  Trotti A,  Jones CU,  Garden AS,  Song G,  Foote RL,  Raben D,  Shenouda G,  Spencer SA,  Harris J,  Le QT
Int J Radiat Oncol Biol Phys 2016 Aug 1;95(5):1346-1354
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27212198
PMC ID: PMC5199017

Dose Specification for NRG Radiation Therapy Trials.

Gladstone DJ,  Kry SF,  Xiao Y,  Chetty IJ
Int J Radiat Oncol Biol Phys 2016 Aug 1;95(5):1344-1345
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27479721
PMC ID: PMC5637531

Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial.

Price DK,  Chau CH,  Till C,  Goodman PJ,  Leach RJ,  Johnson-Pais TL,  Hsing AW,  Hoque A,  Parnes HL,  Schenk JM,  Tangen CM,  Thompson IM,  Reichardt JK,  Figg WD
Cancer 2016 Aug 1;122(15):2332-40
Major Program(s) or Research Group(s): Prostate and Urologic CancerNCI Community Oncology Research Program
PubMed ID: 27164191
PMC ID: PMC4956504

Long-Term Cancer Outcomes From Study NRG Oncology/RTOG 9517: A Phase 2 Study of Accelerated Partial Breast Irradiation With Multicatheter Brachytherapy After Lumpectomy for Early-Stage Breast Cancer.

White J,  Winter K,  Kuske RR,  Bolton JS,  Arthur DW,  Scroggins T,  Rabinovitch RA,  Kelly T,  Toonkel LM,  Vicini FA,  McCormick B
Int J Radiat Oncol Biol Phys 2016 Aug 1;95(5):1460-1465
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27479725
PMC ID: PMC5088493

Factors associated with depressive symptoms in young long-term breast cancer survivors.

Cohee AA,  Stump T,  Adams RN,  Johns SA,  Von Ah D,  Zoppi K,  Fife B,  Monahan PO,  Cella D,  Champion VL
Qual Life Res 2016 Aug;25(8):1991-7
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 26883816
PMC ID: PMC4946980

Anthracycline-Associated T1 Mapping Characteristics Are Elevated Independent of the Presence of Cardiovascular Comorbidities in Cancer Survivors.

Jordan JH,  Vasu S,  Morgan TM,  D'Agostino RB Jr,  Meléndez GC,  Hamilton CA,  Arai AE,  Liu S,  Liu CY,  Lima JA,  Bluemke DA,  Burke GL,  Hundley WG
Circ Cardiovasc Imaging 2016 Aug;9(8)
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27502058
PMC ID: PMC5508215

Did death certificates and a death review process agree on lung cancer cause of death in the National Lung Screening Trial?

Marcus PM,  Doria-Rose VP,  Gareen IF,  Brewer B,  Clingan K,  Keating K,  Rosenbaum J,  Rozjabek HM,  Rathmell J,  Sicks J,  Miller AB
Clin Trials 2016 Aug;13(4):434-8
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27006427
PMC ID: PMC4942331

Impact of race, ethnicity, and BMI on achievement of pathologic complete response following neoadjuvant chemotherapy for breast cancer: a pooled analysis of four prospective Alliance clinical trials (A151426).

Warner ET,  Ballman KV,  Strand C,  Boughey JC,  Buzdar AU,  Carey LA,  Sikov WM,  Partridge AH
Breast Cancer Res Treat 2016 Aug;159(1):109-18
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27449492
PMC ID: PMC5011019

Randomized phase III trial of consolidation therapy with bortezomib-lenalidomide-Dexamethasone (VRd) vs bortezomib-dexamethasone (Vd) for patients with multiple myeloma who have completed a dexamethasone based induction regimen.

Jacobus SJ,  Rajkumar SV,  Weiss M,  Stewart AK,  Stadtmauer EA,  Callander NS,  Dreosti LM,  Lacy MQ,  Fonseca R
Blood Cancer J 2016 Jul 29;6(7):e448
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27471864
PMC ID: PMC5030380

Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial.

Brown PD,  Jaeckle K,  Ballman KV,  Farace E,  Cerhan JH,  Anderson SK,  Carrero XW,  Barker FG 2nd,  Deming R,  Burri SH,  Ménard C,  Chung C,  Stieber VW,  Pollock BE,  Galanis E,  Buckner JC,  Asher AL
JAMA 2016 Jul 26;316(4):401-409
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27458945
PMC ID: PMC5313044

N08C9 (Alliance): A Phase 3 Randomized Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy.

Miller RC,  Petereit DG,  Sloan JA,  Liu H,  Martenson JA,  Bearden JD 3rd,  Sapiente R,  Seeger GR,  Mowat RB,  Liem B,  Iott MJ,  Loprinzi CL,  Alliance for Clinical Trials in Oncology
Int J Radiat Oncol Biol Phys 2016 Jul 15;95(4):1168-74
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27354129
PMC ID: PMC4955745

Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting.

Navari RM,  Qin R,  Ruddy KJ,  Liu H,  Powell SF,  Bajaj M,  Dietrich L,  Biggs D,  Lafky JM,  Loprinzi CL
N Engl J Med 2016 Jul 14;375(2):134-42
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27410922
PMC ID: PMC5344450

Validation of a Prediction Tool for Chemotherapy Toxicity in Older Adults With Cancer.

Hurria A,  Mohile S,  Gajra A,  Klepin H,  Muss H,  Chapman A,  Feng T,  Smith D,  Sun CL,  De Glas N,  Cohen HJ,  Katheria V,  Doan C,  Zavala L,  Levi A,  Akiba C,  Tew WP
J Clin Oncol 2016 Jul 10;34(20):2366-71
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27185838
PMC ID: PMC5321104

Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer.

Lee WR,  Dignam JJ,  Amin MB,  Bruner DW,  Low D,  Swanson GP,  Shah AB,  D'Souza DP,  Michalski JM,  Dayes IS,  Seaward SA,  Hall WA,  Nguyen PL,  Pisansky TM,  Faria SL,  Chen Y,  Koontz BF,  Paulus R,  Sandler HM
J Clin Oncol 2016 Jul 10;34(20):2325-32
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27044935
PMC ID: PMC4981980

Prognostic Impact of the Combination of Recurrence Score and Quantitative Estrogen Receptor Expression (ESR1) on Predicting Late Distant Recurrence Risk in Estrogen Receptor-Positive Breast Cancer After 5 Years of Tamoxifen: Results From NRG Oncology/National Surgical Adjuvant Breast and Bowel Project B-28 and B-14.

Wolmark N,  Mamounas EP,  Baehner FL,  Butler SM,  Tang G,  Jamshidian F,  Sing AP,  Shak S,  Paik S
J Clin Oncol 2016 Jul 10;34(20):2350-8
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27217450
PMC ID: PMC4981975

Randomized Phase II Evaluation of Bevacizumab Versus Bevacizumab Plus Fosbretabulin in Recurrent Ovarian, Tubal, or Peritoneal Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study.

Monk BJ,  Sill MW,  Walker JL,  Darus CJ,  Sutton G,  Tewari KS,  Martin LP,  Schilder JM,  Coleman RL,  Balkissoon J,  Aghajanian C
J Clin Oncol 2016 Jul 1;34(19):2279-86
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27217446
PMC ID: PMC4962710

How Will Big Data Improve Clinical and Basic Research in Radiation Therapy?

Rosenstein BS,  Capala J,  Efstathiou JA,  Hammerbacher J,  Kerns SL,  Kong FS,  Ostrer H,  Prior FW,  Vikram B,  Wong J,  Xiao Y
Int J Radiat Oncol Biol Phys 2016 Jul 1;95(3):895-904
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 26797542
PMC ID: PMC4864183

Lessons From Large-Scale Collection of Patient-Reported Outcomes: Implications for Big Data Aggregation and Analytics.

Sloan JA,  Halyard M,  El Naqa I,  Mayo C
Int J Radiat Oncol Biol Phys 2016 Jul 1;95(3):922-929
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27302508
PMC ID: PMC6544440

The Scientific Impact of Positive and Negative Phase 3 Cancer Clinical Trials.

Unger JM,  Barlow WE,  Ramsey SD,  LeBlanc M,  Blanke CD,  Hershman DL
JAMA Oncol 2016 Jul 1;2(7):875-81
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 26967260
PMC ID: PMC4945370

Effect of Vitamin D Supplementation on Breast Cancer Biomarkers: CALGB 70806 (Alliance) Study Design and Baseline Data.

Apoe O,  Jung SH,  Liu H,  Seisler DK,  Charlamb J,  Zekan P,  Wang LX,  Unzeitig GW,  Garber J,  Marshall J,  Wood M
Am J Hematol Oncol 2016 Jul;12(7):4-9
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 29081880
PMC ID: PMC5656380

Evaluation and Management of Hearing Loss in Survivors of Childhood and Adolescent Cancers: A Report From the Children's Oncology Group.

Bass JK,  Knight KR,  Yock TI,  Chang KW,  Cipkala D,  Grewal SS
Pediatr Blood Cancer 2016 Jul;63(7):1152-62
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 26928933
PMC ID: PMC5520626

Development and Evaluation of an Approach to Using Value of Information Analyses for Real-Time Prioritization Decisions Within SWOG, a Large Cancer Clinical Trials Cooperative Group.

Bennette CS,  Veenstra DL,  Basu A,  Baker LH,  Ramsey SD,  Carlson JJ
Med Decis Making 2016 Jul;36(5):641-51
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27012232
PMC ID: PMC5963256

Selenium- or Vitamin E-Related Gene Variants, Interaction with Supplementation, and Risk of High-Grade Prostate Cancer in SELECT.

Chan JM,  Darke AK,  Penney KL,  Tangen CM,  Goodman PJ,  Lee GM,  Sun T,  Peisch S,  Tinianow AM,  Rae JM,  Klein EA,  Thompson IM Jr,  Kantoff PW,  Mucci LA
Cancer Epidemiol Biomarkers Prev 2016 Jul;25(7):1050-1058
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27197287
PMC ID: PMC5086806

Interventions to improve the quality of life and survivorship of older adults with cancer: The funding landscape at NIH, ACS and PCORI.

Flannery M,  Mohile SG,  Dale W,  Arora NK,  Azar L,  Breslau ES,  Cohen HJ,  Dotan E,  Eldadah BA,  Leach CR,  Mitchell SA,  Rowland JH,  Hurria A
J Geriatr Oncol 2016 Jul;7(4):225-33
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27197917
PMC ID: PMC4969185

Survivorship care for older adults with cancer: U13 conference report.

Guerard EJ,  Nightingale G,  Bellizzi K,  Burhenn P,  Rosko A,  Artz AS,  Korc-Grodzicki B,  Canin B,  Dale W,  Ferrell B
J Geriatr Oncol 2016 Jul;7(4):305-12
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27424802
PMC ID: PMC4969136

Prostate Cancer Susceptibility in Men of African Ancestry at 8q24.

Han Y,  Rand KA,  Hazelett DJ,  Ingles SA,  Kittles RA,  Strom SS,  Rybicki BA,  Nemesure B,  Isaacs WB,  Stanford JL,  Zheng W,  Schumacher FR,  Berndt SI,  Wang Z,  Xu J,  Rohland N,  Reich D,  Tandon A,  Pasaniuc B,  Allen A,  Quinque D,  Mallick S,  Notani D,  Rosenfeld MG,  Jayani RS,  Kolb S,  Gapstur SM,  Stevens VL,  Pettaway CA,  Yeboah ED,  Tettey Y,  Biritwum RB,  Adjei AA,  Tay E,  Truelove A,  Niwa S,  Chokkalingam AP,  John EM,  Murphy AB,  Signorello LB,  Carpten J,  Leske MC,  Wu SY,  Hennis AJM,  Neslund-Dudas C,  Hsing AW,  Chu L,  Goodman PJ,  Klein EA,  Zheng SL,  Witte JS,  Casey G,  Lubwama A,  Pooler LC,  Sheng X,  Coetzee GA,  Cook MB,  Chanock SJ,  Stram DO,  Watya S,  Blot WJ,  Conti DV,  Henderson BE,  Haiman CA
J Natl Cancer Inst 2016 Jul;108(7)
Major Program(s) or Research Group(s): Cancer Prevention Fellowship ProgramNCI Community Oncology Research Program
PubMed ID: 26823525
PMC ID: PMC4948565

Understanding cognition in older patients with cancer.

Karuturi M,  Wong ML,  Hsu T,  Kimmick GG,  Lichtman SM,  Holmes HM,  Inouye SK,  Dale W,  Loh KP,  Whitehead MI,  Magnuson A,  Hurria A,  Janelsins MC,  Mohile S
J Geriatr Oncol 2016 Jul;7(4):258-69
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27282296
PMC ID: PMC4969091

Designing exercise clinical trials for older adults with cancer: Recommendations from 2015 Cancer and Aging Research Group NCI U13 Meeting.

Kilari D,  Soto-Perez-de-Celis E,  Mohile SG,  Alibhai SM,  Presley CJ,  Wildes TM,  Klepin HD,  Demark-Wahnefried W,  Jatoi A,  Harrison R,  Won E,  Mustian KM
J Geriatr Oncol 2016 Jul;7(4):293-304
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27197916
PMC ID: PMC4969104

Margin reduction from image guided radiation therapy for soft tissue sarcoma: Secondary analysis of Radiation Therapy Oncology Group 0630 results.

Li XA,  Chen X,  Zhang Q,  Kirsch DG,  Petersen I,  DeLaney TF,  Freeman CR,  Trotti A,  Hitchcock Y,  Bedi M,  Haddock M,  Salerno K,  Dundas G,  Wang D
Pract Radiat Oncol 2016 Jul-Aug;6(4):e135-e140
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 26852173
PMC ID: PMC4870138

Chemotherapy-related cognitive impairment in older patients with cancer.

Loh KP,  Janelsins MC,  Mohile SG,  Holmes HM,  Hsu T,  Inouye SK,  Karuturi MS,  Kimmick GG,  Lichtman SM,  Magnuson A,  Whitehead MI,  Wong ML,  Ahles TA
J Geriatr Oncol 2016 Jul;7(4):270-80
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27197918
PMC ID: PMC4969145

Geriatric assessment with management in cancer care: Current evidence and potential mechanisms for future research.

Magnuson A,  Allore H,  Cohen HJ,  Mohile SG,  Williams GR,  Chapman A,  Extermann M,  Olin RL,  Targia V,  Mackenzie A,  Holmes HM,  Hurria A
J Geriatr Oncol 2016 Jul;7(4):242-8
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 27197915
PMC ID: PMC4969156

A comparison of discharge strategies after chemotherapy completion in pediatric patients with acute myeloid leukemia: a report from the Children's Oncology Group.

Miller TP,  Getz KD,  Kavcic M,  Li Y,  Huang YS,  Sung L,  Alonzo TA,  Gerbing R,  Daves M,  Horton TM,  Pulsipher MA,  Pollard J,  Bagatell R,  Seif AE,  Fisher BT,  Gamis AS,  Aplenc R
Leuk Lymphoma 2016 Jul;57(7):1567-74
Major Program(s) or Research Group(s): NCI Community Oncology Research Program